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Abstract 
 Increased levels of blood glucose are associated with the vascular complications 
of diabetes. Microvascular complications lead to delayed wound healing in patients 
suffering from diabetes. Hypoxia and hyperglycaemia characterise a wound environment 
of a person with diabetes. Angiogenesis is central to restore the supply of oxygen and 
nutrients to the wounded tissue. Endothelial cell migration is central to angiogenesis which 
is aided by hypoxia and attenuated by hyperglycaemia. However, the molecular 
mechanisms underlying the disruption to angiogenesis of diabetic wounds are not 
completely understood. The effect of hypoxia and/or high glucose concentration on the 
endothelial cell migration in vitro was studied and an anti-oxidant, silymarin formulated as 
freeze dried wafer discs was tested for its beneficial effect.  
A radial migration and a wound healing assay were developed, validated and used 
to assess the effect of hypoxia and/or high glucose concentration on the migration of 
human endothelial cells of dermal origin. Circular and semi-circular monolayers of 
endothelial cells were used for the measurement of the migration by radial migration and 
wound healing assay respectively. Net migration was calculated by subtracting the radii at 
a specified time point from that measured at time zero. The migration was studied under 
normal (20%) or below (5%) normal oxygen tension in combination with normal (5mM) or 
high (20mM) glucose concentration. Endothelial cells were treated with an anti-
proliferative agent, intracellular signal inhibitors and silymarin.  
Results demonstrated that hypoxia and high glucose concentration have opposing 
effects of increase (p<0.001) and decrease (p<0.001) respectively on the migration of 
endothelial cells. The results of the wound healing assay revealed that re-
endothelialisation occurs faster (p<0.001) than endothelialisation. The effects of hypoxia 
and high glucose concentration appeared to be mediated via PI3K-Akt and PKCβII 
pathways respectively. Further investigations revealed the possibility of HIF-1α being 
involved in both the pathways. High glucose concentration-induced decrease in cell 
migration was successfully restored (p<0.001) by the use of an anti-oxidant silymarin. This 
could be due to anti-oxidant activity of silymarin on glucose-induced overproduction of 
reactive oxygen species. Silymarin formulated as freeze dried wafer discs, sterilised by 
gamma irradiation was successful in retaining its effect (p<0.001) against the high glucose 
impaired cell migration compared to control wafers. 
In conclusion, delayed wound healing due to disrupted endothelial cell migration 
was reaffirmed to be due to elevated glucose concentration. Silymarin was successful in 
restoring glucose-induced attenuation of cell migration. Freeze dried wafers show 
promising potential as a topical application for the treatment of chronic wounds for people 
with diabetes. 
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Diabetes is a debilitating disease and whose incidence has increased significantly 
in recent years. The associated vascular complications remain a major cause of morbidity 
and mortality within this patient group. Central to vascular complications are the 
endothelial cells that line or form the basis of a blood vessel as these cells are exposed to 
high and/or fluctuating concentration of glucose and reduced oxygen availability that are 
associated with diabetes. The focus of this study is to establish an in vitro model of wound 
healing in order to investigate the key parameters of endothelial cell growth, migration 
and/or proliferation that are affected by elevated glucose concentration and reduced 
oxygen availability. The role of silymarin in the amelioration of the condition and the 
development of a novel silymarin formulation for topical application are part of this study. 
In this first chapter the rationale and the context of the existing work is explored in order to 
demonstrate the integrity and feasibility of the study and the conclusions that have been 
made. 
1.1 Diabetes Mellitus 
The International diabetes federation (IDF) defines diabetes mellitus as ‘‘a group of 
heterogeneous disorders with the common elements of hyperglycaemia and glucose 
intolerance, due to insulin deficiency, impaired effectiveness of insulin action, or both’’ 
(International Diabetes Federation 2009). The current WHO criteria for diagnosis of 
diabetes include fasting plasma glucose level at ≥7.0mmol/L (120mg/dL) or 2-h after 75g 
oral glucose load challenge with plasma glucose at ≥11.1mmol/L (200mg/dL) (World 
Health Organisation Consultation 2006). 
Diabetes currently affects approximately 285 million adults worldwide (i.e. 6.6% of 
world population), 70% of whom belong to the developing world. It is expected that 
diabetes will affect 439 million adults (7.8% of world population) by 2030. Presently, one 
million more women than men are estimated to suffer from diabetes and this difference is 
likely to go up to six million by 2030 (International Diabetes Federation 2009). Diabetes is 
the fourth or fifth leading cause of global death by disease in the developed world with 
approximately four million deaths, accounting for around 6.8% of global all-cause mortality 
each year. The high mortality is estimated to be from India, China, USA and Russia as 
there is a larger population size and thus relatively more people suffering from diabetes 
(International Diabetes Federation 2009). 
Diabetes is one of the largest non-communicable diseases, imposing heavy 
economic burden on individuals, families, health systems and nations with an expected 
11.6% of a total global healthcare expenditure spent on it. Today, the estimated global 
healthcare expenditure is 360 billion United States Dollars (USD). This is expected to 
increase to 490 billion USD by 2030. However, there is a huge disparity in the money 
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spent on diabetes by different countries, with USA spending the majority and countries 
like India, Burundi and Myanmar spending meagre amount of total global spending 
(International Diabetes Federation 2009). The economic implications of this are of greater 
significance if lost productivity and the consequent loss of national income are included in 
the finances.  
Etiologically, diabetes mellitus is classified into type 1 diabetes mellitus (T1DM) 
and type 2 diabetes mellitus (T2DM) which were previously known as insulin dependent 
diabetes mellitus (IDDM) and non insulin dependent diabetes mellitus (NIDDM) 
respectively. Type 1 diabetes, primarily considered to be an autoimmune disorder, is a 
result of lack of insulin due to the destruction of beta cells from the islets of Langerhans in 
the pancreas, and type 2 diabetes is a result of insulin resistance and/or insulin 
insufficiency (Balkau and Eschwege 2003). Gestational diabetes and other specific types 
like genetic defects of β-cell function, genetic defects of insulin action, disease of exocrine 
pancreas, endocrinopathies, drug- or chemical- or infection-induced, uncommon forms of 
immune-mediated diabetes and other genetic syndromes associated with diabetes are 
also recognized (Balkau and Eschwege 2003). 
Acute complications of T1DM include ketosis, ketoacidosis, hypoglycemic 
episodes, hyperglycemic crises and infections (Slama Gerard 2003). Later complications 
include retinopathy, cataract, nephropathy (renal insufficiency and hypertension), 
neuropathy (polyneuropathy, mononeuropathy, foot ulcers and impotence), cardiovascular 
complications (macro vascular disorders like coronary heart disease, cerebrovascular 
disease, and peripheral vascular disease), skin disorders (infections, mycosis, 
lipodystropy) and psychosocial disorders like depression (Slama Gerard 2003). The 
complications of T2DM are similar to those of T1DM although prevalence of respective 
complications does vary. Blindness due to proliferative retinopathy and risk of 
development of end stage renal disease are low in T2DM compared to T1DM patients. On 
the other hand, the rate of mortality due to cardiovascular diseases is high in T2DM 
compared to T1DM patients (Katsilambros and Tentolouris 2003). 
The Diabetes Control and Complication Trial (DCCT) and the United Kingdom 
Prospective Diabetes Study (UKPDS) were two milestone studies conducted in the USA 
and UK respectively on diabetes and its complications. The DCCT was a multi-centre (29 
centres) randomized clinical trial conducted during 1983 to 1993 and involved 1,441 
patients suffering from type 1 diabetes for a minimum of a year to a maximum of 15 years. 
After 1993, the follow up study called Epidemiology of Diabetes Interventions and 
Complications (EDIC) was continued with more than 90% patients of DCCT. The EDIC 
trial continues to study the incidences of CVS and other diabetes related complications 
(National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2008). The 
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DCCT has shown that intense therapy of adjusted doses of insulin with diet and exercise 
reduced the risks of developing complications compared with conventional therapy of 
unadjusted doses of insulin with only education about diet and exercise. Intensive therapy 
reduced the development of proliferative or non severe retinopathy by 47% and clinical 
neuropathy by 60%. The risk of albuminurea and microalbumin urea was reduced by 54 
and 39% respectively indicating dramatic risk reduction in nephropathy in patients 
receiving intensive insulin therapy compared with conventional therapy (DCCT Group 
1993). The follow-up study, EDIC, showed that there was a reduction in cardiovascular 
events by 42% and nonfatal myocardial infraction, stroke or death from diabetes by 57% 
in the intensive insulin therapy group (DCCT/EDIC Study Research Group et al. 2005). 
The UKPDS was designed and conducted between 1977 to 1997 by Professor 
Robert Turner and Rury Holman of diabetes trial unit of Oxford University. It was a 
multicentre (23 UK clinical sites) trial involving randomized glucose therapies in 5,102 
newly diagnosed type 2 diabetes patients (Diabetes Trials Unit 2010a). The post trial 
monitoring ran for another ten years until 2007 with all the surviving patients of UKPDS 
trial (Diabetes Trials Unit 2010b). The UKPDS was conducted in T2DM patients over a 
period of 10 years with the patients assigned to either intense glucose control with 
sulphonylurea or with insulin or conventional glucose control through diet. Haemoglobin 
A1c (HbA1c), any diabetes related deaths and microvascular endpoints were lower by 11, 
10 and 25% respectively in the group receiving intense therapy compared to their 
counterparts assigned to conventional glucose control treatment of dietary restrictions 
(UKPDS Group 1998). The UKPDS post trial monitoring study indicated that although the 
reduction in HbA1c was lost after a year, the reductions in the risk of diabetes related 
deaths and microvascular complications continued in the intensive glucose therapy group 
(Holman et al. 2008). These reports conclusively suggest that the prolonged exposure to 
hyperglycaemia is a primary causal factor in the development of vascular and other 
complications of diabetes. 
1.2 Vascular complications of Diabetes 
1.2.1 Macrovascular complications 
Macrovascular complications of diabetes include coronary heart disease (CHD), 
stroke, myocardial infarction and peripheral vascular disorders. The CHD in patients 
suffering from diabetes may result due to a number of risk factors including hypertension, 
hyperglycaemia and effects of advanced glycation end (AGE) products, dyslipidemia, 
microvascular disease and autonomic neuropathy (Adler et al. 2002). Dyslipidemia is 
thought to be a major contributory risk factor for CHD. In T1DM increased lipolysis and 
overproduction of non esterified fatty acids, and decreased activity of lipoprotein lipase 
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results in hypertriglyceridemia which acts as a risk factor. In T2DM, dyslipidemia is a 
result of raised triglycerides, decreased high density lipoproteins (HDL), raised low density 
lipoproteins (LDL) and increased levels of apolipoprotein B (apoB), an integral part of very 
low density lipoprotein (VLDL) (Poirier and Despres 2003). Hypertension is another major 
risk factor which worsens both macro and microvascular complications in diabetes. Insulin 
resistance associated with T2DM contribute to hypertension by loss of insulin’s normal 
vasodilator activity or through effects of accompanying hyperinsulinaemia (Kashyap and 
Defronzo 2007). Furthermore atheroma is known to develop earlier and faster in diabetes 
causing widespread lesions throughout the arterial walls (Renard et al. 2004). 
1.2.2 Microvascular complications 
1.2.2.1 Diabetic Retinopathy 
Diabetic retinopathy results from damage to the microvasculature of the retina. 
Retinal vessels consist of an inner layer of endothelial cells covered by a protein-
proteoglycan basement membrane and contractile pericytes. Hyperglycaemia is known to 
be the major causative factor for retinopathy causing damage to all the three parts of 
retinal vessels (Knott and Forrester 2003). Hyperglycaemia increases the auto-oxidation, 
polyol pathway flux and diacylglyerol (DAG) synthesis (reviewed in Knott and Forrester 
2003). The auto-oxidation and polyol pathway lead to the formation of free radicals due to 
depletion of two major non-enzymatic anti-oxidants glutathione and ascorbate, and this 
deleterious effect of glucose on the retina could be overcome by treatment of antioxidants 
(Knott and Forrester 2003, Obrosova et al. 2005). Higher glucose levels also cause de-
novo synthesis of DAG leading to activation of the protein kinase C (PKC) pathway which 
may lead to an increase in the expression of vascular endothelial growth factor (VEGF) 
and increased production of endothelin-1 causing increased vascular permeability, 
vasoconstriction and ischemia respectively (Idris and Donnelly 2006, Matsuo et al. 2009, 
Park et al. 2000). Studies have suggested that endothelial cells (EC) and pericytes 
undergo apoptosis in hyperglycaemic conditions leading to the structural and functional 
alterations of retinal blood vessels (Kowluru  2005). Interestingly, when co-cultured, retinal 
endothelial cells proliferated and pericytes underwent apoptosis in the presence of 
elevated glucose level and this was attenuated by fidarestat, an antioxidant (Takamura et 
al. 2008). Apoptosis of retinal endothelial cells in hyperglycaemia has been linked to 
mitochondrial fragmentation with decreased oxygen consumption (Trudeau et al.  2010). 
Hyperglycaemia leading to the formation of advanced glycation end products (AGEs) is 
also known to cause the thickening of the basement membrane altering its barrier 
functions (Gardiner, Anderson and Stitt  2003). 
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1.2.2.2 Diabetic Nephropathy  
In diabetic nephropathy both the glomerulus and the tubular interstitium are 
affected. The glomerulus consists of a tuft of around 20 to 30 capillary loops supported by 
mesengium made up of cells and matrix. The lumen of the capillary loop consists of 
fenestrated endothelial cells lying on basement membrane and podocytes on the 
extraluminal side. Hyperglycaemia causes expansion of the mesengium and basement 
membrane thickening due to synthesis and accumulation of extracellular matrix (Wolf, 
Chen and Ziyadeh 2005). The hypertrophy of renal and glomerular cells and podocytes, 
hyaline deposits, glomerular sclerosis and tubulointerstitial fibrosis are also associated 
with diabetic nephropathy (Herbach et al. 2009). The expansion of glomerular mesengium 
leads to a decrease in the glomerular filtration rate and development of protienuria (Gnudi, 
Gruden and Viberti 2003, Wolf 2002). Some patients with diabetes do not develop 
nephropathy even though the hyperglycaemia is a known factor in the development of 
renal damage (Gnudi, Gruden and Viberti 2003). Other factors like increased glomerular 
capillary pressure, proteinuria on its own and hypertension are known to contribute 
towards the development of diabetic nepropathy (Gnudi, Gruden and Viberti 2003).  
The mediators of hyperglycaemia induced nephropathy are thought to result from 
a change in the expression of growth factors such as transforming growth factor–β1 (TGF- 
β1), connective tissue growth factor (CTGF), insulin like growth factor (IGF), VEGF and 
angiotensin -2 (Gnudi, Gruden and Viberti 2003). The intracellular signalling pathways that 
have been associated with diabetic nephropathy include the activation of PKC and 
mitogen activated protein kinase (MAPK) pathways along with transcription factors such 
as nuclear factor–kβ (NF–kβ) and activator protein–1 (Toyoda et al. 2004). The enhanced 
expression of janus kinase/signal transducer and activator of transcription (JAK/STAT) 
has also been implicated in the progression of diabetic nephropathy (Berthier et al. 2009, 
Marrero et al. 2006). The biochemical mechanisms of glucose toxicity are discussed 
further in section 1.5. 
1.2.2.3 Diabetic Neuropathy 
 Diabetes mellitus causes peripheral neuronal degeneration leading to diabetic 
neuropathies. Distal symmetrical polyneuropathies (DSPs) and focal and multifocal 
neuropathies are two main categories of diabetic neuropathies. The third category, 
entrapment neuropathies are highly prevalent in patients suffering from diabetes although 
they are seen also in non-diabetic patients.  The DSPs are nerve length dependant, hence 
severely affect the nerves of feet and contribute towards the development of foot ulcers. 
Focal neuropathies are acute and cause damage to single nerves or bundles of single 
nerves, usually in isolation and independent of other complications of diabetes. The early 
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manifestations of DSPs include abnormal sensations followed by sensory loss, 
anaesthesia, paraesthesia, allodynia and hyperalgesia. The loss of thermal sensation is 
due to damage to the small fibres and loss of sensation of touch, pressure, joint position 
and vibration are due to damage to the longer fibres (Tomlinson 2003). Hyperglycaemia 
causes the loss of proliferation and migration of Schwann cells and regeneration of axons 
contributing towards diabetic neuropathy (Gumy, Bampton and Tolkovsky 2008). The 
biochemical pathways, due to oxidative stress, responsible for diabetic complications 
including neuropathy involve advanced glycation endproducts/receptor for advanced 
glycation endproducts (AGE/RAGE), polyol pathway, hexosamine pathway, PKC pathway, 
poly-ADP ribose polymerase pathway (PARP) and inflammation (Figueroa-Romero, 
Sadidi and Feldman 2008) are detailed in section 1.5.  
1.3 Impaired wound healing of diabetes  
The chronic wounds of diabetes are another set of daunting challenges of 
microvascular complications. The wound healing process involves four continuous and 
overlapping phases of coagulation, inflammation, migration-proliferation (including matrix 
deposition) and remodelling (Falanga 2005, Guo and Dipietro 2010). Initial phases of 
coagulation and inflammation set in early after injury. The formation of the fibrin plug helps 
in recruiting the inflammatory cells to the site of injury. The aggregated platelets at the site 
of injury release a range of growth factors such as platelet-derived growth factor (PDGF), 
TGF-β1, epidermal growth factor (EGF) and proinflammatory cytokines like interlukin – 1 
(IL – 1) (reviewed in Barrientos 2008). The release of growth factors help in the 
recruitment of neutrophils and macrophages to the wound site. The neutrophils 
decontaminate the wound site by phagocytosising the bacteria and with help of 
macrophages, augment the inflammatory response and tissue debridement. Further, 
neutrophils and macrophages release various growth factors like EGF, TGF – β, PDGF, 
fibroblast growth factor (FGF) and cytokines like IL – 1α and β, IL – 6, IL – 8 and tissue 
necrosis factor - 1α (TNF-1α) (Christian et al. 2006, Hubner et al. 1996). These secretions 
activate fibroblasts and keratinocytes which help in the development of tissue granulation 
(reviewed in Barrientos et al. 2008, Martin 1997). The newly recruited monocytes 
differentiate into macrophages and degrade extracellular matrix by producing enzymes 
such as hyaluronidase, elastase and collagenase which degrade hyaluronic acid, elastin 
and collagen in connective tissue (Christian et al. 2006). This process helps in the 
migration of keratinocytes, fibroblasts and endothelial cells to the site of wound.   
Decreased oxygen tension (hypoxia) at the site of wound, due to injury to the 
blood vessels immediately after wounding, is essential for the progression of wound 
healing process. Hypoxia activates the migration of keratinocytes in order to re-epithelise 
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the epidermal tissue by secretion of extracellular matrix proteins (Fitsialos et al. 2008, 
Woodley et al. 2009). Hypoxia also enhances the migration and proliferation of fibroblasts 
through the expression of hypoxia inducible factor - 1α (HIF-1α) and the consequent 
secretion of growth factors like VEGF and matrix metalloproteinases (MMPs) (Lerman et 
al. 2003, Mace et al. 2007). The fibroblasts play a crucial role during the wound healing 
process of extracellular matrix deposition and remodelling. Hypoxia is also essential for 
the migration of endothelial cells in order to form new blood vessels out of the pre-existing 
ones at the site of injury (Im et al. 2009, Wang et al. 2009). However, exposure of 
endothelial cells to hypoxia and hyperglycaemia is known to cause endothelial cell DNA 
damage which was attenuated by treating with the antioxidant, Silymarin (Weidmann et al. 
2005). The positive effect of the antioxidant illustrates the key role that oxidative damage 
has in this process. The migration and proliferation of these cells and the presence of the 
cocktail of growth factors and cytokines at the site of injury help the wound healing 
process to progress to the next stage. 
The events of migration and proliferation during wound healing are important as 
the migration of keratinocytes and fibroblasts to the wound site is due to the secretions of 
pro-migratory cocktail of growth factors and cytokines. The restoration of supply of oxygen 
and nutrients due to angiogenesis play an important preparatory role for the wound 
closure. The collagen, fibronectin and growth factors such as CTGF secreted by 
fibroblasts aid the formation of the extracellular matrix (Qiu, Kwon and Kamiyama 2007, 
Thomson et al. 2010). Myofibroblasts, a specialised form of fibroblasts which express α-
smooth muscle actin, facilitate the wound closure with help of focal adhesion proteins by 
contracting the extracellular matrix (Leask et al. 2008). Finally, the formation of extra 
cellular matrix at the beginning and later its degradation by serine proteases and MMPs 
assist in the remodelling of the wound healing process (Christiansen et al. 2007, Thomson 
et al. 2010). 
The presence of diabetes is reported to impair all of the phases of wound healing 
outlined above. These phases are shown in the following table (Table 1), which also 
summarises the main events during each phase with key cells (Falanga 2005). The 
functional changes responsible for the vascular complications of recalcitrant wounds of 
diabetes are known to be due to three main factors - endothelial dysfunction, smooth 
muscle cell dysfunction and impairment of the nerve-axon reflex (Dinh and Veves 2005). 
The endothelial function/dysfunction is dealt in detail in the following section. 
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Table 1.1: Phases of wound healing Major types of cells involved in each phase with 
selected specific events of wound healing (Adapted from Falanga 2005). 
 
Time Phases Main cell types Specific events 
 
 
 
 
 
 
Hours 
Coagulation 
Fibrin plug formation, release 
of growth factors, cytokines, 
hypoxia 
 
 
Platelets 
 
 
Neutrophils, 
monocytes 
Platelet aggregation, 
release of fibrinogen 
fragments and other 
proinflammatory 
mediators 
 
Selectins slow down 
 Inflammation 
Cell recruitment and 
chemotaxis, wound 
debriment 
 
 
 
 
 
 
 
Macrophages 
blood cells and binding to 
integrins - diapedesis 
Days 
 
 
 
 
Migration/proliferation 
Epidermal resurfacing, 
fibroplasia, angiogenesis, 
ECM deposition, contraction 
 
 
Keratinocytes, 
fibroblasts, 
endothelial 
cells 
Hemidesmosome 
breakdown- Keratinocyte                   
migration 
 
 
 
Weeks 
to 
months 
 
 
 
 
Remodelling 
Scar formation and revision, 
ECM degradation, further 
contraction and tensile 
strength 
 
Myofibroblasts 
Cross talk between 
MMPs, integrins, cells, 
cytokines - Cell migration,                                          
ECM production 
 
Phenotypic switch to 
myofibroblasts from 
fibroblasts 
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1.4 Diabetes and the endothelium 
The endothelium is an active inner monolayer of the blood vessels and participates 
in many homeostatic mechanisms. Different responses of the endothelium to intrinsic and 
extrinsic factors are observed due to the phenotypic variations observed in endothelial 
cells (ECs) at different vascular sites. The lining of ECs from the liver, spleen and bone 
marrow sinusoids is discontinuous so that nutrients and other macro molecules can pass 
through the intercellular gaps. The retina and brain are lined with continuous ECs to 
maintain the blood retinal and brain barrier respectively, while the endocrine glands and 
kidneys are lined with fenestrated ECs that facilitate selective permeability (Cines et al. 
1998). ECs also differ with respect to the genes expressed that may be classified 
depending on whether they are constitutively or inducibly expressed. Many extracellular 
signals like hypoxia, hemodynamic forces, chemokines and cytokines, growth factors, 
hormones, glucose, lipoproteins, and drugs alter transcription of specific genes and bring 
about various functional changes (Minami and Aird 2005). 
Endothelial dysfunction has increasingly been implicated in the vascular diseases 
as it is known to play a central role in both micro and macro vascular complications of 
diabetes (Rask-Madsen and King 2007, Tesfamariam and DeFelice 2007). Endothelium 
regulates the vascular tone by secreting vasodilators and vasoconstrictors. The presence 
of diabetes impairs the vascular tone by upsetting the balance between vasodilators and 
vasoconstrictors (Schalkwijk and Stehouwer 2005). The vasodilator agents such as nitric 
oxide (Victor et al. 2009), endothelium derived hyperpolarisation factor (EDHF) (Hosoya et 
al. 2010) and prostacyclins (Wotherspoon et al. 2005) and vasoconstrictor agents such as 
endothelin I and angiotensin II (Kobayashi et al. 2008) secreted by endothelium help in 
maintaining the vascular tone. 
Platelet adhesion and aggregation is regulated by the balance between pro and 
anti-aggregants. Prostacyclin (PGI2) and nitric oxide (NO) prevent platelet adherence to 
endothelium and platelet adhesion and aggregation involve phosphorylation by cAMP and 
cGMP dependant protein kinases respectively (Dunn and Grant 2005). The balance 
between coagulation and fibrinolysis is impaired by diabetes, otherwise well regulated by 
endothelium with the help of thrombomodulin/protein C, heparan sulphate/antithrombin, 
tissue factor/tissue factor inhibitor interactions, tissue-type plasminogen activator (t-PA) 
and plasminogen activator inhibitor-1 (PAI-1) (Schalkwijk and Stehouwer 2005, Stegenga 
et al. 2006, Stegenga et al. 2008). The level of cellular fibronectin was elevated in patients 
with diabetes indicating the disruption to the subendothelial matrix due to the damage to 
the endothelium by glucotoxicity (Kanters et al. 2001). 
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The endothelium plays a vital role in the inflammatory process by recruiting 
neutrophils, monocytes/macrophages and lymphocytes to the site of inflammation. The 
neutrophils initiate inflammation reaction by secreting a variety of destructive enzymes like 
myeloperoxidase, elastase, matrix metalloproteases and cathespins (Kaneider, Leger and 
Kuliopulos 2006). The exposure of endothelium to inflammatory agents increases the 
production of selectins, cell adhesion molecules (CAMs) and other cytokines which help in 
the rolling, tethering, adhesion and transmigration of leukocytes (Kubes, Suzuki and 
Granger 1991, Ulbrich, Eriksson and Lindbom 2003). Normal endothelial function is 
summarized in the following figure (Figure 1.1). 
 
 
 
 
Figure 1.1: Physiological functions of endothelium Endothelial cells perform important 
functions in the body. Endothelium A) acts as a semi permeable barrier for the transport of 
various proteins and other soluble molecules; B) maintains the haemostatic balance and 
regulates the coagulation; C) facilitates leukocyte extravasation during inflammation; D) 
actively participates in angiogenesis.  
EC, endothelial cells; IgSF, Ig superfamily; PAI-1, plasminogen activator inhibitor; PBMC, 
peripheral blood mononuclear cells; sLex, sialyl Lewis X; TFPI, Tissue Factor pathway 
inhibitor; TM, thrombomodulin 
(Reproduced with permission from Griffioen and Molema 2000). 
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Endothelial cells exposed to high concentration of glucose in vitro increase the 
production of extra cellular matrix components such as collagen and fibronectin, and of 
procoagulant proteins such as vWF and tissue factor. Due to the increase in the 
production of these factors, hyperglycaemia decreased the proliferation, migration and 
fibrinolytic potential of cells and has been reported to increase apoptosis (Baumgartner-
Parzer et al. 1995b, Boeri et al. 1989, Cagliero et al. 1988, Graier et al. 1995, Maiello et 
al. 1992, McGinn et al. 2003b). During diabetes, hyperaggregability of platelets coupled 
with activation of leukocytes and increased expression of adhesion molecules on 
endothelial cells (Ouedraogo et al. 2007) disrupts the homeostasis and may lead to 
protracted inflammation resulting in a chronic wound. In patients with diabetic retinopathy, 
lymphocytes were activated with reduced expression of surface L-selectin but increased 
circulation of L-selectin resulting in an increase in the adhesion of leukocytes (MacKinnon, 
Knott and Forrester 2004). Incubation of HUVECs with 25mM glucose induced the 
expression of P-selectin and intercellular adhesion molecule – 1 (ICAM-1), which was 
reversed by the addition of 1nM insulin and anti-P-selectin monoclonal antibody implying 
that the activation of ECs leads to the adhesion of monocytes in high glucose 
concentration (Puente Navazo et al. 2001). In vitro exposure of ECs to hyperglycaemia 
resulted in the induction of E-selectin, vascular cell adhesion molecule – 1 (VCAM-1), 
ICAM-1 and endothelial leukocyte adhesion molecule-1 (ECAM-1) mediated by a cytokine 
tissue necrosis factor – α (TNF-α), NF-kB and PKC (Altannavch et al. 2004, Morigi et al. 
1998). 
A large number of studies show that high glucose concentration causes adverse 
changes indirectly in endothelial cell function by impairing the synthesis of growth factors 
and vasoactive agents in other cells. Various growth factors like VEGF, PDGF, TGF- , 
IGF, bFGF, NGF, EGF and others have been reported to play a role in vascular 
complications of diabetes (Kofler, Nickel and Weis 2005). In human retinal endothelial 
cells (HREC) glucose up-regulated the production of TGF-β1 at 15mM concentration, and 
TGF-β1 mRNA and TGF-β receptors expression showed glucose dependant and time 
dependant changes (Pascal, Forrester and Knott 1999) suggesting a role for growth 
factors in advancing diabetic retinopathy. The expression of growth factors by leukocytes 
may also be altered by diabetes. In leukocytes of patients with diabetic retinopathy, the 
expression of VEGF121 and VEGF165-189 mRNA was found to be lower at the early stage of 
the disease compared to increased levels at later stage (Knott et al. 1999).  This increase 
in the level of transcription of the mRNA could result in a higher level of VEGF expression 
leading to neovascularisation aggravating the complications of retinopathy. Increased 
expression of VEGF protein has also been shown to be associated with retinal disease by 
aggravating the fibrosis by inducing the expression of CTGF genes via PI3K-Akt pathway 
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(Suzuma et al. 2000). Furthermore insulin resistance, hyperinsulinemia, dyslipidemia or 
hyperlipidemia, hypertension, impaired fibrinolysis and abdominal obesity are implicated in 
the development of T2DM and cause endothelial dysfunction either directly or indirectly 
(Cacicedo et al. 2004, Schalkwijk and Stehouwer 2005). 
1.5 Mechanisms of diabetic complications 
 Chronic hyperglycaemia in persons with diabetes increases the intracellular 
concentration of glucose in certain cells such as endothelial cells, mesangial cells and 
neurons and Schwann cells of peripheral nerves (Berthier et al. 2009, Gumy, Bampton 
and Tolkovsky 2008). The rate of glucose transport is similar in all the above mentioned 
cells. Glucose transport into endothelial and vascular smooth muscle cells occurs by 
GLUT-1 mediated facilitated diffusion and is thus insulin-independent. Glucose transport 
is auto regulated in smooth muscle cells, but not in endothelial cells, in which an increase 
in blood glucose concentration will increase the intracellular accumulation of glucose and 
its metabolites. The increased levels of glucose inside these cells produces deleterious 
effects leading to the diabetic complication through the following four pathways 
a. Increased flux of glucose through the polyol pathway 
b. Increased intracellular production of advanced glycation end products (AGEs) 
c. Protein kinase C (PKC) activation 
d. The hexosamine pathway 
The polyol pathway is regulated by aldose reductase (AR) enzyme which converts 
the glucose to sorbitol. Under normal circumstances, AR converts the toxic aldehydes into 
non-toxic alcohols. During hyperglycaemia, the increased concentration of glucose in the 
cells is reduced to sorbitol by AR and this is later oxidised to fructose by sorbitol 
dehydrogenase (SDH).  NADPH is increasingly oxidised to NADP+ and NAD+ is 
increasingly reduced to NADH during this process. The decrease in NADPH adversely 
affects the production of reduced glutathione, an important intracellular antioxidant.  The 
decreased amount of reduced glutathione increases the oxidative stress of the cells, 
leading to diabetic complications (Brownlee 2001, Nakamura et al. 2000, Srivastava, 
Ramana and Bhatnagar 2005). 
Advanced glycation end products (AGEs) are a group of hetergenous compounds 
resulting from non-enzymatic glycation of proteins and other molecules such as nucleic 
acids by glucose and other glycating dicarbonyl compounds such as 3-deoxyglucosone, 
methylglycoxal and glyoxal (Taguchi and Brownlee 2003). The AGEs are formed through 
a reaction pathway known as the Maillard pathway, in which the carbonyl group of 
reducing sugars are converted to reversible Schiff bases and amadori products, but 
eventually leading to the formation of irreversible AGEs. The fructose-3-phosphate and 3-
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deoxyglucosone produced as a result of metabolism of fructose by the polyol pathway 
also contribute to the formation of AGEs (Schalkwijk, Stehouwer and van Hinsbergh 
2004). The accumulation of excessive triosphosphates within the cells converts the 
intracellular proteins and lipids into oxoaldehyde and AGEs (Thornalley 2005). These 
AGEs cause cell damage by modifying the functioning of intracellular and extracellular 
proteins, alteration of the 3D configuration of the extracellular matrix molecules and by up-
regulation of receptor for AGEs (RAGEs) (Brownlee 2001, Brownlee 2005). 
The different isoforms of protein kinase-C (PKC), mainly α, β, δ, ε and δ are 
activated by hyperglycaemia via de novo synthesis of diacylglycerol (DAG) (Das Evcimen 
and King 2007). Activated PKCβ produces many effects including impairment of blood flow 
and contractility by altering the production of eNOS and ET-1 (Kuboki et al. 2000, Matsuo 
et al. 2009) and increased vascular permeability and angiogenesis by increasing the 
expression of VEGF (Rask-Madsen and King 2008). It is also reported to cause an 
increase in basement membrane thickness and capillary occlusion by increasing the 
production of collagen and fibronectin via CTGF and TGF- β (Koya et al. 2000). The 
activation of PKC is also reported to cause vascular occlusion by decreasing fibrinolysis 
via increasing PAI-1 (Ahn et al. 2001), activation of adhesion by increasing ICAMs 
(Ramana et al. 2004) and various other effects by increasing the expression of NF-κΒ and 
ROS (Brownlee  2005, Das Evcimen and King 2007). 
Glucose is mainly metabolised through glycolysis inside the cells. It is first 
converted to glucose-6-phosphate, next to fructose-6-phosphate and later to the 
remaining steps of glycolysis to yield pyruvate and lactate. However, during normal 
conditions two to three percent of fructose-6-phosphate undergoes metabolism via the 
hexosamine pathway, in which it is converted to glucosamine-6 phosphate with the help of 
the enzyme glutamine:fructose-6 phosphate amidotransferase (GFAT) and finally uridine 
phosphate N-acetyl glucosamine (UDP-GlcNAc). UDP-GlcNAc and other nucleotide 
hexosamines are substrates for glycosylation of many cytoplasmic and nuclear proteins. 
These proteins are glycosylated by the addition of a single molecule of O-linked β-GlcNAc 
on their serine and/or threonine residues (Bouche et al. 2004). During diabetes, glucose 
metabolism through hexosamine pathway is increased resulting in an increase in the level 
of expression of TGF- β1 and PAI-1 (Du et al. 2000), cardiomyopathy (Clark et al. 2003, 
Kohda et al. 2009) and impaired gene expression in endothelial cells (El-Osta et al. 2008, 
Xue et al. 2008).  
Michael Brownlee (2005) and his co-workers have proposed a unifying mechanism 
linking the four pathways outlined above to a common upstream event (Brownlee 2005, 
Nishikawa et al. 2000). The common link is the overproduction of superoxide (reactive 
oxygen species) (ROS) by the mitochondria as a result of excessive glucose metabolism. 
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In support of their hypothesis, Brownlee and his team demonstrated that three pathways 
of glucotoxicity were blocked by preventing the over production of mitochondrial 
superoxides (Nishikawa et al. 2000). Hyperglycaemia is known to over produce the 
mitochondrial superoxides by inhibiting the glycolytic enzyme glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). The inhibition of GAPDH activates the upstream intermediates 
of the glycolytic pathway, which in turn lead to the metabolism of glucose through the four 
above-mentioned pathways mainly by activating poly (ADP-ribose) polymerase (PARP) 
(Du et al. 2003). The following figure 1.2 summarises the unifying mechanism of 
complications of hyperglycaemia that has been proposed. 
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Fig. 1.2 The main four biochemical pathways of diabetes complications with 
unifying mechanism. In normal physiology, glucose is metabolised to pyruvate by 
glycolytic pathway, which later enters into TCA cycle to produce ATP. In hyperglycaemic 
condition cells become unable to metabolise the glucose sufficiently and lead to the 
overproduction of ROS, which in turn activates PARP and inhibit GAPDH. As the inhibition 
of GAPDH slows down the glycolytic pathway and increases the upstream substrates of 
glycolysis, more of accumulating intracellular glucose passes through four deleterious 
pathways: polyol, hexosamine, protein kinase C and AGE pathway (Adapted from 
Brownlee 2001, Brownlee 2005). 
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1.6 Hypoxia and Angiogenesis  
Blood vessels of the microvasculature are formed by two different mechanisms 
namely vasculogenesis and angiogenesis. Vasculogenesis, like in embryonic 
development, is the de novo formation of endothelial cells from angioblasts.  Angiogenesis 
in adult life is the formation of new capillary blood vessels from existent micro vessels. It is 
a complex and regulated process which involves multiple gene products expressed by 
different cell types, all contributing to an integrated sequence of events. (Carmeliet 2005, 
Griffioen and Molema 2000, Nussenbaum and Herman 2010). Angiogenesis has gained 
importance since Folkman published his pioneering hypothesis in 1971 about the need of 
angiogenesis in order for tumours to grow and metastasize (Folkman 1971).  
Angiogenesis is crucial in cancer therapy and diabetic retinopathy from the perspectives 
of anti-angiogenic strategies and in different ischemic conditions like cardiovascular 
diseases and impaired wound healing of diabetes for therapeutic angiogenesis (Cook and 
Figg 2010, Ferrara and Kerbel 2005). In the physiological condition, the activity of 
inducers and inhibitors of angiogenesis maintains it in balance (Conway, Collen and 
Carmeliet 2001). Table 1.2 lists the stimulatory and inhibitory regulators of the 
angiogenesis. 
Hypoxia stimulates angiogenesis by regulating the expression of growth factors 
such as VEGF, VEGFR, bFGF, PDGF and other cytokines via expression of the 
transcription factor HIF-1 and other transcription factors (Pugh and Ratcliffe 2003). Table 
1.3 summarizes the action of hypoxia on some molecules involved in different steps in 
angiogenesis. 
Angiogenesis involves different stages. The initial vasodilation acts as a prelude 
leading to the increased permeability and matrix degradation of pre-existing vessels. The 
endothelial cells proliferate and migrate as shown in Fig. 1.1D which later lead to the 
formation of cords and lumen. Once the endothelial cells along with others mature into a 
vessel, they remodel according to the local environment forming a complex functional 
network (Conway, Collen and Carmeliet 2001). Out of these different stages of vessel 
development, endothelial proliferation and migration are pertinent to this project and are 
detailed in the following sections as general cell proliferation and migration. 
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Table 1.2: Selected list of regulators of angiogenesis (Adapted from Pandya, Dhalla 
and Santani 2006) 
Stimulators Inhibitors 
HIF-1α, VEGF, VEGFR Angiostatin 
Angiopoietin-1 and Tie2 receptors Anti-angiogenic anti-thrombin III 
β-Estradiol Canstatin 
FGF, HGF, MCP-1 Endostatin (collagen XIII fragment) 
IL-8 Fibronectin fragment 
Leptin Heparinases 
PAI-1 IFN- , β, γ; IP-10 
MMPs IL4, IL12, IL18 
NOS and COX-2 TIMPs 
PDGF-BB and receptors PEDF 
TNF-  Prolactin 16 kDa fragment 
Angiogenin TSP-1 
TGF-β1, endoglin, TGF-β receptors Retinoids 
Integrins αvβ3, αvβ5 Meth-1, Meth-2 
VE-cadherin, PECAM-1 Platelet factor-4 
Abbreviations: HIF-1α – hypoxia inducible factor - 1α; VEGF—vascular endothelial growth 
factor;  VEGFR – VEGF receptors; FGF—fibroblast growth factor; HGF – hepatocyte 
growth factor; MCP-1 -macrophage chemoattractant protein; IL - interleukin; PAI-1 - 
platelet activator inhibitor-1;  MMPs - matrix metalloproteases; NOS - nitric oxide 
synthase; COX-2 – cyclooxygenase – 2; PDGF-BB - platelet derived growth factor-BB; 
TGF - transforming growth factor; VE-cadherin – vascular endothelial cadherin; PECAM-1 
– platelet endothelial cell adhesion molecule-1; TNF - tumour necrosis factor; IFN - 
interferon; TIMPs – tissue localised inhibitors of metalloproteinases; PEDF - pigment 
epithelium derived growth factor; TSP-1 - thrombospondin-1. 
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Table 1.3: Action of hypoxia on angiogenesis Some of the molecules involved in 
different steps in angiogenesis (Adapted from Pugh and Ratcliffe 2003). 
 
Steps in angiogenesis Stimulatory factors Inhibitory factors 
Vasodilation NOS  
Increased vascular permeability VEGF, Flt-1, Kdr ANGPT-1, Tie-2 
Extravasation of plasma proteins VEGF ANGPT-1, Tie-2 
Endothelial sprouting ANGPT-2, Tie-2  
Degradation of extra cellular 
matrix 
Balance between MMPs 
(MMP-2) and TIMPs 
(TIMP-1), Collagen prolyl-
4-hydroxylase 
PAI-1 
Liberation of growth 
factors(including VEGF, IGF-1 
and bFGF) 
uPA receptors 
Thrombospondin-1 
PAI-1 
Endothelial cell proliferation & 
migration 
Interplay between VEGFs, 
angiopoietins and FGFs. 
MCP-1, PDGF 
 
Pericyte and smooth muscle 
recruitment 
PDGF  
Endothelial assembly & lumen 
acquisition 
VEGF121/165, ANGPT-1, 
Tie-2,  Integrins 
VEGF189 
Thormbospondin-1 
Stabilization of nascent vessels PAI-1  
Maintenance, differentiation and 
remodelling 
ANGPT-1, Tie-2 ANGPT-2; Tie-2 
 
Blue, direct transcriptional targets of HIF;  
Red hypoxia regulated genes which are indirectly connected via cobalt, iron chelators or 
von Hippel–Lindau (VHL) inactivation to HIF or related pathways; 
Green responses unconnected to HIF pathway. 
IGF, insulin like growth factor; bFGF, basic fibroblast growth factor; MMP, matrix 
metalloproteinase; TIMP, tissue inhibitor of metalloprotienase; uPA, urokinase 
plasminogen activator; MCP, monocyte chemoattractant protein; PDGF, platelet-derived 
growth factor; PAI, plasminogen activator inhibitor; ANGPT, angiopoietin 
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1.7 Cell proliferation 
All eukaryotic cells undergo proliferation through cell division. The events of the 
cell cycle include duplicating all the cell contents and a subsequent division into two 
daughter cells. The cell cycle involves four phases: gap phase 1 (G1), DNA synthesis (S), 
gap phase 2 (G2) and mitosis (M). Interphase constitutes G1, S and G2 phases and the M 
phase consists of mitosis and cytokinesis. In a typical proliferating human cell in culture, 
interphase is around 23 h and M phase is around 1 h. The chromosomes are duplicated 
during S phase (around 10 to 12 h) and segregated before the cell division during M 
phase. Two DNA molecules are disentangled and condensed into pairs known as sister 
chromatids during prophase of mitosis. Sister chromatids attached to the opposite poles of 
the spindle are aligned at the equator in metaphase stage. The sister chromatids are 
separated after the destruction of their cohesion and pulled to the opposite poles of the 
spindle in anaphase stage. The spindle is disassembled and separated chromosomes are 
packed into separate nuclei at telophase, which is followed by separation of daughter cells 
by cytokinesis. The two gap phases – G1 between M and S phase and G2 between S and 
M phase are utilised by the cells to increase their mass of proteins and organelles and to 
monitor external and internal conditions. If the extracellular conditions are unfavourable 
during early G1, after M phase, the cells may under go an additional gap phase known as 
G0. If the conditions are favourable, cells in early G1 or G0 progress through a commitment 
point known as restriction point (R). Once the cells pass through the irreversible restriction 
point, the DNA duplication begins taking the cell into S phase (Alberts et al.  2008). 
Increase in the glucose level prevented the progression of HUVECs from G1 to S phase 
by increasing the cells in G0/G1 phase and reducing the cell count in S phase. This effect 
was reported to be mediated through PI3K/Akt/eNOS/NO pathway (Zhong et al. 2010). In 
porcine aortic endothelial cells, high glucose caused the cell cycle progression into S 
phase and increased expression of FGF-2 failed to protect TNF-α induced cell death 
(Clyne, Zhu and Edelman 2008).    
The complex, orderly and unidirectional cell cycle is regulated by cell cycle control 
system which involves cyclins, cyclin dependant protein kinases (CDKs) and CDK 
inhibitors. The cell cycle progresses through three biochemical switches which are known 
as check points. The first one is restriction point (R) or G1/S check point where the cell is 
committed to enter into S phase and duplicates the chromosomes. The second is the 
G2/M checkpoint where the cell enters into M phase leading to the alignment of 
chromosomes on the spindle. The third is the metaphase to anaphase transition, where 
the sister chromatids are separated followed by the completion of mitosis and 
chemokinesis (Alberts et al.  2008). 
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Central to the cell cycle regulation are the activities of CDKs, which are in turn 
regulated by cyclins. The CDK subunit, a serine/threonine protein kinase alone is inactive 
as its catalytical activity is produced only upon the tight binding with cyclins and 
phosphorylation of their T loops by CDK activating kinase (CAK) (Lorincz and Reed 1984, 
Russo et al. 1996). Four types of CDKs i.e. CDK 1, 2, 4 and 6, are known to have active 
role in the regulation of cell cycle (Morgan 1997). Two types of cyclins are known, ones 
involved in cell cycle (cyclin A, B, D and E) and others which are not (cyclin H and C) 
(Meeran and Katiyar 2008). Cyclins involved with cell cycle are G1/S cyclins (E), S cyclins 
(A), M cyclins (B) and G1 cyclins (D). Cyclin E and D by pairing with CDK2 and CDK4/6 
respectively are known to play a vital role in the progression of cell cycle from G1 to S 
phase. Others involved at different stages are cyclin A with CDK2 then with CDK1 at S 
phase, cyclin B with CDK1 at M phase and cyclin D with CDK4/6 at G1 phase (Sherr 1994, 
Sherr 1996). The levels of cyclins change, as shown by the semi-circular shapes in Fig. 
1.3, during the cell cycle resulting in the activation of cyclin-CDK complexes. Cyclin D 
synthesized during early G1 gets degraded at the end of G1 as the cell enters S phase. 
Cyclin E synthesized at late G1 is degraded in S, cyclin A synthesized in S gets degraded 
at the exit of G2 and cyclin B synthesized in late G2 gets degraded at late M phase. 
However, unlike cyclins the levels of CDKs remain constant throughout the cell cycle 
(Alberts et al.  2008). Increased glucose concentration has been proved to lead to cycle 
arrest of endothelial progenitor cell (EPC) at G0/G1 phase by decreasing the expression of 
cyclin A and E, CDK2 and proliferating cell nuclear antigen (PCNA) (a marker of S phase) 
(Zhang et al. 2008). 
Several mechanisms control the activities of CDKs at specific stages of cell cycle. 
A protein kinase known as Wee 1 inhibits CDK activity by phospohrylation and a 
phosphatase known as Cdc25 increases CDK activity by dephosphorylation (Enders 
2010, Gutierrez et al. 2010). Along with these, CDK inhibitor proteins (CKIs) also regulate 
the cyclin-CDK complexes by acting as checkpoint effectors. There are two families of 
CKIs with multiple members in each family. The first family known as Cip/Kip (CDK 
inhibitor protein/Kinase inhibitor protein) consists of p21Cip1, p27Kip1 and p57Kip2 (Lee, 
Reynisdottir and Massague 1995, Toyoshima and Hunter 1994). The CKIs bind with the 
cyclin-CDK complex and render it inactive. CKIs undergo ubiquitination and protesomal 
degradation by an ubiquitin ligase called Skp1-Cul1-F box (SCF) protein complex and 
allow the progression of cell cycle to next phase (Kitagawa, Kotake and Kitagawa 2009). 
The coexistence of hypertension with diabetes has been reported to decrease the 
proliferation of retinal cells by increasing the expression of p27Kip1, a negative regulator of 
cell cycle (Lopes de Faria et al. 2008). A second family of CKIs, known as the INK4 
(inhibitors of CDK4) family of p15INK4b, p16INK4a, p18INK4c and p19INK4d bind to cyclin D - 
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CDK4/6 complex causing the arrest of cell cycle at G1 phase (Dai and Grant 2003, 
Hannon and Beach 1994, Hirai et al. 1995, Kim and Sharpless 2006, Serrano, Hannon 
and Beach 1993). 
The following figure 1.3 is a simple summary of the events of cell cycle. 
 
 
 
 
 
 
 
Fig.1.3 Cell cycle events G1 and G2 are the gap phases between mitosis (M) and DNA 
synthesis (S) phase. Cells go into a special gap phase (G0) or into quiescence to avoid 
aberrant proliferation taking the cues from the internal and external cellular environment. 
The level of individual cyclin (indicated by inner shapes) varies as the cell progresses 
through the cell cycle assuring the uni-directionality of the cycle, whereas the levels of 
cyclin dependent kinases (CDKs) remain same. The complexes of cyclins-CDKs with CDK 
inhibitors (CKIs) play a central role in the progression of cell cycle. The CDK inhibitors 
(CKIs) need to be deactivated to allow the progression of cell cycle; otherwise activated 
CKIs play an inhibitory role by acting at different check points.   
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1.8 Cell migration 
 Cell migration is a crucial step for the wound healing process including endothelial 
cell migration during the angiogenesis (Lauffenburger and Horwitz 1996). Cells migrate 
randomly (chemokinesis) when their sense of intrinsic directionality is low and external 
cues are not present (Petrie, Doyle and Yamada 2009, Seppa et al. 1982). On the other 
hand, directional migration is driven by the intrinsic directionality and external regulation 
(Petrie, Doyle and Yamada 2009). Chemotaxis in response to soluble cues (Liu et al. 
2009), haptotaxis in response to surface gradient like adhesion molecule or ECM (Hsu, 
Thakar and Li 2007), electrotaxis or galvanotaxis in response to electric fields (Lin et al. 
2008) and durotaxis or mechanotaxis in response to mechanical signals (Li et al. 2002) 
follow directional migration. The following figure 1.4 schematically represents the 
cytoskeletal arrangement of a migrating cell (Le Clainche and Carlier 2008). 
The cell motility cycle is also a highly organised event which includes polarization, 
protrusion, traction and retraction of a cell (Cell Migration Gateway 2010). The process of 
reorganisation of the cell into a leading front edge and trailing rear edge is known as 
polarization. Polarization initiates on the application of chemoattractants like VEGF 
leading to the next steps of migration (Shamloo et al. 2008). The cell’s polarity signalling 
network consists of the Par (partitioning defective) protein complex, PKCε and PKCδ as 
atypical protein kinase C (aPKC) and RhoGTPase signalling molecule cdc42 (Cell 
Migration Gateway 2010, Joberty et al. 2000). The par3 and par6 are part of Par protein 
complex and participate in the formation of rear-front axis in a moving cell and apical-
basal polarity with help of VE-cadherins and adherence junctions (Lampugnani et al. 
2010). Cdc42 and Rac1 by recruiting the par3/6 complex activates aPKC in order to 
reorient the microtubule-organising centre (MTOC) from which the microtubule network 
radiates and Golgi apparatus towards the leading edge of a moving cell (Koh, Mahan and 
Davis 2008, Tzima et al. 2003). The nucleus of the cell moves rearward rather than MTOC 
moving between the nucleus and leading edge and reorientation is known also to involve 
dynactin and dyanein along with cdc42 (Etienne-Manneville and Hall 2001, Palazzo et al. 
2001). Cdc42 acting through myotonic dystrophy kinase related cdc42 binding kinase 
(MRCK) was sufficient to make the nucleus move rearwards while others held the MTOC 
at the cell centroid with help of myosin dependant actin flow finally leading to the front-rear 
axis (Gomes, Jani and Gundersen 2005). Cdc42 and Rac1 phosphorylate p21 activated 
protein kinase 1 (Pak1), Pak2 and Pak4 which act as a downstream target for PKCε to 
initiate protrusion and stimulate the lumen and tube formation (Koh, Mahan and Davis 
2008, Kupfer, Louvard and Singer 1982). 
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Fig. 1.4 ‘‘Schematic illustration of the actin cytoskeleton in a migrating cell. This 
schematic cell contains the major structures found in migrating cells common to different 
cells. Migrating cells have A) lamellipodia, where branched actin filaments are generated 
at the plasma membrane by the signal responsive WASP-Arp2/3 machinery and 
maintained in fast treadmilling by a set of regulatory proteins (ADF, capping proteins, 
profilin), B) fingerlike protrusions called filopodia to sense the environment at the tip of 
which, formins like mDia2 catalyze the processive assembly of profilin-actin. The 
processive assembly of profilin-actin is catalyzed by formins. C) Focal adhesions formed 
in response to RhoA signaling, connect the extracellular matrix to contractile bundles 
made of actin filaments, myosin II, and bundling proteins including α-actinin. Focal 
adhesions contain a variety of actin binding proteins including side binding proteins, 
capping proteins, and nucleators. D) Lamella contains the signature proteins tropomyosin 
and myosin II’’. 
Lp, lamellipodium; Fp, filopodium; Lm, lamella; SF, stress fiber; FA, focal adhesion; FC, 
focal complex. 
(Reproduced with permission from Le Clainche and Carlier 2008) 
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 The actin filament polarization leads to the polymerization or formation of barbed 
ends and de-polymerization of pointed ends at the leading edge of a cell (Pollard and 
Borisy 2003). Polymerization of actin assembly at the leading edge extends the flat 
membrane (lamella) protrusions known as lamellopodia and finger like protrusions known 
as filopodia (Le Clainche and Carlier 2008, Pollard and Borisy 2003). The protrusions 
develop and initiate cell motility by a process known as ‘treadmilling’ which is accelerated 
by many actin binding proteins (Kueh and Mitchison 2009). These proteins are actin 
depolymerising factor (ADF) or cofilin, capping protein, Arp2/3 complex, an activator of 
Arp2/3 complex - profilin and many others and are involved in monomer sequestration, 
nucleation, capping, depolymerisation and termination of actin filament (Pollard and Borisy 
2003). 
The growth of the actin filament depends on the availability of un-polymerised actin 
monomers which are present in abundance bound to profilin and sequestering proteins 
such as thymosin-β4 and which are reported to increase the directional migration of cells 
(Ding et al. 2006, Malinda, Goldstein and Kleinman 1997, Malinda et al. 1999). Assembly 
or elongation of actin filament at the leading edge begins by the activation of nucleating 
promoting factors such as Wiscott-Aldrich Syndrome protein (WASp), neuronal WASp (N-
WASp) and suppressor of cAMP receptor (Scar)/WASp-family Verprolin homologous 
(WAVE) proteins (Kang et al. 2010, Vicente-Manzanares, Webb and Horwitz 2005). 
WASp, N-WASp and Scar/Wave proteins are activated by signalling molecules such as 
the Rho-family GTPase (cdc42), phosphotidylionsitol-4,5-biphsophate (PIP2) and Src 
homology 3 (SH3) domain containing  proteins like Grb2, Nck, or Abil (Carlier et al. 2000, 
Innocenti et al. 2005, Rohatgi, Ho and Kirschner 2000, Rohatgi et al. 2001). The 
WASp/WAVE proteins regulate actin polymerization by their ability to initiate the 
nucleation by Arp2/3 complex at the barbed end of actins (Kang et al. 2010, Hufner et al. 
2001). Cotractin, an F-actin binding protein is also known to promote nucleation of actin 
filament by binding with Arp2/3 complex (Kinley et al. 2003) 
The Arp2/3 complex localized at the lamellopodia, upon the activation by 
nucleating proteins caps the attachment of actin monomers at the pointed ends (Mullins, 
Heuser and Pollard 1998, Svitkina and Borisy 1999). Additionally, the Arp2/3 complex 
nucleates the barbed ends and extends the pre-existing actin filament at an angle of 700 
leading to the formation of dendritic networks of actin filament branches (Mullins, Heuser 
and Pollard 1998, Fletcher and Mullins 2010). The elongation of actin filament is aided by 
another set of actin binding proteins, mDia1 and mDia2 – mammalian Diaphanous of 
Formin family. RhoA regulated mDia1 and cdc42 regulated mDia2 bind to the barbed 
ends and recruit profilin bound G actins in order to polymerize the actin filament and aid in 
the formation of the stress fibres (Vicente-Manzanares, Webb and Horwitz 2005, 
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Watanabe and Higashida 2004). The elongation of actin filaments at the barbed ends is 
stopped by capping by proteins known as Cap Z and gelsolin (Cooper and Schafer 2000). 
The activities of elongation, branching and capping of the actin filament lead to the 
formation of protrusive lamellopodia (Fletcher and Mullins 2010). The finger-like 
protrusions, filopodia sense the external environment in which the actin polymerization is 
carried out by mDia2 and vasodilator stimulated phoshoprotein (VASP). The polymerized 
actin filaments in filopodia are arranged as bundles with the help of fascin and Irsp53-
Eps8 complex (Le Clainche and Carlier 2008, Mattila and Lappalainen 2008). 
The de-branching of actin filament begins with the hydrolysis of ATP to ADP with 
the release of a phosphate group or due to the loss of ATP (Blanchoin, Pollard and 
Mullins 2000, Hinshaw et al. 1993). Loss of phosphate causes the detachment of Arp2/3 
complex from the side of the actin filament and the free Arp2/3 complex caps the pointed 
ends and accelerates the de-branching (Blanchoin, Pollard and Mullins 2000). The de-
branching of the actin filament and loss of ATP are mediated by the activation or 
dephosphorylation of ADF/cofilin (Suurna et al. 2006). ADF/cofilins sever the actin 
filaments and thus increase the availability of actin monomers. This activity of ADF/cofilin 
is regulated by phosphorylation of its upstream regulator LIM kinase (LIMK). LIMKs are in 
turn regulated by RhoA-ROCK or PI3-K, Ca2+, phospholipid dependant PKC, Rac 
activated PAK1. PAK1 is in turn regulated by small G proteins or the DAG pathway 
(Campos et al. 2009, Gong, Stoletov and Terman 2004, Maciver and Hussey 2002). 
Profilin acting as a nucleotide exchange factor binds competitively to ADP actin and 
increases the disassociation of ADP from actin. This allows the actin to bind to abundantly 
available ATP leading to the formation of ATP-actin monomers ready to re-enter the cycle 
of actin polymerization (Pollard and Borisy 2003, Ding et al. 2006). 
In cultured cells, the network of actin and myosin produce the retrograde flow, 
where the actin filaments of lamellopodia move rearward with respect to the substratum. 
Hence, the rate of forward protrusion of a cultured cell is a result of the difference between 
the retrograde flow and actin polymerization (Ridley 2004). The process of the protrusion 
is detailed in the following figure 1.5.  
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Fig. 1.5 ‘‘Dendritic nucleation/Array treadmilling model for protrusion of the leading 
edge. (1) Extracellular signals activate receptors. (2) The associated signal transduction 
pathways produce active Rho-family GTPases and PIP2 that (3) activate WASp/Scar 
proteins. (4) WASp/Scar proteins bring together Arp2/3 complex and an actin monomer on 
the side of a pre-existing filament to form a branch. (5) Rapid growth at the barbed end of 
the new branch (6) pushes the membrane forward. (7) Capping protein terminates growth 
within a second or two. (8) Filaments age by hydrolysis of ATP bound to each actin 
subunit (white subunits turn yellow) followed by dissociation of the γ phosphate (subunits 
turn red). (9) ADF/cofilin promotes phosphate dissociation, severs ADP-actin filaments 
and promotes dissociation of ADP-actin from filament ends. (10) Profilin catalyzes the 
exchange of ADP for ATP (turning the subunits white), returning subunits to (11) the pool 
of ATP-actin bound to profilin, ready to elongate barbed ends as they become available. 
(12) Rho-family GTPases also activate PAK and LIM kinase, which phosphorylates 
ADF/cofilin. This tends to slow down the turnover of the filaments.’’ 
(Reproduced with permission from Pollard and Borisy 2003). 
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The adhesions, points of interaction between the cell and the substratum, form at 
the leading edge and disassemble at the trailing edge of a cell in order to facilitate the 
traction and retraction of cells leading to rapid migration (Le Clainche and Carlier 2008, 
Vicente-Manzanares, Webb and Horwitz 2005). Along with the actin cytoskeleton, 
components of adhesions such as integrins, adaptor and signalling proteins and 
microfilament structures play a vital role in the assembly, maturation and turnover of 
adhesions (Lock, Wehrle-Haller and Stromblad 2008, Vicente-Manzanares, Choi and 
Horwitz 2009). Focal complexes, focal adhesions, fibrillar adhesions and 3D-matrix 
adhesions are different types of adhesions observed in cells such as fibroblasts (Berrier 
and Yamada 2007, Le Clainche and Carlier 2008). Nascent adhesions of focal complexes 
are assembled and disassembled during the adhesion turnover at the leading edge of a 
cell. The focal complex which is not disassembled mature into focal adhesions and 
contain integrins, vinculin, talin, α-actinin, paxillin, zyxin, VASP, focal adhesion kinase 
(FAK), actopaxin and phosphotyrosine proteins (Le Clainche and Carlier 2008). 
Integrins are transmembrane glycoproteins expressed as alpha-beta heterodimers 
and 24 of them composed of eighteen alpha and eight beta subunits have been identified 
to constitute the receptors for ECM proteins (Hynes 2002). The outer domain of integrin 
binds to extracellular ligand and cytoplasmic domain binds the various signalling 
molecules and actin in order to produce the effect of protrusion and traction (Huveneers 
and Danen 2009). The cytoplasmic domain of integrin binds directly or indirectly to talin, 
vinculin, α actinin, FAK, Arp2/3 complex and actin filaments (Vicente-Manzanares, Choi 
and Horwitz 2009). The linkage between the actin and integrin acts as a molecular clutch 
integrating adhesion, retrograde flow and actin polymerization in order to produce the 
traction at the leading edge and retraction at the trailing edge (Le Clainche and Carlier 
2008, Vicente-Manzanares, Choi and Horwitz 2009). The activation of integrin-actin 
linkage regulates Rho family GTPases such as RhoA, Rac1 and Cdc42. Activation of Rho 
GTPases is initiated by the recruitment of upstream molecules such as FAK, Src family of 
tyrosine kinases (SFKs) and paxillin. The SFKs regulate guanine exchange factors 
(GEFs) and GTPase activating factors (GAPs), which in turn control Rho GTPases 
(Huveneers and Danen 2009).  
The disassembly of adhesions and retraction at the trailing end of a cell aided by 
the myosin-II induced contractility completes the cell motility cycle. Apart from creation of 
tension and retraction, myosin II plays role during polarization, protrusion and the traction 
as well (Vicente-Manzanares et al. 2009). 
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1.9.1 Hypoxia inducible factor-1 (HIF-1) 
Hypoxia produces its effect by activating different transcriptional pathways 
including HIF, fos, jun, NF- B and p53 (Pugh and Ratcliffe 2003).  Out of these, the 
pathway for the hypoxia controlled regulation of the growth factors through hypoxia 
inducible factor -1 (HIF-1) is come to be known as the master regulator of oxygen 
homeostasis (Semenza 2002). Wang and Semenza first identified and purified HIF-1α as 
a nuclear factor induced by the hypoxia. Later it was characterised as a heterodimeric 
transcription factor composed of hypoxia inducible HIF-1α subunit and a constitutively 
expressed HIF-1  subunit, also known as aryl hydrocarbon nuclear translocator (ARNT) 
(Fig. 1.6) (Semenza et al. 1991, Semenza and Wang 1992, Wang and Semenza 1993). In 
addition to HIF-1α and HIF-1β, other isoforms of HIF-α such as HIF-2α and HIF-3α with its 
splice variant inhibitory PAS (IPAS) have been described (Ema et al. 1997, Gu et al. 1998, 
Makino et al. 2001). 
 
 
 
 
 
Fig. 1.6: ‘‘Domain structure of HIF-1  Important functional domains of the HIF-1α and 
HIF-1β subunits are indicated as follows: a, alternate exon encoding 15 amino acids (aa) 
in HIF-1β; bHLH, basic-helix-loop-helix domain; ID, inhibitory domain; NLS-N and NLS-C, 
amino- and carboxyl-terminal nuclear localization signal; PAS, Per-ARNT-Sim homology 
domain with internal A and B repeats; PSTD, proline-serine-threonine-rich protein stability 
domain; TAD-N and TAD-C, amino- and carboxyl-terminal transactivation domain; REF-1, 
redox factor 1; TRX, thioredoxin’’ 
(Reproduced with permission from Semenza  2000). 
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The human HIF-1α gene is located on chromosome 14 (14q21-q24) and the HIF-
1  gene on chromosome 1 (1q21). HIF-1α and HIF-1  are large proteins consisting of 826 
and 789 amino acids respectively. Both subunits contain nuclear localization signals and a 
basic helix–loop–helix motif (bHLH). The HLH and basic domain are responsible for 
dimerization and DNA binding respectively (Jiang et al. 1996, Wang et al. 1995). Per-
ARNT-Sim (PAS) domain is common to both HIF-1α and HIF-1β. This sequence identifies 
a protein super family which was found in Drosophilia proteins period (Per) and single 
minded (Sim) and the vertebrate protein aryl hydrocarbon nuclear translocator (ARNT) 
(Wang et al. 1995). The dimerization of HIF-1α and HIF-1β is mediated by both HLH and 
PAS domain, which in turn is necessary for DNA binding by the basic domains (Jiang et 
al. 1996). In addition, the HIF-1α subunit contains two transactivating domains (TAD), the 
N- and C-terminal transactivating domains NTAD and CTAD, between residues 531–575 
and 813–826 respectively (Ruas, Poellinger and Pereira 2002). The NTAD overlaps with a 
larger domain denoted as O2-dependent degradation (ODD) domain, which confers 
regulation of HIF-1α protein levels as a function of O2 concentration (Huang et al. 1998). 
The main function of CTAD is to recruit and interact with transcriptional co-activator 
proteins including CBP/p300, SRC-1 and TIF-2 (Kung et al. 2000, Hirota and Semenza 
2006). 
Under hypoxia HIF-1α and HIF-1β dimerize and bind to hypoxia response 
elements (HREs) within target genes. This HIF-HRE complex activates the transcription of 
target genes by recruiting the co activators p300 and CBP (Ruas, Poellinger and Pereira 
2005). HIF-1α in non-hypoxic conditions is synthesized, ubiquinated and degraded 
whereas in hypoxic conditions HIF-1α stabilizes to dimerize with HIF-1β and 
transactivates the target genes (Webb, Coleman and Pugh 2009). Regulation of HIF-1α 
involves pVHL dependant as well as pVHL independent pathways (Yee Koh, Spivak-
Kroizman and Powis 2008).  
1.9.1.1 pVHL dependant degradation 
In the presence of oxygen, HIF-1α is hydroxylated by prolyl hydroxylase domain-
containing proteins (PHDs) 1, 2 and 3 at two proline residues Pro402 and Pro564 situated 
in the ODD domain (Masson et al. 2001). These modifications are mediated by Fe2+, 
ascorbate and 2-oxoglutarate (Huang et al. 2002, Jaakkola et al. 2001). Hydroxylation of 
Pro402 and Pro564 promotes interaction between HIF-1α and the tumour supressor 
protein von Hippel–Lindau (pVHL) (Min et al. 2002). The VHL protein functions as a 
substrate recognition component of an E3 ubiquitin ligase complex that mediates 
ubiquitination of HIF-1α, leading to its rapid degradation by proteasomes (Kamura et al. 
2000). The E3 ubiquitin ligase includes at least four other proteins: elongin B, elongin C, 
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cullin-2 and ring-box 1 (also called ROC1 or Hrt1) (Clifford et al. 2001, Maxwell et al. 
1999). Acetyl transferase arrest defective-1 (ARD-1) mediated acetylation of lysine 
residue (Lys) 532, located in ODD domain of HIF-1α, increases the interaction of HIF-1α 
and pVHL leading to the destabilisation of HIF-1α (Jeong et al. 2002). Apart from pVHL, 
tumour suppressor protein p53 promoted murine double minute 2 (MDM2) also regulates 
proteasomal degradation of HIF-1α (Ravi et al. 2000). On the contrary, the pVHL 
interacting deubiquitanting enzyme 2 (VDU2) stabilises the HIF-1α by binding to it and 
deubiquitylating it and thus preventing its proteasomal degradation (Li et al. 2005). 
A second type of modification, β-hydroxylation of an asparaginyl residue, Asn803, 
in the CTAD allows for direct O2-dependent regulation of HIF-1 activity (Lando et al. 
2002b). This modification which is mediated by factor inhibiting HIF-1 (FIH-1) blocks 
interaction of CTAD with the transcriptional co-activators CBP/p300 in the presence of 
oxygen, thereby inhibiting HIF-dependent transactivation (Lando et al. 2002a). Similar to 
PHDs, the asparaginyl hydroxylation of FIH-1 requires 2-oxoglutarate dependant 
dioxygenase, Fe2+ and ascorbate as coactivators (Lando et al. 2002a). 
However during hypoxia, the activities of PHDs are inhibited leading to the 
stabilisation of HIF-1α. Reactive oxygen species (ROS) acting as an oxygen sensing 
mechanism increases during hypoxia. Further, ROS convert the oxidative status of Fe2+ to 
Fe3+ which leads to an inhibition of PHDs activity and stabilisation of HIF-1α (Simon 2006). 
Hypoxia is also known to stabilise the HIF-1α by inducing the expression of small ubiquitin 
like modifiers (SUMO)-1 through a process known as SUMOlyation (Bae et al. 2004). 
However, newer reports suggest that the SUMOlyation lead to the HIF-1α degradation 
which could be reversed by a nuclear SUMO protease known as sentrin/SUMO-1 specific 
peptidase (SENP) 1 (Xu et al. 2010b). 
The stability and affinity of pVHL towards HIF-1α is regulated by E2 endemic 
pemphigus foliaceus (EPF) ubiquitin carrier protein (UCP). The UCP degrades pVHL by 
ubiquitylation and causes accumulation of HIF-1α during normoxia (Jung et al. 2006). 
Apart from UCP, osteosarcoma-9 (OS-9) and spermidine/spermine-N1-acetyltransferase 
(SSAT) 2 have been recognised as novel regulatory molecules (Yee Koh, Spivak-
Kroizman and Powis 2008). 
1.9.1.2 pVHL independent degradation 
 pVHL and oxygen independent degradation of HIF-1α is mediated through heat 
shock protein 90 (HSP90) and receptor of activated protein kinase C (RACK1). RACK1 
competes with HSP90 for binding to HIF-1α at PAS domain leading to its binding with HIF-
1α and subsequent homodimerization and recruitment of components of elongin E3 ligase 
complex and finally the degradation of HIF-1α (Liu et al. 2007a). RACK1 pathway is 
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regulated by SSAT1 which is essential for the stability of HIF-1α RACK1 interaction (Baek 
et al. 2007). RACK1 pathway is regulated also by calcineurin, a calcium and calmodulin 
dependent serine/threonine specific protein phosphatase which inhibits RACK1 mediated 
degradation of HIF-1α by blocking the dimerization due to dephosphorylation of the 
RACK1 (Liu et al. 2007b). 
 Phosphotidylinositol 3-kinase-Akt (PI3K-Akt) pathway not only regulates the 
transcriptional activity of HIF-1α, but also regulates its degradation via glycogen synthase 
kinase (GSK) 3β and forkhead transcription factors  (FOXO) 4 or 3a (Yee Koh, Spivak-
Kroizman and Powis 2008). The overexpression of GSK3β, which could be 
phosphorylated and degraded by protein kinase B, results in the ubiquitylation and 
proteasomal degradation of HIF-1α whereas inhibition of GSK3β resulted in the induction 
of HIF-1α (Flugel et al. 2007). The expression of FOXO4, which is negatively regulated by 
PI3K-Akt, leads to the down regulation of HIF-1α due to the induction of pVHL 
independent ubiquitylation and degradation of HIF-1α (Tang and Lasky 2003). Similarly, 
PTEN mediates FOXO3a over expression which is negatively regulated by PI3K-Akt, 
leads to the p300 dependant inactivation of transcriptional activity of HIF-1α (Emerling et 
al. 2008). The following figure 1.7 (Yee Koh, Spivak-Kroizman and Powis 2008) 
summarizes the regulation of HIF-1α degradation by various pathways. 
1.9.1.3 Translational regulation of HIF-1α 
Many mechanisms have been proposed to control the translational activity 
including HIF-1α induction by activation of PI3K-Akt mammalian target of rapamycin 
(mTOR) and mitogen activated protein kinase (MAPK) pathways (Yee Koh, Spivak-
Kroizman and Powis 2008). In human microvascular endothelial cells (HMEC-1), hypoxia 
was able to induce the phosphorylation of both ERK1 and ERK2 MAPKs (Minet et al. 
2000). In hypoxia, ERK1/2 was shown to be involved in the activation of HIF-1 
transcriptional activity by directly phosphorylating the HIF-1  confirming the involvement 
of MAPKs (Minet et al. 2000, Richard et al. 1999). Along with ERK1/2 inhibitor, the p38 
kinase inhibitor has also been known to cause the inactivation of HIF-1α (Sodhi et al. 
2000). Further, the hypoxia induced DAG accumulation and HIF-1α stabilization was 
through the action of phosphatidylcholine phospholipase C (PC-PLC)/sphingomyelin 
synthase (SMS) activity and not through DAG-dependent protein kinase C (PKC) activity 
(Aragones et al. 2001, Temes et al. 2004). However, there are other reports suggesting 
the involvement of PKC in the regulation of HIF-1  activation (Kruger et al. 1998, Lee et 
al. 2007, Yun et al. 2009). The transcriptional activity of HIF-1α has also been shown to be 
regulated by other signalling pathways such as phosphatidylinositol-3 kinase/protein 
kinase B (PI3K/Akt) and p53 (Fang et al. 2005, Lin et al. 2010, Zhong et al. 2000). 
Chapter 1 - Introduction 
- 33 - 
 
 
 
 
 
 
Fig 1.7 ‘‘Important pathways regulating HIF-1α degradation HIF-1α degradation is 
regulated by multiple pathways that are either dependent (a) or independent (b) of oxygen 
and pVHL. (a) Under normoxic conditions, HIF-1α is hydroxylated by prolyl hydroxylases 
(PHDs) leading to the recruitment of the pVHL E3 ligase complex to HIF-1α. SSAT2 binds 
to HIF-1α, pVHL and elongin C and the pVHL E3 ligase complex ubiquitylates HIF-1α 
leading to its degradation. Alternatively, pVHL can be ubiquitylated and degraded by EPF 
UCP. Hypoxia results in HIF-1α SUMOylation, which can facilitate the recognition of HIF-
1α by the pVHL E3 ligase complex and lead to HIF-1α degradation. HIF-1α SUMOylation 
can be reversed by SENP1 resulting in stabilization. However, hypoxia-induced RSUME-
mediated SUMOylation (RSUME) can increase HIF-1α stability indicating that the role of 
SUMOylation in HIF-1α regulation is still unclear. (b) Oxygen-independent regulators of 
HIF-1 include GSK3β and RACK1.’’ 
(Reproduced with permission from Yee Koh, Spivak-Kroizman and Powis 2008). 
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In addition to hypoxia, a variety of growth factors including EGF, FGF2, insulin, 
IGF1 and 2, IL-1 and NO are know to regulate the transactivational ability of HIF-1 
(Natarajan, Fisher and Fowler 2003, Semenza  2002). Other than these, ROS are also 
known to regulate the HIF-1α activity (Chandel et al. 1998, Klimova and Chandel 2008). In 
streptozotocin induced diabetic rats under ischemic conditions, mRNA expression of HIF-
1α was found to be reduced, which was restored by normoglycaemia or glutathione, a free 
radical scavenger indicating the role of ROS in regulating the expression of HIF-1α 
(Marfella et al. 2002). In another study HIF-1α protein was reported to be expressed in 
sciatic nerves of mice within three months of streptozotocin induced diabetes and anti-
oxidant alpha lipoic acid attenuated the expression of HIF-1α suggesting the role of ROS 
in expression of HIF-1α (Knott et al. 2002, Knott et al. 2003). 
1.9.2 Physiological and pathophysiological role of HIF-1 
HIF-1 regulates most of the genes involved in oxygen homoestasis, including 
genes known to be responsible for angiogenic factors, erythropoiesis, cell proliferation and 
survival, apoptosis, glucose metabolism, pH regulation and protein metabolism (Brahimi-
Horn and Pouyssegur 2009, Ke and Costa 2006). The following table 1.4 gives the list of 
some of the genes activated by HIF-1. 
Many reports confirm VEGF as a potent angiogenic mitogen and a major target 
gene of HIF-1 (Rey and Semenza 2010). Apart from tumour angiogenesis HIF-1 is also 
involved in other hypoxic conditions like ischemic conditions of diabetes and delayed 
wound healing of diabetes. In diabetic patients with unstable angina, after myocardial 
ischemia low levels of HIF-1α and VEGF levels led to impaired angiogenesis in 
comparison with non diabetic patients (Marfella et al. 2004). Gene therapy of HIF-1α 
activated many angiogenic cytokines such as VEGF, Ang-1, Ang-2, PDGF, PLGF, HO-1 
and iNOS correcting the impaired wound healing of diabetes (Mace et al. 2007, Liu et al. 
2008). Ferulic acid, an anti-oxidant produced angiogenic effects by increasing HIF-1α 
mRNA and protein along with VEGF and PDGF through PI3K/MAPK activation (Lin et al. 
2010). The 2-oxoglutarate analogue dimethyloxalylglycine (DMOG) and iron chelator 
deferoxamine (DFX) stabilised and activated HIF-1α by inhibiting HIF hydroxylases 
leading to the improvement in the wound healing of diabetic mice (Botusan et al. 2008). 
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Table 1.4: HIF-1 mediated transcriptional activation of genes (Adapted from Lee et al. 
2004) 
Function Genes 
Cell proliferation Cyclin G2, IGF2, IGF-BP1,2,3, WAF-1,TGF-α, TGF-β3 
Cell survival ADM, EPO, IGF2, IGF-BP1,2,3, NOS2, TGF-α , VEGF 
Apoptosis NIP3, NIX, RTR801 
Motility ANF/GPI, c-MET, LRP1, TGF-  
Cytoskeletal structure KRT14, KRT18, KRT19, VIM 
Cell adhesion MIC2 
Erythropoiesis EPO 
Angiogenesis EG-VEGF, ENG, LEP, LRP1, TGF-β3, VEGF 
Vascular tone  ARα1β, ADM, ET1, Haem oxygenase-1, NOS2 
Transcriptional regulation  DEC1, DEC2, ETS-1, NUR77 
pH regulation  Carbonic anhydrase 9 
Regulation of HIF-1 activity  P35srj  
Epithelial homeostasis  Intestinal trefoil factor 
Drug resistance  MDR1 
Nucleotide metabolism  Adenylate kinase 3, Ecto-5'-nucleotidase 
Iron metabolism Ceruloplasmin, Transferrin, Transeferrin receptor 
Glucose metabolism HK1, HK2, AMF/GPI, ENO1, GLUT1, GAPDH, LDHA, 
PFKBF3, PFKL, PGK1, PKM, TPI, ALD-A, ALD-C 
Extracellular-matrix 
metabolism 
CATHD, Collagen type V ( 1), FN1, MMP2, PAI1, 
Prolyl-4-hydroxylase   
Energy metabolism LEP 
Amino-Acid metabolism Transglutaminase 2 
ADM, adrenomedullin; ALD, aldolase; AMF, autocrine motility factor; AR, adrenergic receptor 
CATHD, cathepsin D; DEC, differentiated embryo chondrocyte; EG-VEGF, endocrinegland- 
derived VEGF; ENG, endoglin; ET1, endothelin-1; ENO1, enolase 1; EPO, erythropoietin; FN1, 
fibronectin 1; GLUT, glucose transporter; GAPDH, glyceraldehyde-3-P-dehydrogenase; HK, 
hexokinase; IGF2, insulin-like growth-factor 2; IGF-BP, IGF-factor-binding-protein; KRT, keratin; 
LDHA, lactate dehydrogenase A; LEP, leptin; LRP1, LDL-receptor-related protein 1; MDR1, 
multidrug resistance 1; MMP2, matrix metalloproteinase 2; NOS2, nitric oxide synthase 2; PFKBF3, 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-3; PFKL, phosphofructokinase L; PGK 1, 
phosphoglycerate kinase 1; PAI1, plasminogen-activator inhibitor 1; PKM, pyruvate kinase M; TGF-
, transforming growth factor- ; TGF-β3, transforming growth factor-β3; TPI, triosephosphate 
isomerase; VEGF, vascular endothelial growth factor; UPAR, urokinase plasminogen activator 
receptor; VEGFR2, VEGF receptor-2; VIM, vimentin. 
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HIF-1α is also reported to play a key role in apoptosis and cell survival. At the 
cellular and molecular level, cell survival is controlled by a balance between pro-apoptotic 
and anti-apoptotic signals. These signals are mediated by a large number of gene 
families. Pro-apoptotic signalling gene families include Bcl-2 family members like bcl-2, A1 
and bcl-X, whereas anti-apoptotic signalling gene families include Bax, Bad and Bid. HIF-
1α transfected HUVEC and HDMEC were observed to show an inhibition of proliferation 
by increasing the levels of tumour suppressor protein p53 induced p21Cip1, a cyclin 
dependant kinase inhibitor (CKI) and decreasing the levels of Bcl-2, a pro-apoptotic gene. 
Further reduction in the kinase activity of CDK4/6 was also observed in HIF-1  
transfected HMEC. Hence Iida et. al. propose that by up regulating p21 and reducing the 
activity of CDK4/6, HIF-1α plays a pivotal role in the cell cycle arrest at the G0/G1 phase 
(Iida et al. 2002). In murine embryonic fibroblasts and splenic B lymphocytes HIF-1α 
causes the arrest of cell cycle by inducing p21Cip1 and p27Kip1 independent of p53 (Goda et 
al. 2003). 
Few studies have investigated the role of diabetes/hyperglycaemia in the 
regulation of HIF-1α. Increased level of glucose in isolated fibroblasts of diabetic and non-
diabetic patients and ischemic tissues of wild type and diabetic mice caused decrease in 
the transactivation ability of HIF-1α leading to reduction in the expression of VEGF in 
response to hypoxia (Thangarajah et al. 2009). In human dermal fibroblasts and 
microvascular endothelial cells, hyperglycaemia in the presence of hypoxia dose 
dependently interfered with the stability and activity of HIF-1α. Inhibition of pVHL and p53 
independent proteosomal degradation of HIF-1α rectified the destabilising effect of 
hyperglycaemia (Catrina et al. 2004). High glucose concentrations and chronic hypoxia 
increased proliferation of bovine aortic smooth muscle cells (BASMC) via a HIF-1α 
mediated pathway. Higher glucose concentration attenuated the hypoxia-induced BASMC 
apoptosis by decreasing the levels of activity and expression of pro-apoptotic caspase-3 
and BNIP3L, with a concurrent increase in the expression of the anti-apoptotic protein Bcl-
xL (Gao et al. 2007). At an early stage of diabetic nephropathy, HIF-1α mRNA was found 
to be up regulated and remained elevated in isolated glomeruli of diabetic mice (Makino et 
al. 2006). In diabetic retinopathy, Alb-AGE activated the HIF-1 DNA binding activity 
mediated by an increase in the accumulation of the HIF-1α protein through an ERK-
dependent pathway. Thus, stimulation of VEGF expression by Alb-AGE, through the 
activation of HIF-1α, could play an important role in the development of diabetic 
retinopathy (Treins et al. 2001). Genetic polymorphisms associated with HIF-1α have also 
been demonstrated. A report suggests that HIF-1α is associated with the occurrence of 
T2DM by identifying a susceptibility coding SNP (cSNP) (P582S) and haplotype in the 
HIF-1α gene for T2DM (Yamada et al. 2005). 
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1.10 Silymarin 
 Hypoxia and hyperglycaemia are known to produce reactive oxygen species which 
have been implicated as a causative factor for the damage of tissues in diabetes. An anti-
oxidant such as silymarin has the potential to overcome the adverse effects of high 
glucose concentration and/or hypoxia on cell migration. Silymarin is an extract of the 
seeds of the milk thistle plant [Silybum marianum (L.) Gaertn. (Asteraceae); synonym 
Carduus marianus L.] native to the Mediterranean region (Kroll, Shaw and Oberlies 2007, 
Ramasamy and Agarwal 2008). It is a mixture containing 65-80% of silyamarin complex 
(made up of at least seven flavonlignans and a flavnoid) and 20-35% of fatty acids such 
as linoleic acid and other polyphelonic compounds (Kroll, Shaw and Oberlies 2007). 
Silyamrin mixture constitutes of seven flavanolignans namely silybin A, silybin B, isosilybin 
A, isosilybin B, silychristin, isosilychristin, silydianin and a flavanoid – toxifolin (Fig. 1.8) 
(Kim et al. 2003). 
The majority of therapeutic activity of silymarin is attributed to silybin, also spelt as 
silibin or called silibinin, as it is the most abundant constituent of silymarin. Silybin and 
isosilybin (also known as isosilibinin) are roughly 1:1 mixtures of two diastreoisomeric 
compounds of Silybin A and B and isosilybin A and B respectively and isosilybins are 
regioisomers of silybin (Lee and Liu 2003). Tincture prepared from milk thistle fruit has 
been reported to contain newer flavonolignan, silymandin (MacKinnon et al. 2007). The 
white flowering variety of Silybum marianum is known to contain silandrin, silymonin, 
silyhermin and neosilyhermin A and B in addition to the above mentioned regular 
flavonolignans (Szilagi et al. 1981). Along with the above mentioned compounds, the 
impurities present in the silymarin extracts could also be responsible for producing the 
anti-oxidant effects (Kvasnicka et al. 2003). 
1.10.1 Uses of silymarin 
 Silymarin has been in the use for the past 2000 years for the treatment of liver and 
biliary diseases (Post-White, Ladas and Kelly 2007). In the United States silymarin is sold 
under the different brand names such as Legalon, Silipide and Siliphos as dietary 
supplement, hence regulated as a food and so far not approved by US Food and Drug 
Administration for the treatment of any disorders (Post-White, Ladas and Kelly 2007). 
Silymarin produces its hepatoprotective activity by a unified mechanism through its 
anti-inflammatory, anti-oxidant and immunomodulatory effects involving scavenging and 
anti-oxidant effects on ROS induced oxidative stress and sustained inflammation in 
tissues (Comelli et al. 2007). Oxidative stress increases the production of ROS leading to 
the damage of cells and tissues. Many anti-oxidant enzymes such as superoxide 
dismutase (SOD), glutathione peroxidase (GSHPx), glutathione reductase (GR) and 
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catalase (CAT) help in the elimination of the ROS (Comelli et al. 2007). Silymarin is 
reported to produce its hepatoprotective actions by decreasing the levels of serum alanine 
aminotransferase (ALT), aspartate amino transferase (AST) and alkaline phosphatase 
(ALP) as well as total bilirubin against isoniazid, refampicin and pyrazinamide induced 
hepatotoxicity (Eminzade, Uraz and Izzettin 2008). 
 
 
 
Fig. 1.8 Chemical structures of main flavanolignans and a falvanoid (Reproduced with 
permission from Kim et al. 2003). 
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 Pretreatment of animals with silymarin prevented the hepatotoxicity caused by 
Cisplatin, an anti-cancer drug by decreasing the levels of ALT, AST, ALP and NO and by 
increasing the levels of GSHPx, SOD and GSH (Mansour, Hafez and Fahmy 2006). 
Similarly silymarin has been shown to produce hepatoprotective activities against many 
other hepato-toxins such as acetaminophen, methotrexate, diethylnitrosamine, ethanol 
and ionizing radiations (Comelli et al. 2007, Pradeep et al. 2007). Silymarin produces its 
hepatoprotective effect against hepatitis C virus by inhibiting the NF-κβ which in turn 
control the secretion of many cytokines such as TNF-α, interferon (IFN)-γ and IL-1 to 6 
from T-cells (Morishima et al. 2010). Silymarin and its components protect the liver tissue 
against hepatitis C infection through their anti-viral, anti-oxidant, anti-proliferative effects 
and by inhibition of TNF-α induced NF-κβ dependant transcription with a varying degree 
(Polyak et al. 2010). 
The results of clinical trails of silymarin use for hepatoprotective activity have not 
been uniform. In a study involving 170 patients, the treatment with silymarin proved to be 
effective against alcoholic cirrhosis compared to placebo treatment (Ferenci et al. 1989). 
In another trail involving 97 patients of acute and subacute liver disorder induced by 
alcohol received silymarin for the duration of four weeks. At the end of four weeks 
treatment, the silymarin group showed significantly lower levels of ALT and AST whereas 
the levels of total and conjugated bilirubin remained unchanged compared to the placebo 
group (Salmi and Sarna 1982). However, in a study involving 200 patients of liver injury 
due to alcohol the silymarin, after treating for two years, had no positive effect either on 
survival rate or on the prevention of liver injury (Pares et al. 1998). In a meta-analysis of 
the eighteen randomised trials conducted about the efficacy of silymarin, Rambaldi A et al. 
(2007) express their scepticism about the efficacy of silymarin as a hepatoprotectant 
against alcohol and/or hepatitis B or C induced liver damage (Rambaldi, Jacobs and 
Gluud 2007). 
In recent years silymarin has received attention for its ability to affect the outcome 
of cancer and its usefulness as an adjuvant therapy for cancer (Ramasamy and Agarwal 
2008). Silymarin is not only used as hepatoprotecatant but also to protect kidneys and 
heart during cancer treatment (Greenlee et al. 2007). Silymarin is proposed to produce its 
anti-cancer activity as a result of a combination of effects such as anti-inflammation, cell 
cycle regulation, induction of apoptosis, inhibition of invasion and metastasis, inhibition of 
proliferation and inhibition of angiogenesis (Ramasamy and Agarwal 2008). Silibinin 
produces its anti-cancerous activity by causing the arrest of progression of G1 phase of 
the cell cycle by inducing CKIs such as p21Cip1 and p27Kip1 in prostate cancer cell lines 
(Roy et al. 2007). Further, silibinin is also to known to inhibit cell proliferation by arresting 
the G2/M phase progression and by interfering with cell cycle regulators by decreasing the 
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levels of cyclin D1, D3, A and B1 and CDK 1, 2, 4 and 6 along with increasing the levels of 
p21Cip1 and p27Kip1 in advanced colorectal cancer and other tumour cell lines (Agarwal et 
al. 2006, Kaur et al. 2009). Apart from interfering with cell cycle regulators silibinin caused 
cell cycle arrest by down regulating the Rb-phosphorylation and E2F1/DP1 transcription 
complex and promotes apoptosis by down regulating survivin and up regulating the 
activated caspase-3 and 9 in hepatocarcinoma cells (Lah, Cui and Hu 2007). 
Silibinin is reported to produce antiangiogenic effect by decreasing the size of 
microvessels and the tumour expression of angiogenic cytokines such as IL-13 and TNF-α 
in lung adenocarcinoma of A/J mice (Tyagi et al. 2009). The expression of TIMP-1 and 2 
which are inhibitors of MMPs and ANG-2 and Tie-2 was increased by silibinin which 
produce an anti-angiogenic effect (Tyagi et al. 2009). Further, silibinin decreased the 
expression and nuclear localisation of HIF-1α and phosphorylation of NF-κβ and STAT-3 
which act as stimulants in angiogenesis in tumour cells (Tyagi et al. 2009). Silibinin 
inhibited angiogenesis by decreasing the expression of angiogenic stimulants such HIF-
1α, iNOS, PECAM-1, VEGF and down regulated VEGFR1 in trangenic adenocarcinoma of 
the mouse prostate model (Raina et al. 2008). In colorectal carcinoma, silibinin produced 
antiangiogenic effects by inhibiting not only HIF-1α, iNOS and VEGF but also by inhibition 
of COX1 and 3 (Singh, Gu and Agarwal 2008). Silymarin reduced the number of HUVECs 
and inhibited tube formation by decreasing the secretion of MMP-2 and VEGF (Jiang, 
Agarwal and Lu 2000). In HUVECs and HMVECs, silymarin caused the arrest of cell cycle 
progression by increasing the expression of p21, p27 and p53 and induce apoptosis by 
the increase of Bax and the decrease of Mcl-1 and survivin proteins (Singh et al. 2005). 
Topical application as well as oral feeding of silibinin decreased the ultraviolet B 
irradiation induced proliferation and apoptosis in SKH1 hairless mouse skin by inhibiting 
the phosphorylation of MAPK/p38, ERK1/2, JNK1/2 and Akt (Gu et al. 2005). Silibinin 
produces its anti-proliferative and pro-apoptotic activity by inhibiting the phosphorylation of 
MAPK/ERK pathways in gastric and renal cancer cells (Kim et al. 2009, Li et al. 2008). 
Further, Zi and Agarwal (1999) suggested that silibinin produced anti-proliferative and pro-
apoptotic effects in skin cancer cells by MAPK/ERK inactivation at a lower dose and 
MAPK/JNK1 activation at higher dose (Zi and Agarwal 1999). Silibinin reduced the 
invasiveness of lung cancer cells by inhibiting ERK1/2 and Akt activation along with 
inactivation of NF-κβ and JNK pathways. Further, PI3K and MEK inhibitors reduced the 
expression of MMP-2 and u-PA which were in turn inhibited by silibinin, suggesting that 
the silibinin effects involve MAPK and PI3K pathway (Chen et al. 2005). Silibinin produce 
anticancer effects in cervical and hepatoma cancer cells by reducing the accumulation 
and transcriptional activity of HIF-1α and decreasing the expression of VEGF which was 
potentiated by PI3K inhibitor (Garcia-Maceira and Mateo 2009). In other cells such as glial 
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cells, cardiac myocytes and neutrophils beneficial effects of silibinin are regulated by PKC 
activity along with other pathways (Tsai et al. 2010, Varga et al. 2004, Zhou et al. 2007). 
1.10.2 Silymarin and diabetes 
 In spite of established anti-oxidant effect of silymarin being exploited in hepatic 
and cancer disorders, very few reports exist about the effect of silymarin in diabetes. In 
clinical trails involving type 2 diabetes patients, silymarin reduced the levels of fasting 
glucose level, glycated haemoglobin, total cholesterol, LDL, triglyceride, SGOT and SGPT 
when administered along with conventional or glibenclamide (Huseini et al. 2006, Hussain 
2007). In another study involving patients of diabetes with liver cirrhosis, the blood 
glucose levels and fasting insulin levels decrease due to the administration of silymarin 
leading to reduced lipid peroxidation and insulin resistance (Velussi et al. 1997). These 
results were further confirmed in patients of T2DM with concomitant liver disorder when 
silybin-beta-cyclodextrin, a silibinin formulation reduced the blood glucose and 
triglycerides levels (Lirussi et al. 2002). 
Silymarin prevented the alloxan from producing its deleterious effects on renal 
tissues and restored the level of SOD, GSPHx and CAT to their normal levels in rats (Soto 
et al. 2010). Earlier Soto et al. (2004) argued that silymarin reduced alloxan induced 
pancreatic tissue damage and was able to bring the level of glucose and expression of 
insulin and glucagon close to the level of control animals (Soto et al. 2004). In addition to 
improving the above mentioned glutothione enzymes levels, silymarin prevented alloxan 
induced pancreatic destruction by preventing the lipid peroxidation as well (Soto et al. 
2003). Silibinin has been reported to produce its anti-hyperglyceamic effects by inhibiting 
the gluconeogenesis and glycogenolysis in hepatic cells of rats by inhibiting glucose-6-
phosphatase activity and decreasing the phosphorylation of glucose-6-phospahate which 
is essential for production of glucose (Guigas et al. 2007). This decrease in hepatic 
glycolysis is accompanied by a reduction in the formation of ROS from the mitochondrial 
electron transfer chain (Detaille et al. 2008). Pretreatment of RINm5F insulinoma cells and 
human islet cells with silymarin protected them against IL-1β and/or IFN-γ induced cell 
damage by partial decrease of the production of NO and expression of iNOS in a dose 
dependent manner. Further, silymarin protected RINm5F insulinoma cells from IL-1β 
induced NO production and cell destruction via partial inactivation of c-Jun NH2 terminal 
kinase (JNK) and human islets from IFN-γ induced iNOS expression and cell destruction 
via inactivation of Janus kinase/stress transducer and activator of transcription 
(JAK/STAT) proteins (Matsuda et al. 2005). Taken together, the anti-hyperglycaemic 
effect of silibinin is a result of directly decreasing glycolysis, cytoprotective effects on 
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pancreatic cells, augmentation of anti-oxidant enzymes as well as free radical scavenging 
activity. 
1.11 Topical Applications 
 One of the aims of this project was to develop a freeze dried wafers containing 
silymarin for topical application. Developments in the topical applications field has 
witnessed a rapid growth from simple bandages to modern topical applications for 
sustained release of therapeutic agents (reviewed in detail by Boateng et al. 2008). As 
with any other wound treatment, recalcitrant diabetic wounds require a suitable drug 
delivery system which releases the drug at the wound site with minimum systemic effects, 
while maintaining the stability of therapeutic agent intended to be released and also to 
show considerable therapeutic effect. One such drug delivery system is lyophilized or 
freeze dried wafers for the delivery of drugs as a topical applicant. Many reports suggest 
that lyophilized wafers could be prepared for the delivery of various therapeutic agents 
such as anti-bacterials, growth factors and other supplements such as vitamins and anti-
oxidants using a variety of vehicles (Boateng et al. 2008). 
Various polymers are used as vehicles to deliver the drugs in preparation of topical 
applications. Matthews and co-workers report the preparation of lyophilized wafers using 
sodium alginate and xanthan gum containing methyl cellulose. They tested these wafers 
on cut water melon serving as a suppurating wound surface model for qualitatative 
measurement (Matthews et al. 2005). The water insoluble drugs such as UK370106, a 
MMP-3 inhibitor could be formulated as lyophilized preparations using non ionic surfactant 
and xanthan gum as a vehicle (Matthews et al. 2008). 
PDGF and other growth factors have been proved to be beneficial in normal 
wound healing and some of their formulation as topical application has led to their 
regulatory approval (Falanga 2005). Attempts have been made to test the effect of growth 
factors on fibroblast cells of diabetic wounds by the incorporation of EGF, IGF-1, PDGF-
AB, and bFGF in various formulations (Loots et al. 2002). A chitosan film, prepared by 
freeze-drying hydroxypropylchitosan acetate buffer solution incorporated with bFGF 
solution applied on full-thickness wounds created on the backs of genetically diabetic mice 
reduced the wound size (Mizuno et al. 2003). In another study the chitosan hydrogels 
prepared by UV irradiation containing bFGF are reported to enhance the HUVECs growth 
and also induce the faster contraction of wounds in diabetic mice (Obara et al. 2003). 
TGF-β1 incorporated into various formulations was successfully tested for wound healing 
activity in diabetic rats (Puolakkainen et al. 1995). 
There are very few reports about the lyophilisation of anti-oxidants with an 
intention of using them as topical applications for diabetic wounds. The wound dressings 
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prepared by lyophilising chlorhexidine diacetate with 5-methylpyrrolidinone chitosan as a 
vehicle produced not only anti-bacterial but also anti-oxidant activity (Rossi et al. 2007). 
Topical application of silymarin successfully prevented the photo-carcinogenesis of UV 
radiation on skins of mice and different components of silymarin permeate through skin 
with varying degree (Gu et al. 2005, Hung et al. 2010). However, there are no reports 
about the lyophilized preparations of silymarin as a topical application for wounds except 
for a report which uses lyophilized silymarin nano particles to characterise a development 
of a new polymer (Guhagarkar, Malshe and Devarajan 2009). 
Sterile formulations are desirable in the treatment of chronic wounds of diabetes in 
order to avoid the possibility of increasing the microbial load at the wound site. Lyophilised 
wafers cannot be heat sterilised or autoclaved as the wafer structure would collapse due 
to heat and/or pressure risking the stability of the therapeutic agent. Therefore, gamma 
irradiation was employed to sterilise the lyophilised wafers (Matthews et al. 2006). Further 
detail about the freeze dried wafers is provided in chapter 7. 
Taken together, there is a need to understand the effect of high glucose and 
hypoxia on the migration of endothelial cells at molecular level in order to understand 
angiogenesis during the wound healing process. As the production of ROS is proven to be 
a precursor in the development of vascular complications of diabetes, the therapeutic 
potential of anti-oxidants such as silymarin at least as an adjuvant therapy should be 
explored. 
1.12.1 Aim and objectives of the study 
This study aims to develop a suitable in vitro method of measuring the migration of 
endothelial cells simulating the angiogenesis stage of the wound healing process in 
diabetes and determine if there are any beneficial effects of silymarin on cell migration. 
1.12.2 Objectives of the study 
1. Develop a migration and wound healing method by validating and optimising a pre-
existing model. 
2. Determine the effects of hypoxia and hyperglycaemia on the migration of dermal 
microvascular endothelial cells and underlying molecular mechanisms. 
3. Develop a freeze dried formulation containing silymarin and test the beneficial 
effects of silymarin on the changes in the migration owing to varying concentration 
of glucose and oxygen tension. 
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2.1.1 Materials 
All chemicals used in the study were purchased from Sigma-Aldrich (Poole, UK) 
unless otherwise stated. Cell culture materials were purchased from Invitrogen (Paisley, 
UK) and all cell culture plastics and glassware from Fisher Scientific UK Ltd 
(Loughborough, UK), unless otherwise stated. Microvascular cell reagents were 
purchased from Cascade biologics (Invitrogen Ltd. Paisley, UK). All the materials were 
used as supplied as described in the text. 
2.1.2 Endothelial Cells (ECs) 
Human umbilical vein endothelial cells (HUVECs) and human microvascular 
endothelial cells (adult dermis) (HMVECad) were used at different stages during the 
study. The majority of the preliminary work was carried out with HUVEC before moving 
onto the primary HMVECad cell line. 
HUVECs were cultured from an immortalised cell line purchased from the 
European Collection of Cell Cultures (ECACC). HUVECs were propagated from a 
cryopreserved primary culture isolated from normal human umbilical vein. The cells used 
during the study were of passages between 60 and 70. 
The primary human microvascular endothelial cells were cryopreserved from adult 
dermis at the end of tertiary culture (i.e passage 2) were purchased from Cascade 
Biologics (Invitrogen Ltd. Paisley, UK). The cells were tested by the company for the 
presence of von Willebrand factor (vWF), CD31 antigen, and CD36 antigen and for the 
absence of α-actin. The uptake of DiI-Ac-LDL (Acetylated Low Density Lipoprotein, 
labelled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate) was 
confirmed. The absence of Hepatitis B, Hepatitis C, and HIV-1 viruses, mycoplasma, 
yeast and fungi was also confirmed. The HMVECad of passage number of 7 to 16 were 
used for all experiments carried out in this study. 
2.2 Methods 
2.2.1.1 Cell count by Trypan blue dye exclusion method 
Viable cell number was determined by means of trypan blue dye exclusion. The 
cells were counted in order to seed experimental six well culture plates or for further sub 
culturing or for cryopreservation with the appropriate number of cells. An aliquot of 20µl of 
cell suspension was mixed by a gentle swirl (finger vortex) with 0.4% v/v of trypan blue 
dye at a 1:1 ratio and left to stand for 2 min to allow the dye to penetrate any non-viable 
cells. Trypan blue dye stains any dead or dying cells dark blue by permeating through 
their damaged cell membrane. Using a Pasteur pipette, a small volume ~10µl of the cell 
suspension was applied to the edge of cover slip placed on a Neubeur haemocytometer 
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and allowed to fill the area under the cover slip by means of capillary action. The cells 
were viewed under a microscope at 100x magnification. Viable cells were counted in the 
25 squares contained within the large square (of 1mm2 area) edged by double lines on 
both grids. The mean value of the two sides of the slide was noted before calculating total 
viable cell number as follows; 
 
Number of cells/ml = cell count per large square x dilution factor x 104 
 
The 104 in the above equation is a conversion factor used to convert 10-4ml to 1ml. This 
conversion factor is based on volume of the cell suspension present in one large square 
(of 1mm2 area) of the haemocytometer. 
(Volume of 1 large square = 1mm x 1mm x 0.1mm = 0.1cm x 0.1cm x 0.01cm = 10-4 cm3 = 
10-4 ml) 
2.2.1.2 Cell resuscitation 
 Aseptic procedures were used when working with cultured cells or any procedures 
linked to their use. A dedicated cell culture lab with a laminar flow air hood (Aura 2000, 
Bioair Instruments) was used. All solutions were filter or autoclave sterilised, plastics were 
autoclave sterilised and glassware was heat (180 0C for 2.5 h) sterilised prior to their use. 
The HUVECs and HMVECad were supplied as a cryopreserved vial of ≥ 3.75 x 105 
and 5 x 105 viable cells per ml respectively.  The cell lines of HUVECs were initiated into 
75cm2 flasks (T-75) and HMVECad into 25 cm2 flasks (T-25). The T-75 flasks for HUVECs 
were non-coated, whereas the T-25 flasks used for HMVECad were coated prior to use 
with sterile attachment factor (AF) (1x) solution made up of 0.1% gelatine (Cascade 
Biologics, UK). Two ml of AF solution was added to each of T-25 flasks. The flasks were 
gently agitated to allow the AF to cover the flask surface and incubated at 37 0C for 30 min 
or at room temperature for 2 h. The AF solution was completely removed by aspiration 
prior to the addition of cell suspension or medium. The coated flasks were used either 
immediately or capped tightly and stored at room temperature for using within 24 h. 
A cryopreserved vial of HUVECs or HMVECad was thawed by dipping the lower 
half of the vial in 37 0C water bath. The cell count was determined using Trypan blue as 
explained in previous section 2.2.1.1. A cryopreserved vial containing HUVEC suspension 
(1ml) was pipetted into a T-75 flask containing 10ml of culture media at the rate of 5x103 
to 1x104 cells per cm2 area of a flask. The culture media for HUVECs was prepared by 
diluting glucose free Glasgow’s Minimal Essential Medium (G-MEM) (10x) (40ml) with 
15ml of 7.5% NaHCO3, 5ml of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) buffer and 50ml of tryptose phosphate broth to make 432ml of 1x G-MEM 
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(Macpherson and Stoker 1962). The diluted G-MEM was prepared into 87ml aliquots and 
stored at 4 0C until required. When used for HUVEC, the diluted G-MEM was combined 
with 10% (v/v) foetal calf serum (FCS), 2mM L-glutamine, 5mM D-glucose and 1 unit/ml 
penicillin, 1µg/ml streptomycin. All media for HUVEC was warmed to 37 0C before use. 
The contents of the vial (1ml) containing HMVECad was diluted to a concentration 
of 2.5 x 104 viable cells/ml using microvascular growth supplement (MVGS) supplemented 
M-131. Each of an AF-coated T-25 flask was added with 5ml of the resulting cell 
suspension. M-131 is a basal medium containing essential and non essential amino acids, 
vitamins, other organic compounds, trace minerals, inorganic salts and 5.6mM D-glucose. 
MVGS is supplied as a concentrated (20x) solution containing foetal bovine serum (5% v/v 
final concentration), hydrocortisone, recombinant human fibroblast growth factor, heparin, 
recombinant human epidermal growth factor, and dibutyryl cyclic AMP.  
Following initial cell seeding, the flasks were left undisturbed for 24 h in humidified 
atmosphere of 5% CO2/95% air in an incubator (Galaxy S, Wolf Laboratories) at 37 
0C. 
The media was replaced after 24 h to remove the traces of dimethylsulfoxide (DMSO) and 
any dead cells/debris. The media was changed every alternative day until the cells 
reached 60 % confluence. Once the cells reached 80% confluence, they were trypsinised 
for either sub-culturing as explained in section 2.2.1.4 or frozen for long term storage as 
explained below. 
2.2.1.3 Cell storage 
The supernatant obtained after centrifugation of trypsinised cell suspension was 
removed and the cell pellet was re-suspended in cryopreservation medium. The HUVECs 
were frozen in G-MEM containing 10% v/v of DMSO at a concentration of 3.75x105 to 
7.5x105 cells per ml. The HMVECad were re-suspended in cold Synth-a-Freeze solution 
at a concentration of 5x105 to 3x106 cells per ml. Synth-a-Freeze solution is a sterile liquid 
cryopreservation medium containing 10% DMSO. It does not contain any antibiotics, 
antimycotics, hormones, growth factors, serum, or proteins and is HEPES and 
bicarbonate buffered. The cell suspension was aliquoted into an appropriate number of 
cryopreservation vials. The vials containing 1ml of cell suspension were cooled to 4 0C as 
quickly as possible and were transferred overnight to -80 0C. The following day the vials 
were transferred to the vapour phase of a liquid nitrogen refrigerator (LS3000, Taylor and 
Wharton, USA, liquid nitrogen capacity – 81l). 
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2.2.1.4 Routine sub-culture 
To harvest HUVECs for subculture, growth medium was poured off and the 
monolayer was rinsed three times with 10ml calcium and magnesium free Hank’s 
balanced salt solution (HBSS). The final wash was allowed to incubate for 10 min to 
remove all trace of serum containing medium. The cells were removed from the flask by 
incubating for 10 min with 5ml of 0.25% (v/v) trypsin solution. The flask was gently 
agitated for no longer than 2 min to detach the cells. An equal volume of medium 
containing FCS was then added to the flask to neutralize the enzymatic activity of the 
trypsin. The cell suspension of the flask was removed to a sterile universal tube. The cells 
in the suspension were pelleted by centrifugation (Biofuge PrimoR, Heraeus, Germany) at 
220g force for 5 min. The supernatant was removed and the cell pellet was re-suspended 
in 1ml of fresh medium. The cell count was then determined using the Neubeur 
haemocytometer as explained earlier in section 2.2.1.1. For routine subculture, a sterile T-
75 flask was used and 5x103 cells per cm2 were supplemented with 10ml of fresh medium. 
To harvest HMVECad for subculture, growth medium was poured off into a sterile 
empty beaker. Following the addition of 3ml of Trypsin/EDTA solution (Trypsin/EDTA 
solution (1x) is a phosphate buffered, sterile solution containing 0.025% trypsin and 0.01% 
ethylenediaminetetraacetic acid (EDTA), Cascade Biologics, UK) the flask was gently 
rocked to ensure that the entire surface was covered. The flask was immediately emptied 
and 1ml of fresh Trypsin/EDTA solution was added. The cells were incubated at room 
temperature (RT) for approximately 4 to 6 min until they were completely round. The flask 
was agitated gently, without exposing the cells for an excessive length of time to the 
Trypsin/EDTA solution, to dislodge the cells from the surface of the flask. Trypsin 
Neutraliser (3ml) solution (a sterile, phosphate buffered, calcium and magnesium free 
solution (1x) containing 0.5% newborn bovine serum) (Cascade Biologics, UK) was added 
to the flask and detached cells were transferred to a sterile universal tube. An additional 
3ml of Trypsin Neutraliser solution was added to the flask and the solution was pipetted 
over the flask surface several times to dislodge any remaining cells. This solution was 
aspirated into a universal tube and centrifuged at 180g for 7 minutes. The supernatant 
was removed from the tube. The cell pellet was re-suspended in 5ml of MVGS 
supplemented M-131 and gently pipetted up and down several times to ensure a 
homogenous cell suspension. The cell count was determined using the Neubauer 
haemocytometer as explained earlier in section 2.2.1.1. The cell suspension was diluted 
in MVGS supplemented M-131 to give 5000 cells per cm2 and added to the new culture 
flasks freshly coated with AF. 
The flasks containing newly sub-cultured cells were transferred to an incubator 
and left undisturbed overnight to allow the cells to adhere and begin to grow. The growth 
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of cells was checked daily under the microscope and by observation of any change in the 
colour of medium, indicative of pH changes. 
2.2.1.5 Cell growth conditions 
The effect of normoxia (ambient O2 tension) (N) or hypoxia (5% O2 tension) (H) 
and normal (5mM) or elevated (20mM) glucose level was assessed by exposing the cells 
to these conditions for a specified period of time. The N5mM or N20mM conditions were 
achieved by growing the cells in media containing 5 or 20mM of D-glucose concentration 
in humidified atmosphere of 5% CO2/95% air in an incubator (Galaxy S, Wolf 
Laboratories) (subsequently referred to as normoxia) at 37 0C. Similarly, the H5mM or 
H20mM conditions were achieved by growing the cells in media containing 5 or 20mM D-
glucose in a humidified atmosphere of 5% O2/ 5% CO2/ 90% air in a  Galaxy R CO2 
incubator (Wolf Laboratories) (subsequently referred to as hypoxia) at 37 0C. The hypoxic 
condition was created and maintained by purging oxygen from the incubator with nitrogen.  
Different levels of glucose concentration (either 5mM or 20mM) in the media were 
achieved by adding the required quantities of previously prepared 1M D-glucose stock 
solution. Ten ml of 1M D-glucose stock solution was prepared by filter sterilisation 
(0.22µm syringe filter, Millipore) and stored at 4 0C until further use. It was prepared using 
glucose free/serum free (GF/SF) G-MEM to supplement the media of HUVEC and M-131 
to supplement the media of HMVECad. 
All the experiments involving the endothelial cells were carried out using 6 well 
plates. Where appropriate, the cells were supplemented with hydroxyurea 5mM, D-
Mannitol 5 or 20mM, silymarin (SM) 50µM, α-lipoic acid (aLA) 100µM, PKCβII/EGFR 
Inhibitor [4,5-bis(4-Fluoroanilino)-phthalimide] 1µM (Calbiochem, Merck Chemicals, 
Nottingham), p42/p44 MAPK Inhibitor (2′-Amino-3′-methoxyflavone) (PD98059) 2µM 
(Calbiochem, Merck Chemicals, Nottingham) and PI3K Inhibitor   [2-(4-Morpholinyl)-8-
phenyl-4H-1-benzopyran-4-one] (LY294002) 10µM (Invitrogen, UK). DMSO and ethanol of 
molecular biology grade were used as a solvent wherever appropriate at a final 
concentration of ≤ 0.7% v/v. 
The methods described below are the final methods used following the validation 
of radial migration and wound healing assay. The process by which the methods were 
validated is dealt with, in detail in chapter 3. 
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2.2.2 Formation of circular monolayers 
Heat sterilised (180 0C for 2.5 h) glass cloning rings (Corning, UK) of 6 x 8mm 
(outer diameter x height) were placed centrally within each well of a non-coated 6 well 
tissue culture plates (Nunc, Denmark) having an area of 10.17 cm2 per well (Fig. 2.1). The 
HUVECs were grown on non-coated surface without any coating. The culture plates were 
coated with 1.5ml of AF as described in section 2.2.1.2 before placing the glass rings in 
them, if HMVECad were to be grown onto them. The HUVEC and HMVECad were 
seeded into each glass ring at a density of 2 x 105 viable cells per ml, in a volume of 40µl.  
The 6 well plates were returned to the normoxic incubator for either overnight (in case of 
HUVECs) or 4 h (in case of HMVECad) to allow the cells to adhere to the plastic surface. 
The HMVECad successfully adhered to the treated surface within 4 h, but HUVEC took 
around 12 h to attach to the non-treated surface of the plates. The optimal incubation 
required for the cell adhesion of different cell types was determined experimentally. The 
shorter time period required for HMVECad may be due to the presence of AF and/or the 
other cell surface properties. This was not investigated further. After cell adhesion, the 
rings were taken off and the wells were supplemented with 2.5ml of appropriate growth 
media. The plates with circular cell monolayers were returned to the appropriate 
incubation conditions for further 24 and/or 48 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 – Materials and methods 
- 51 - 
a) Cross sectional view with rings 
 
b) Cross sectional view after the removal of rings 
 
c) Aerial view of cell monolayers 
 
Fig. 2.1 Formation of circular cell monolayers The HMVECad or HUVEC were seeded 
in to glass rings (6mm outer diameter) at the centre of the wells of a 6 well plate (a). After 
initial incubation, the rings were taken off and the plates were returned to an incubator 
with wells filled with 2.5ml of media (b). Aerial view of the plates would reveal the 
formation of circular monolayer (4-5mm) of cells (c). 
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2.2.3 Radial migration assay 
The images of the circular monolayers were acquired digitally at 0 h, before 
incubating in different conditions, and at 24 and 48 h using an inverted microscope (DMI 
4000B, Leica Microsystems, Germany) at 25x magnification. The photomicrographs were 
analyzed by measuring the radii of the circular cell monolayers to determine the migration 
of cells with the help of Leica (QWin Standard v 2.8, Image Processing and Analysing 
System) software. 
An image acquired at 0 h was opened (Fig. 2.2a) using File Menu >Open tool. 
 
 
 
Fig. 2.2a Radial migration assay Image of a cell monolayer photographed at 0 h used to 
illustrate image analysis. 
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The annotation toolbox was opened using Image Menu > Annotate Applet > Start 
tool. A circle was drawn by selecting three points on the circumference of the monolayer 
with help of a Circle calibrated measurement button on the annotation toolbox. A circle 
with its diameter at the centre was displayed. The annotation was stopped by pressing 
Image Menu > Annotate Applet > Stop tool. 
 
 
 
Fig. 2.2b Radial migration assay The annotated circle was overlaid on the cell 
monolayer, with the diameter of the circle displayed at the centre.   
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Next Binary Menu > Binary graphics tool was used to open the binary graphics 
dialog box. The radial blue lines were drawn within a binary plane of an image by 
selecting Spokes type of graphics (Fig. 2.2c). The settings for spokes were defined by 
Spacing at an angular spacing of 90 between two spokes. The position of the spokes was 
adjusted so that the blue radial lines were originating from the centre of a circle. The size 
of the spokes was also adjusted, so that the blue radial lines nearly touched the 
circumference of the annotated circle. 
 
 
 
Fig. 2.2c Radial migration assay The blue coloured radial spokes with the angular 
spacing at 90 was overlaid at the centre of the annotated circle. The lengths of spokes 
were adjusted to not to touch the circumference of the monolayer as they could obscure 
the visibility of the cells at the edge. 
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Annotation toolbox was displayed again by using Image Menu > Annotate Applet > 
Start tool. The circle was selected with help of Select object button and deleted using 
Remove selected objects button on the annotation toolbox. Ten black lines were manually 
drawn on either side of the monolayer using a Point-Point calibrated measurement button. 
These black lines were drawn on the blue spokes from centre to the circumference of a 
circular monolayer. The distance (in µm) of black lines was displayed at their centre (Fig. 
2.2d). 
 
 
 
Fig. 2.2d Radial migration assay The manually drawn black lines on the blue spokes 
display the radius of each line. The radial distances on either side of the monolayer were 
regarded as the radial migration.    
In total, lengths of twenty radial lines per image were noted down on a excel 
spread sheet. The same procedure was repeated for the images of 24 and 48 h. Net 
migration was defined as the difference between the length of radial lines at 24 or 48 h 
with that 0 h. Net migration as mean ± SEM of twenty radii, unless otherwise stated, is 
presented in the results section. 
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2.2.4 Wound healing assay 
The HMVECad were grown in a circular monolayer in 6 well plates as explained in 
section 2.2.2. Once the glass rings were removed, the centre of a circular monolayer was 
approximately marked on the underside of the plastic to provide a reference point for 
subsequent measurements. Approximately half of the circular monolayer was removed 
using a cell scraper (Cell scraper, 23, Nunc, Denmark) and the well was then washed with 
phosphate buffered saline (PBS) to remove the detached cells and cell debris. This 
resulted in a semi-circular monolayer with both an intact edge and a wounded edge (Fig. 
2.3a). The plates were returned to the appropriate incubation conditions for 48 h with 
2.5ml of medium in each well. 
Images of a semi-circular monolayer were acquired digitally at 0 h, before 
incubating in different conditions, and at 24 and 48 h using an inverted microscope (DMI 
4000B, Leica Microsystems, Germany) at 25x magnification. The photomicrographs were 
analyzed by measuring ten radial distances from the intact edge and ten parallel distances 
from the wounded edge of the semi-circular cell monolayers (Fig. 2.3g). The migration 
distance of cells was measured with the help of Leica (QWin Standard v 2.8, Image 
Processing and Analysing System) software. 
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The image of the monolayer at 0 h was opened by File Menu > Open tool. The 
annotation toolbox was opened with help of Image Menu > Annotate Applet > Start tool. 
The shape of a semi-circular monolayer with a pre-marked reference point was drawn 
using Draw free hand button of annotation toolbox. The pre-marked reference point was 
helpful in identifying the original edges of monolayer when the annotated shape at 0 h 
would be superimposed over the images of either 24 or 48 h. 
 
 
 
Fig. 2.3a Wound healing assay The shape of the semi-circular monolayer and the pre-
made point mark on underside of the plate as a reference point was annotated on the 
image of a monolayer. 
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An image of a same monolayer acquired at 24 h was opened by File Menu > Open 
tool. The annotated shape of semi-circular monolayer of 0 h was superimposed on an 
image taken at 24 h as shown in Fig. 2.3b. A circle was drawn by selecting three points on 
the circumference of the intact edge of monolayer with help of a Circle calibrated 
measurement button on the annotation toolbox. A circle with its diameter was displayed at 
the centre. After drawing the circle, the annotation was stopped by pressing Image Menu 
> Annotate Applet > Stop tool. 
 
 
 
Fig. 2.3b Wound healing assay Annotated shape of 0 h was superimposed on the image 
of 24 h and its position is adjusted using the pre-drawn underside reference point.  
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Next Binary Menu > Binary graphics tool was used to open the binary graphics 
dialog box. The blue radial lines were drawn within a binary plane of an image by 
selecting Spokes type of graphics. The settings for spokes were defined by Spacing at an 
angular spacing of 90 between two spokes. The position of the spokes was adjusted so 
that the blue radial lines were originating from the centre of a circle. The size of the 
spokes was also adjusted, so that the blue radial lines nearly touched the circumference 
of the annotated circle (Fig. 2.3c). 
 
 
 
Fig. 2.3c Wound healing assay The blue coloured radial spokes with the angular 
spacing at 90 was overlaid at the centre of the annotated circle. The lengths of spokes 
were adjusted to lie between the circumference of the annotated image of 0 h and the 
circumference of the monolayer at 24 h. 
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Annotation toolbox was displayed again by using Image Menu > Annotate Applet > 
Start tool. The annotated circle was selected with the help of Select object button and 
deleted using Remove selected objects button on the annotation toolbox. Ten black lines 
were manually drawn on intact edge of the monolayer using the Point-Point calibrated 
measurement button. These black lines were drawn on the blue spokes from the 
circumference of annotated image taken at 0 h to the circumference of semi-circular 
monolayer of 24 h. The length (in µm) of black lines was displayed at their centre. The 
length of these lines was considered as the net migration of cells from intact edge of 
monolayer. The lengths of ten radial lines per image were noted down on a excel spread 
sheet. 
 
 
 
Fig. 2.3d Wound healing assay The black lines were drawn on the blue spokes from the 
circumference of the annotated image of 0 h to the circumference at 24 h. 
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Annotation was stopped and the binary graphics dialog box was opened. The 
dialog box was used to draw the parallel lines by selecting Grid type of graphics within a 
binary plane of the image. It produces a rectangular grid consisting of a number of 
horizontal and vertical lines.  The settings for the grid were defined by Spacing (µm) 
resulting in lines of 200µm x 80µm (width x height). The position of the grid was adjusted 
so that the left arm of the grid was near to the wounded edge of monolayer. The size (µm) 
of the grid was 200 x 1040 (width x height). The graphic’s orientation was used to rotate 
the grid so that it was in line with the wounded edge. 
 
 
 
Fig. 2.3e Wound healing assay The blue coloured rectangular grid with the lines of 
length 200µm wide and spacing of 80µm between them was overlaid at the wounded 
edge of the monolayer. The blue rectangular grid was adjusted so that one arm of it is 
within the black line representing the wounded edge of 0 h and the other arm near to the 
edge of the monolayer of 24 h. 
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Annotation toolbox was displayed again by using the Image Menu > Annotate 
Applet > Start tool. Ten lines were manually drawn from the wounded edge of the 
monolayer using Point-Point calibrated measurement button. These lines were drawn on 
the lines of grid from wounded edge of 0 h to the new edge at 24 h. The lengths (in µm) of 
these lines were displayed at their centre. The length of these lines was considered as the 
net migration of cells from the wounded edge of a monolayer. The lengths of ten parallel 
lines per image were noted down on a excel spread sheet. 
 
 
 
Fig. 2.3f Wound healing assay The black lines were drawn on the blue lines from the 
wounded edge of the annotated image of 0 h to the edge at 24 h. 
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The whole procedure was repeated for an image of 48 h or alternatively the 
graphics on an image of 24 h were superimposed on an image of 48 h. The net migration 
was recorded by extending the lines to the new edge on the either side of the monolayer. 
 
 
 
Fig. 2.3g Wound healing assay The lengths of black radial and parallel lines were noted 
as net migration from the intact and the wounded edge of the monolayer respectively. 
 
Net migration presented in the results section, is given as the mean value of ten 
lines from each image, unless otherwise stated, each from the intact and wounded edge. 
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2.4 Immunocytochemical staining 
2.4.1 Background 
Immunocytochemical staining was employed to visualise specific proteins viz. 
hypoxia inducible factor -1α (HIF-1α), p27Kip1, platelet endothelial cell adhesion molecule 
(PECAM) -1 and actin in endothelial cells. The method employed is known as streptavidin-
biotin complex/alkaline phosphatase method (Fig. 2.4). This method was used for the 
detection of an antigen by light microscopy. The high affinity non-covalent bonding of 
biotin (vitamin H) with avidin and streptavidin is exploited in immunocytochemical 
detection (Molecular probes, handbook, Invitrogen). Avidin, an egg white protein and 
streptavidin, obtained from bacteria possess four binding sites for biotin. Avidin, being a 
glycoprotein with isoelectric point of 10, binds non-specifically to lectin like and negatively 
charged cell components at physiological pH. On the other hand, streptavidin with its 
more neutral iso-electric point and lack of oligosaccharide residues results in less non-
specific binding. The biotin molecule conjugates easily with antibodies and enzymes. Up 
to 150 biotin molecules can be attached to one antibody molecule. The secondary 
antibodies are conjugated to biotin and function as a link between antigens on the tissue 
or cell bound primary antibodies. The labelled streptavidin-biotin method utilizes a 
biotinylated secondary antibody that links primary antibody to a streptavidin-alkaline 
phospatase conjugate. Streptavidin-alkaline phosphate conjugate is a highly sensitive 
detector conjugate. This conjugate binds to biotin labelled secondary antibody. A single 
primary antibody subsequently is associated with multiple enzyme molecules, and 
because of the large enzyme-to-antibody ratio, a considerable increase in sensitivity is 
achieved.  
Endogenous alkaline phosphatase activity can be inhibited by addition of levamisol 
to the substrate solution. Napthol AS-MX phosphate is used as substrate. The alkaline 
phosphatase hydrolyses napthol phosphate esters (substrate) to phenolic compounds and 
phosphates. Insoluble coloured azo dyes are produced when the phenols couple with 
colourless diazonium salts (chromogen). The chromogen FastRed TR produces bright red 
end product. Aqueous mounting media must be used as FastRed TR is soluble in 
alcoholic and other organic solvents. 
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Fig. 2.4 Alkaline phosphatase labelled Streptavidin-Biotin method Alkaline 
phosphatase labelled streptavidin conjugates with biotinylated secondary antibody. The 
primary antibody is attached to multiple enzymes. The amplification of antigen signal is 
considerable due to the large enzyme to antibody ratio. (As adapted from 
‘Immunohistochemical Staining Methods’, Fourth Edition, Dako Corporation, 2006) 
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2.4.2 Method 
The circular or semi-circular endothelial cell monolayers were washed three times 
in ice cold PBS (0.01M phosphate buffer, 0.0027M potassium chloride and 0.137M 
sodium chloride, pH 7.4) at 48 h and fixed for 10 min in 4% paraformaldehyde (PFA) 
prepared in PBS solution. Preparation and fixation using PFA was carried out in a fume 
cupboard. After fixation, the cells were air dried and were either used immediately or 
stored at -20 0C for later use. The cells which were frozen were removed from the -20 0C 
freezer, and allowed 90 min to come up to room temperature prior to immunocytochemical 
detection. 
The region to be stained was delineated either using a wax pen (Mini Pap Pen, 
Zymed, Invitrogen) or in situ frames of 25µl capacity (Eppendorf AG, Germany). The cells 
in 6 well plates were equilibrated in tris buffered saline (TBS) (0.05M Tris, 0.15M NaCl, pH 
7.6) for 5 min before removal of excess liquid. Two more washes with TBS were given for 
5min each. In order to reduce non specific binding of the secondary antibodies and 
background staining, the plates were incubated for 30min with 10% normal goat serum. 
Excess serum was aspirated and the plates were washed with TBS three times for 5min 
each. The plates were incubated with primary antibody diluted in TBS in a humid chamber 
overnight at 4 0C. The different primary antibodies and their dilutions used are listed in 
table 2.1 and are also mentioned in the relevant text. Mouse or rabbit isotype control 
depending on the primary antibody, was used as a negative control. After washing the 
plates with TBS three times for 5 min each, they were incubated for 60 min with 
biotinylated secondary antibody. The relevant secondary antibody is mentioned in table 
2.1 and also in relevant text. The plates were washed in TBS three times for 5 min each 
and were incubated with streptavidin-alkaline phosphatase conjugate for 30 min. After 
removal of the conjugate, the plates were washed three times with TBS for 5min each. 
The substrate (1.2mM Napthol AS-MX phosphate disodium salt, 1mM Levamisol, 1.9mM 
Fast Red TR salt) was prepared in veronal acetate buffer (0.029M sodium acetate (tri-
hydrate), 0.028M sodium diethyl barbiturate, pH 9.2) and the cells were incubated at room 
temperature for 10min until a bright red colour developed. The plates were washed with 
distilled water and allowed to dry and then aqueous mounting media (Vectamount, Vector 
Lab) was added and cover slip applied prior to visualisation. 
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Table 2.1 Various antibodies and ancillary materials used in ICC 
 
Description of antibodies with their host and isotype Type 
Dilution used 
(in TBS)  
Manufacturer 
Anti-HIF-1α Monoclonal (Host /Isotype – Mouse/IgG1) Primary 1:50 MA1-516, Affinity Bioreagents 
Anti - HIF-1α Unconjugated Polyclonal (Host /Isotype – Mouse/IgG1) Primary 1:50 38-9800, Zymed 
Anti-phospho-p27 (Ser10) Unconjugated Polyclonal (Host – Rabbit) Primary 1:100 34-6300, Invitrogen 
Monoclonal anti human CD31 (PECAM-1) 
(Host /Isotype – Mouse/IgG1) 
Primary 1:100 P8590, Sigma 
Anti – Actin, N – terminal Polyclonal (Host – Rabbit) Primary 1:100 A2103, Sigma 
Isotype Control (Host – Mouse, Isotype - IgG and IgM) Primary control 0.5µg/ml 08-6599, Invitrogen 
Isotype Control Polyclonal (Host – Rabbit, Isotype - IgG and IgM) Primary control 0.5µg/ml 08-6199, Invitrogen 
DSB-X biotin anti-mouse (Host/Isotype – Goat/IgG(H+L)) Secondary 1:300 D20691, Invitrogen 
F(ab’)2 Anti Rabbit Ig’s biotin (Host /Isotype – Goat/Ig’s) Secondary 1:300 ALI 4409, Biosource 
AP-Streptavidin Conjugate - 1:300 43-8322, Zymed 
Normal goat serum - 10% PCN5000, Biosource 
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2.5 Statistical analysis 
The data obtained from the radial migration (n=180) and the wound healing (n=90) 
assay of cells are shown as mean ± SEM The sample size is arrived at by multiplying the 
number of observation (i.e. 20 radii for radial migration assay or 10 distances for each 
edge of the wound healing assay) multiplied by number of samples (i.e. 3) and number of 
times the experiments were repeated (i.e. 3). The images for the measurement of 
migration by both radial migration and wound healing assay were acquired with 
pixel:distance ratio of 1:3.69. However, it should be noted that the images were analysed 
using pixel:distance ratio of 1:1. The differences among different conditions and/or 
treatments were evaluated, wherever appropriate using either one way analysis of 
variance (ANOVA) followed by Bonferroni post hoc test or independent t test. The level of 
significance was conveyed using the general notations *p<0.05, **p<0.01 and ***p<0.001 
or as mentioned in the relevant legends of data figures. In addition, coefficients of 
variation were calculated to determine the reproducibility of the data. 
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3.1 Introduction 
Endothelial cell migration is an essential aspect of angiogenesis during the wound 
healing process. A range of in vitro methods have been developed to simulate in vivo 
conditions in order to understand the mechanism of cell migration and wound healing 
(Auerbach et al. 2003, Eccles, Box and Court 2005). These methods are helpful in 
providing an insight into the cellular and molecular mechanisms of impaired wound 
healing of diabetes. This chapter deals with development, validation and optimisation of 
cell migration and wound healing methods. 
A commonly employed method to measure the migration in vitro includes 
scratching the cell monolayer and measuring the distance covered by the endothelial cells 
into the scratched region (Li et al. 2006). Some studies include the use of Boyden 
chambers (transwell migration) to study the cellular migration (Hervé et al. 2005, Lee et al. 
2005), while other studies include wounding cell monolayer and counting the migrated 
cells into the wounded region (Hamuro et al. 2002). 
The method employed in carrying out the cell migration assay in this study is an 
adaptation of the omni-directional migration method described by Dolle et al. (Dolle et al. 
2005). The development of radial migration was carried out using HUVECs in the 
beginning and later made use of HMVECad. Endothelial cells were seeded as circular 
monolayers as explained in section 2.2.2 of previous chapter while developing and 
validating the migration assay. The measurements of area, length and radii of circular cell 
monolayer were carried out to validate the assay. 
The development of a method to measure the migration of endothelial cells in the 
milieu of a wound environment was another objective of this project. In connection with 
this, a scratch wound and a radial wound method were developed. The wounds were 
made on a monolayer of cells either by using a sterile pipette tip or by removing half of the 
monolayer and the migration of cells was measured. 
Unlike other chapters, this chapter is structured slightly differently. The section 
dealing with the development of the radial migration assay (section 3.2) has one general 
materials and methods section (section 3.2.1) and few subsections in the combined 
results and discussion section (section 3.2.2) where results of each method followed by a 
brief discussion explaining changes made to the method are presented.  The rationale for 
this is that the outcomes of each experiment inform the next stage. The last subsection 
3.2.3 summarises the method development process. 
The development of the wound healing method (section 3.3) also has two 
subsections, one explaining the scratch wound assay (3.3.1) and another explains the 
wound healing assay (section 3.3.2). These subsections, in turn are divided into materials 
Chapter 3 – Validation of methods 
- 71 - 
and methods followed by the combined results and discussion. Similar to radial migration 
assay, wound assays are summarised in section 3.3.3. 
The last two sections (section 3.4 and 3.5) dealing with Haematoxylin & Eosin 
staining and the expression of PECAM-1 and actin expression in microvascular 
endothelial cells respectively have three subsections each of introduction, materials and 
methods and finally combined results and discussion. 
3.2 Radial migration assay 
3.2.1 Materials and methods 
HUVECs or HMVECad were seeded as a circular monolayer (Fig. 3.1a) as 
explained in the section 2.2.2. 
 
 
 
Fig. 3.1a Pictorial presentation of migration assay The HUVECs or HMVECad were 
grown into circular cell monolayers. The scale bar of photomicrographs represents 200µm 
(Magnification: 25 x). 
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Photomicrographs of cell monolayers were acquired before incubation and 
recorded as 0 h samples. Images were subsequently taken at 24 and 48 h after incubation 
and are recorded as 24 and 48 h samples. The images were analyzed by measuring the 
area (Fig.3.1b), length (Fig. 3.1b) and radii (Fig. 3.1b, 2.2a-d) of circular cell monolayers 
to determine the migration of cells. All three parameters viz. area, length and radii were 
measured to find out which of them best represents the migration of endothelial cells. The 
measurement of area and length was recorded by masking the circular monolayers with a 
hand drawn loop using Leica (QWin Standard v 2.8, Image Processing and Analysing 
System) software. The measurement of radii was carried out as explained in section 2.2.3. 
A minimum of 10 or 20 (as specified in the relevant sections) radii were drawn on the 
radial spokes and the measurements were noted down. 
 
 
Fig. 3.1b Pictorial presentation of migration assay The migration was measured in 
terms of area and length by superimposing a manual drawn blue loop on a circular 
monolayer. The area (blue coloured loop) and length (black line) were recorded from the 
same loop, whereas radii (red lines) were measured by superimposing the radial spokes 
as explained in Fig 2.2a-d of previous chapter. The scale bar of photomicrographs 
represents 200µm (Magnification: 25x). 
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Three time points were used to record the migration viz. t0 = 0 h, t24 = 24 h and t48 
= 48 h. Images of cell monolayers were recorded prior to their incubation in test conditions 
as samples of t0, after 24 h incubation as samples of t24 and after 48 h incubation as 
samples of t48.  Different samples were used while developing the methodology. The 
following table 3.1 serves as a guiding point to understand the sampling methods. The 
migration (section 3.2.2.1) was defined as area or length or radii measured at 0, 24 and 
48 h. The analysis of net migration was more accurate and less time consuming 
compared to the measurement of migration; hence it was adopted from section 3.2.2.2 
onwards and for the results of other chapter. The net migration was defined as the 
difference between the measurements of 24 or 48 h with those of 0 h. The migration 
measurements depending on the sample size are presented as median for area (µm2) and 
length (µm) and as mean ± SEM (µm) for radii. 
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Table 3.1 Sampling methods Different samples (S) were used while developing the 
method for migration assay, while having three time points (t) during all the experiments. 
Recording of the net migration involved subtracting values of t0 from either t24 or t48.  
 
Section 
Time point (t) 
(h) 
Sample used to 
capture images 
Samples used to record the 
migration 
Sample 
size 
3.2.2.1 
0 (t0) S1+S2+S3 S1+S2+S3 03 
24 (t24) S4+S5+S6 S4+S5+S6 03 
48 (t48) S7+S8+S9 S7+S8+S9 03 
3.2.2.2 
and 
3.2.2.4 
0 (t0) 
S1+S2+S3 
+S4+S5+S6 
- 06 
24 (t24) S1+S2+S3 (S1+S2+S3)t24 - (S1+S2+S3)t0 03 
48 (t48) S4+S5+S6 (S4+S5+S6)t48 - (S4+S5+S6)t0 03 
3.2.2.3 
The first time point (t0) is 24 h after the formation of circular monolayer 
0 (t0) 
S1+S2+S3 
+S4+S5+S6 
- 06 
24 (t24) S1+S2+S3 (S1+S2+S3)t24 - (S1+S2+S3)t0 03 
48 (t48) S4+S5+S6 (S4+S5+S6)t48 - (S4+S5+S6)t0 03 
3.2.2.5 
and 
3.2.2.6 
0 (t0) S1+S2+S3 - 03 
24 (t24) S1+S2+S3 (S1+S2+S3)t24 - (S1+S2+S3)t0 03 
48 (t48) S1+S2+S3 (S1+S2+S3)t48 - (S1+S2+S3)t0 03 
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3.2.2 Results and discussion 
3.2.2.1 Migration assay using different samples at different time points 
The results for the migration of HUVECs in N5mM condition were obtained by 
using three separate samples (n=3) at one single time point, S1 to S3 at 0 h, S4 to S6 at 
24 h and S7 to S9 at 48 h, as mentioned in table 3.1. Thus, each time point contained 
separate samples of monolayers and did not represent the longitudinal results from an 
individual monolayer at the specified time point. The images were used to record the 
measurements as explained in section 3.2.1. Ten radii measurements were recorded for 
each sample and results are presented in figure 3.2. 
No significant difference between 0 and 24 h was observed in area (µm2) (0 h: 
100884.1 vs. 24 h: 96095.8) and length (µm) (0 h: 375.5 vs. 24 h: 388.6). However, the 
radii (µm) were significantly less (p<0.05) at 24 h (179.8 ± 1.3) compared to 0 h (186.6 ± 
1.1) (Fig. 3.2). The measurement of area, length and radii was 148461.5, 495.3 and 241.7 
± 2.3 respectively at 48 h. The migration was significantly higher (p<0.001)  at 48 h 
compared to 0 and 24 h only in case of radii and no significant difference was detected in 
either area or length. 
The migration assay using different samples at different time points (Fig. 3.2) failed 
to confirm any changes happening in the migration of cells over the period of time. On the 
contrary, the radii of 24 h samples were found to be of lesser size than those of 0 h. This 
clearly suggests that, the monolayers of cells were not of uniform size at the time of 
seeding (i.e. at 0 h). Although the cells might have migrated from their original position, 
this method failed to detect it because a different set of monolayers were used to measure 
the area, length and radii at 24 and 48 h. Hence it was decided that the use of different 
sets of monolayers at different time points was not suitable to record the migration of cells. 
As a result, in the next set of experiments the photographs of same monolayers of 0 and 
24 h and 0 and 48 h were used for image analysis.  
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Fig 3.2 The migration assay using different samples at different time points The 
circular HUVEC monolayers were exposed to N5mM condition for 48 h. The migration 
was measured in terms of area (a), length (b) and radii (c) at 0, 24 and 48 h. The median 
of area and length were analysed by nonparametric (Mann-Whitney) analysis and means 
of radii were analysed by ANOVA followed by post hoc (Bonferroni) test. 
(Area and length: n = 3, Radii: n = 30 (10 radii from each sample), 
* p<0.05, *** and ††† p<0.001 when compared to 0 and 24 h respectively) 
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3.2.2.2 Migration assay using same samples at two different time points 
A few changes were then made from the previous set of experiments. They were as 
follows 
a) Validation of the migration assay was continued by using HMVECad rather than 
HUVECs in N5mM condition. HMVECad were used, as the larger aim of the 
project was to assess the migration of dermal microvascular endothelial cells. 
b) Net migration rather than migration was assessed, as the migration at 0 h (t0) of 
previous set of experiments (section 3.2.2.1) was actually not per se the migration 
but a mere dimension of the monolayers.  
c) The sampling technique was altered in order to improve the accuracy of the 
measurements obtained.  
The results presented here were obtained by using the same three samples at two 
different time points i.e. S1 to S3 at 0 and 24 h and S4 to S6 at 0 and 48 h as explained in 
table 3.1. The photomicrographs of all the six samples i.e. S1 to S6 were captured at 0 h. 
The samples were returned to the incubator and subsequently three samples i.e. S1 to S3 
were photographed again at 24 h and other three i.e. S4 to S6 again at 48 h. That 
effectively meant that there were six samples at 0 h, three to be photographed again at 24 
h and another three to be photographed again at 48 h. The images were later used to 
record the net migration as explained in 3.2.1 by subtracting the distance of cell migration 
at either 24 or 48 h with their respective images taken at 0 h. 
No significant difference in the net migration in N5mM condition (Fig. 3.3) between 24 
and 48 h was observed for area (µm2) (24 h: 157296.0 vs. 48 h: 262240.0) and length 
(µm) (24 h: 163.0 vs. 48 h: 205.0). However, the net migration in terms of radii (µm) was 
significantly higher (p<0.001) at 48 h (116.3 ± 1.5) compared to 24 h (72.0 ± 1.2). 
The results (Fig. 3.3) show that the area and length did not change significantly 
between different time points unlike radii which increased significantly at 48 h compared to 
24 h. This was partly due to the limitation in the dimensions of the image frame. The 
dimension of the images captured at a magnification of 25x was 1392 x 1040 (width x 
height) pixels. The calibrated image size was 5136.5 x 3837.6 (width x height) in µm (1 
pixel = 3.69µm). The circular cell monolayers seeded into a glass ring of 6mm of outer 
diameter could not be captured in its entirety within the image frame.  The height of the 
image that could be captured as the frame height was smaller than the size of the circular 
monolayer, particularly at 24 and 48 h. As a result, the measurement of area and length at 
24 and 48 h did not reflect an accurate migration of cells.  Thus, the measurement of area 
and length at different time points were not sufficiently accurate at determining any 
changes in the migration of cells in specific conditions.  
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Fig 3.3 The migration assay using same samples at two different time points The 
circular HMVECad monolayers were exposed to N5mM condition for 48 h. The net 
migration was measured in terms of area (a), length (b) and radii (c) at 24 and 48 h. The 
data of area and length were analysed by nonparametric (Mann-Whitney) analysis and 
data of radii was analysed by independent t test. 
(Area and length: n = 3, Radii: n = 60 (20 radii from each of 3 samples), 
*** p<0.001 when compared to 24 h) 
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3.2.2.3 Migration assay using the same samples at two different time points with an 
extended incubation time 
The results for the migration of HMVECad in N5mM condition were obtained very 
similarly as in the last section with the following exception. In the previous section 3.2.2.2, 
0 h is when the glass rings were removed and the resulting circular monolayers were 
photographed before returning them to the incubator.  However, to obtain the results of 
this sub-section the circular monolayers supplemented with media were allowed to remain 
in the incubator overnight after removal of the glass rings. Next day, the images of 
monolayers i.e. S1 to S6 were captured and these images were considered as samples at 
0 h. The samples were returned to the incubator until the three samples i.e. S1 to S3 were 
photographed again at 24 h and the remaining three i.e. S4 to S6 at 48 h. The images 
were used to record the net migration as explained in section 3.2.1. 
No significant difference in the net migration in N5mM condition (Fig. 3.4) between 
24 and 48 h was observed for area (µm2) (24 h: 83559.0 vs. 48 h: 146692.0) and length 
(µm) (24 h: 98.0 vs. 48 h: 141.0). However, like previously, in these set of experiments 
also the net migration in terms of radii (µm) was significantly higher (p<0.001) at 48 h 
(77.7 ± 1.4) compared to 24 h (35.6 ± 0.7). 
The results presented (Fig. 3.4) confirm that the area and length failed to change 
significantly at different time points unlike radii which increased significantly at 48 h 
compared to 24 h. The earlier explanation of image frame provided in section 3.2.2.2 
holds true for this section also.  As a result, the measurement of area and length was not 
subsequently used to record the migration of cells. The extra incubation for 24 h after the 
removal of rings produced the results similar to section 3.2.2.2. Hence, in the next set of 
experiments only radii was measured in order to assess the net migration in different 
conditions and further to understand the intra and inter-experimental variabilities. 
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Fig 3.4 The migration assay using the same samples at two different time points 
with an extended incubation time The circular HMVECad monolayers were exposed to 
N5mM condition for 48 h. The net migration was measured in terms of area (a), length (b) 
and radii (c) at 24 and 48 h. The median of area and length were analysed by 
nonparametric (Mann-Whitney) analysis and means of radii were analysed by 
independent t test. 
(Area and length: n = 3, Radii: n = 60 (20 radii from each of 3 samples), 
*** p<0.001 when compared to 24 h) 
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3.2.2.4 The radial migration assay in different conditions using the same samples at two 
different time points 
The method of selecting the samples was similar to that presented in section 3.2.2.2 
with following changes 
a) Only radii, not the area and length, were used to assess the migration of 
endothelial cells. 
b) The radii of the circular monolayer of HMVECad were recorded not only in N5mM 
condition but additionally in three other conditions viz. N20mM, H5mM and 
H20mM. 
c) The migration assay was carried out on three different occasions to verify the 
reproducibility of the results. 
The results obtained on the first occasion (Fig. 3.5a) show that the net migration (µm) 
in N20mM (24 h: 39.5 ± 1.5; 48 h: 91.3 ± 2.3) condition was significantly less (p<0.001) 
than in N5mM (24 h: 48.3 ± 1.5; 48 h: 132.5 ± 5.3) condition at 48 h, but not at 24 h 
(p>0.05). The migration significantly increased in H5mM (24 h: 64.7 ± 6.4; 48 h: 133.8 ± 
2.7) at 24 h (p<0.01), but not at 48 h (p>0.05) compared to N5mM condition. The 
migration in H20mM (24 h: 60.8 ± 1.2; 48 h: 113.4 ± 2.0) condition was significantly less 
(p<0.001) at 48 h, but not at 24 h (p>0.05) when compared to H5mM condition. 
In the next experiment (Fig. 3.5b), the net migration (µm) in N20mM (24 h: 68.6 ± 
2.0; 48 h: 139.0 ± 3.1) condition was not significantly different (p>0.05) from that in N5mM 
(24 h: 65.0 ± 0.9; 48 h: 143.9 ± 4.0) condition at both time points. The migration in H5mM 
(24 h: 73.7 ± 0.7; 48 h: 153.5 ± 1.6) condition was significantly higher at 24 h (p<0.01), but 
not at 48 h (p>0.05) compared to N5mM condition. The migration in H20mM (24 h: 63.8 ± 
2.5; 48 h: 141.4 ± 1.4) condition was significantly lower at 24 h (p<0.001) and 48 h 
(p<0.05) compared to H5mM condition. 
On another occasion (Fig. 3.5c), the net migration (µm) in N20mM (24 h: 92.2 ± 
1.8; 48 h: 139.2 ± 1.9) condition was not significantly different (p>0.05) than in N5mM (24 
h: 92.6 ± 1.7; 48 h: 139.2 ± 1.9) condition at both time points. The migration in H5mM (24 
h: 97.2 ± 0.7; 48 h: 149.3 ± 1.3) condition did not significantly alter at 24 h (p>0.05), but 
was higher at 48 h (p<0.001) compared to N5mM condition. The migration in H20mM (24 
h: 83.0 ± 2.1; 48 h: 127.8 ± 1.3) condition was significantly less (p<0.001) than in H5mM 
condition at both time points. 
The changes in the net migration (Fig. 3.5a-c) happening in response to different 
conditions were not reproducible over different occasions. This could be because of using 
different samples at 24 and 48 h. To overcome this inter- and intra-experimental 
variability, it was decided that the same circular monolayer will be photographed for all the 
time points as explained in next set of experiments. 
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Fig. 3.5 Radial migration assay in different conditions using the same samples at 
two different time points The circular HMVECad monolayers were exposed to either 
5mM glucose or 20mM glucose under normoxic (20% O2 tension) or hypoxic (5% O2 
tension) condition for 48 h. The migration in all the conditions was significantly higher at 
48 h compared to 24 h on all three different occasions represented by figure a, b and c. 
The comparison between the conditions was analysed by ANOVA followed by Bonferroni 
post-hoc test. The comparison between the days of the same condition was analysed by 
independent t test.  
(n=60 for all, except for H20mM at 24 h when n=40 in figure c; 
NS = not significant (p>0.05), * p<0.05, **p<0.01, ***p<0.001 when compared as 
indicated) 
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3.2.2.5 Migration assay using same samples for all the time points 
In this set of experiments, the same monolayers of HMVECad in N5mM condition 
were photographed and analysed at three different time points of 0, 24 and 48 h as 
explained in table 3.1. The photomicrographs of all the three samples (S1 to S3) at 0 h 
were captured. The samples were returned to the incubator and were photographed at 24 
h. The samples were returned to the incubator again for another day and finally 
photographed at 48 h. The images were used to record the net migration as explained in 
3.2.1. 
Area and length along with radii were measured in order to confirm the effect of 
the new sampling technique on the net migration. Similar to the previous set of 
experiments, no significant difference in the net migration in N5mM condition between 24 
and 48 h was observed for area (µm2) (24 h: 160128.0 vs. 48 h: 249116.0) and length 
(µm) (24 h: 162.0 vs. 48 h: 263.0) (Fig. 3.6). However, the net migration in terms of radii 
(µm) was significantly higher (p<0.001) at 48 h (111.0 ± 2.3) compared to 24 h (70.5 ± 
1.4). 
The results suggest that this sampling technique was reproducible over different 
occasions. Hence this method was followed to present the net migration in the all other 
chapters. The effects of different conditions on the migration of cells, using this method 
are presented in the next chapter. However, to overrule the user induced bias a single 
blind study of migration using this method was carried out and is presented in next 
section.   
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Fig 3.6 The migration assay using same samples for all the time points The circular 
HMVECad monolayers were exposed to N5mM condition for 48 h. The net migration was 
measured in terms of area (a), length (b) and radii (c) at 24 and 48 h. The data of area 
and length were analysed by nonparametric (Mann-Whitney) analysis and data of radii 
was analysed by independent t test. 
(Area and length: n = 3, Radii: n = 60 (20 radii from each of 3 samples), 
*** p<0.001 when compared to 24 h) 
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b) 
 
c) 
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3.2.2.6 Single blind analysis of migration assay 
 The images of HMVECad captured as explained in section 2.2.2 were analysed 
before blinding (un-blinded) and after blinding (blinded) the samples to recognise the user 
induced bias, if any. The migration of cells was noted for totally eight test groups to 
compare between blinded and un-blinded samples (table 3.2). No significant difference 
(p>0.05) was found in any of the eight groups between the blinded and un-blinded 
samples. The coefficients of variation (CV) were calculated to assess the variation in a 
single test group for intra-experimental variation. The minimum value of CV was 1.0% for 
un-blinded samples of group 5 and maximum value was 3.1% for blinded samples of 
group 2. The lower values of CV indicate lesser variation in the measurement of radii of 
samples within an experiment. The effects of different conditions on the migration of 
endothelial cells are discussed in the next chapter. 
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Table 3.2 Single blind analysis of radial migration assay The circular HMVECad 
monolayers were grown as circular monolayers and images were captured. The images 
without coding were analysed as un-blind samples and after coding, the same images 
were analysed as blind samples. The coefficients of variation were calculated to analyse 
the reproducibility of the results within an experiment. The comparison between the un-
blind and blind samples of a same condition was analysed by independent t test.  
(n=60 for all, except for test group 4 and 8 when n=40) 
 
 
Test 
groups 
Migration (mean ± SEM) (µm) 
p value 
Coefficient of Variation (%) 
(CV=(SEM/Mean)x100) 
Blinded Un-blinded Blinded  Un-blinded 
1 92.6 ± 1.9 95.8 ± 1.1 0.14 2.1 1.1 
2 75.2 ± 2.3 78.3 ± 1.6 0.26 3.1 2.0 
3 109.6 ± 2.1 111.8 ± 2.0 0.46 1.9 1.8 
4 89.9 ± 1.6 90.0 ± 2.2 0.96 1.8 2.4 
5 166.9 ± 2.2 168.9 ± 1.7 0.48 1.3 1.0 
6 142.0 ± 2.3 144.7 ± 2.6 0.43 1.6 1.8 
7 181.7 ± 3.0 184.5 ± 3.6 0.56 1.7 2.0 
8 142.9 ± 2.3 147.2 ± 2.1 0.17 1.6 1.4 
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3.2.3 Summary 
The following conclusions could be drawn from the different set of experiments of 
migration assay. 
1. Net migration and not simple migration is an accurate indicator of the migration of 
cells. 
2. Area and length are interdependent as they both are calculated by the software at 
a same time using a same image. One can not be used without the other in any of 
the methods explained. 
3. Area and length could not be used as parameters of the migration of cells of a 
circular monolayer due to the 
3.1 limitation posed by the image frame. This limitation could have been possibly 
overcome by making either using lower magnification of 16x or by increasing 
the image frame by altering the C-mount (a hardware part of microscope 
camera) from 0.70x to 0.50x. However this would have been still a problem, if 
the monolayers were to grow larger than image frame at 48 h and the 
3.2 large errors associated with the values of area and length as large internal 
component does not vary. 
4. The use radii of same samples for all the time points is an optimal method to 
measure the radial migration, as it makes the use of a same monolayer over the 
period of time. 
5. Use of same sample for two time point method did not produce reproducible 
results for the migration in different condition suggesting the flaws of sampling 
technique. 
6. Single blind study confirmed that the use of radii and same samples for all the time 
points is an optimal method. 
In conclusion, it was decided to use radii from the same monolayer for all the time 
points in order to record the net migration of endothelial cells. All the observations of 
section 3.2 are summarised in the following table 3.3. The radial migration assay method 
was followed for the results presented in all other chapters; the method was explained as 
a general method in chapter 2. Using the radial migration assay the measurement of 
migration was carried out in different conditions varying the glucose and oxygen tension 
levels and the results are presented in next chapter. 
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Table 3.3 Summary of the sampling methods for migration assay 
 
Section Sampling method Observations Proposed reasons 
3.2.2.1 Different samples at different time points 
No change in the area or length 
or radii over the time 
Variation in sampling technique 
3.2.2.2 
Same samples for two time points (i.e. at t0 and 
t24 or t0 and t48) 
No change in area or length, but 
change in radii over the time 
Image frame size, variation in sampling 
technique and small sample size of area 
and length 
3.2.2.3 
Same samples for two time points (i.e. t0 and t24 
or t0 and t48) with an extended incubation of 24h 
period before t0 
No change in area or length, but 
change in radii over the time 
Image frame size, variation in sampling 
technique and small sample size of area 
and length 
3.2.2.4 
Same samples for two time points (i.e. t0 and t24 
or t0 and t48) in different conditions 
Inter and intra experimental 
variability 
Sampling technique 
3.2.2.5 Same samples for all the time points 
No change in area or length, but 
change in radii over the time 
Image frame size and difference of values 
in net change compared to area and length 
3.2.2.6 Same samples for all the time points 
No difference between blinded 
and un-blinded samples 
Optimal method 
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3.3 Wound healing assay 
Two methods were employed to assess the migration of cells in the wound 
environment, termed for the purpose of this section as the scratch wound assay and the 
wound healing assay. 
3.3.1 Scratch wound assay 
3.3.1.1 Materials and Methods 
The six well plates were seeded with 5x103 HUVECs per cm2 as explained in 
section 2.2.1.4. When confluent, the monolayers were wounded by scratching with a 
sterile pipette tip drawn across the surface of the monolayers into four quadrants (Fig 
3.7a). The detached cells were removed by washing with phosphate buffered saline (PBS) 
and the plates were replenished with fresh 2.5ml of media before returning them to either 
N5mM or H5mM incubation conditions for 24 or 48 h. 
The monolayers were photographed using an inverted microscope (DMI 4000B, 
Leica Microsystems, Germany) at a magnification of  25x at 0 h before incubating cells in 
the above mentioned conditions and again images obtained at either 24 or 48 h. The 
photomicrographs were analysed using Leica (QWin Standard v 2.8, Image Processing 
and Analysing System) software by measuring the wound area of the cell monolayer. A 
circular loop generated using the software, was superimposed at the intersection of the 
monolayer where it was devoid of the cells (Fig. 3.7b). If, one loop was not big enough to 
cover the wounded region, more than one loop were used so as to cover the wounded 
region at the centre of the intersection (Fig.3.7c). The wound healing response presented 
as the median and was defined as the area (μm2) remaining free of cells at 0, 24 and 48 
h. 
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a) 
 
b) 
 
c) 
 
Fig. 3.7 Images of the scratch wound assay The confluent monolayer was scratched 
through to divide it into four quadrants (a). The wounded region was measured by 
recording the area of a software generated circular blue coloured loop superimposed at 
the intersection of quadrants. If a single circular loop (b) could not cover the central region 
of intersection, more than one loop (c) was superimposed to cover that region. The scale 
bar of photomicrographs represents 200µm (Magnification: 25x). 
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3.3.1.2 Results and Discussion 
The wounded area (µm2) in N5mM condition at 0, 24 and 48 h was 17404.3, 
2260.0 and 0.0 respectively (Fig. 3.8). The wounded area in H5mM condition at 0, 24 and 
48 h was 20956.3, 2776.8 and 0.0 respectively. There was no significant difference 
(p>0.05) in wounded area between the normoxic and hypoxic conditions at any of the time 
points. However, the wounded area was more confluent with cells at 24 h in N5mM 
(p<0.001) and H5mM (p<0.05) condition compared to 0 h. The monolayers continued to 
become confluent at 48 h compared to 24 h in N5mM (p<0.01) and H5mM (p<0.05) 
condition. 
 
 
 
 
Fig. 3.8 Scratch wound model The monolayers of HUVECs were exposed to normoxic 
(20% O2 tension) or hypoxic (5% O2 tension) condition after wounding with a sterile pipette 
tip. The data were analysed by non parametric (Mann-Whitney) analysis. 
(n=12 at 0 h and n=6 at 24 and 48 h; NS = not significant (p>0.05), *p<0.05, **p<0.01, 
***p<0.001 when compared as indicated). 
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This method failed to detect the difference in the wound healing response to 
normoxic and hypoxic condition. However, the level of significance in the wound healing 
rate over different time points in normoxic and hypoxic condition were different. These can 
be attributed to the following reasons 
a) HUVECs were detached from the surface unevenly while scratching, leading to 
variability in the level difference in the wounded area in different monolayers.  
b) As the wounding was created in an already confluent monolayer, the monolayers 
were over confluent by the time the wound healing was measured at 24 and 48 h. 
c) Like in the migration assay, the measurement of whole of area as a single value, 
rather than the multiple values of distance was an impediment in getting any 
meaningful results. 
d) The sample size was too small and was an obstacle in getting any meaningful 
difference in wound healing rate between normoxic and hypoxic conditions. 
e) This model did not provide the opportunity of assessing the migration of 
endothelial cells from both the wounded and unwounded edge of the same 
monolayer, which was one of the objectives of this project. 
After considering all the above mentioned reasons, it was decided to design an 
experiment using HMVECad where the earlier explained radial migration assay would be 
brought together with the wound healing assay as explained in section 2.2.4 of the 
previous chapter. 
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3.3.2 Wound healing assay 
3.3.2.1 Materials and methods 
 This method was developed with an aim of combining the wound healing assay 
with the migration assay, as one of the objectives of the project was to understand the 
migration of cells under the influence of a ‘normal’ and/or a ‘wounded environment’ on 
each other. The previously explained scratch wound method was not suitable to realise 
this objective. HMVECad cells were grown as a circular monolayer in 6-well plates and 
half of each monolayer was removed. The wound healing assay was carried out in N5mM 
and H5mM conditions and migration was assessed as explained in section 2.2.4 of 
chapter 2. 
3.3.2.2 Results and discussion 
The migration (µm) of HMVECad (Fig. 3.9a) from the intact edge in N5mM (24 h: 
80.2 ± 1.4; 48 h: 153.7 ± 3.1) was significantly lower (p<0.001) than in H5mM (24 h: 92.9 
± 1.9; 48 h: 183 ± 2.8) condition. Similar to the intact edge, the migration of HMVECad 
from the wounded edge (Fig.3.9b) was significantly lower (p<0.001) in N5mM (24 h: 87.8 
± 1.8; 48 h: 170.5 ± 2.8) compared to H5mM (24 h: 105.1 ± 1.4; 48 h: 208.8 ± 2.8) 
condition. The migration in H5mM condition was significantly higher (p<0.001) compared 
to N5mM condition. The wound healing assay confirmed the increase in the migration of 
cells not only over time but also with decreasing oxygen tension.  
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a) 
 
b) 
 
Fig. 3.9 Wound healing assay The migration of HMVECad in conditions of 5mM glucose 
and 20 (Normoxia – N) or 5% (Hypoxia – H) oxygen tension was assessed by the wound 
healing assay. The results are presented as net migration (mean ± SEM) of cells from the 
intact (a) and the wounded edge (b) of the monolayer. Independent t test was employed to 
compare the results between the two conditions and two time points. 
(***p<0.001 when compared as indicated, n = 90 for each condition at 24 & 48 h, except 
for H5mM of intact edge, n = 80 at 24 h) 
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3.3.3 Summary 
The following conclusions could be drawn from this different set of experiments of 
wound assays. 
1. The scratch wound assay does not provide an opportunity to bring the wound 
healing and migration assay in a single model. 
2. The scratch wound assay creates uneven areas of wound and involves small 
sample size due to measurement of area as a single observation. This would 
necessitate increase in the sample size to produce meaningful results. On the 
other hand wound healing assay not only combines the migration and wound 
healing together but also is able to meaningfully distinguish between the 
differences between the conditions and time points.  
In conclusion, it was decided to use radial and normal distances from un-wounded and 
wounded edge of the monolayer respectively to record the net migration of endothelial 
cells. The wound healing assay method was followed for the results presented in all other 
chapters and the method has been explained in section 2.2.4 as a general method in 
chapter 2. A more detailed look at the effect of glucose concentration and oxygen tension 
using the validated methods was then undertaken and the results are presented in next 
chapter. 
The work involving the development and validation of the migration/wound healing 
assay would benefit further if the cells seeded into a glass ring do not escape through a 
gap between the rings and surface of a plate. On few occasions, lack of sealing at the 
base of glass rings allowed the cells to escape through underneath of rings. This resulted 
in few cells residing at a little distance (few mm away) from the circumference of a circular 
monolayer. As the time progresses the cells at distance try to converge toward the 
monolayer and vice versa acting as a chemoattractants to each other. This could prove to 
be a hindrance to measure the migration and might lead to faulty measurements. Unlike 
Dolle et al. (2005), we avoided placing glass beads on the rings in order to provide the 
seal as we found it not only cumbersome and failed to prevent the cell leakage, but also 
resulted in falling off of beads creating more problem (Dolle et al. 2005).  We also avoided 
using sterile silicone high vacuum grease at the base before placing the rings, as it would 
have possibly hindered capturing of clear images (Ryan 2010). However rare the 
occurrence might be, the method stands benefitted if the way to seal the gap is found. 
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3.4 Haematoxylin and eosin (H&E) staining of endothelial cells 
3.4.1 Introduction  
H&E staining uses two different stains, haematoxylin stains the nucleus and eosin 
stains the cytoplasm and connective tissue. Haematoxylin stains the chromatin of the 
nucleus leaving behind a deep purplish-blue colour. Eosin, an orangish-pink to red dye 
leaves an orange-pink colour after staining the cytoplasmic materials. Both act as counter 
stain to each other giving the sharp contrast colour. 
H&E staining can be achieved by two commonly employed methods known as 
progressive and regressive staining. In progressive staining the slides are treated with 
haematoxylin, and then rinsed, followed by treatment with eosin. In the regressive staining 
procedure the slides are treated with Harris haematoxylin, and then differentiated in acid 
alcohol which takes out haematoxylin from everything except the nucleus, followed by 
treatment with eosin. The progressive staining employs Gill’s 1, Gill’s 2, Gill’s 3 and 
Mayer’s haematoxylin. On the other hand, the regressive staining employs a stronger form 
of haematoxylin called, Harris haematoxylin. Eosin of different strengths can be employed. 
Eosin Y being the mildest followed by Eosin Y Alcoholic and Eosin Y with Phloxine (Skip 
Brown 2010). 
3.4.2 Materials and Methods 
Previously prepared cells were removed from the -200C freezer, and allowed to 
thaw for 90 min to come up to room temperature. The cells were fixed in ice cold 70% 
ethanol in a fume hood before air drying for 10 minutes. The plates were equilibrated in 
tris-buffered saline (TBS) (50mM tris, 40mM HCl, 0.9% NaCl, pH7.6) for five minutes 
before removing the excess liquid. Another wash with TBS was given for five minutes. The 
cell monolayers were washed twice with absolute alcohol for five minutes followed by 70% 
alcohol for three minutes and finally with distilled water for two minutes to hydrate the 
cells. The plates were then treated with Harris haematoxylin for one minute followed by 
washing with water for two minutes. Haematoxylin was removed from the cytoplasm by 
washing with 0.5% acid alcohol {50ml of 5% HCl (2.5ml of Conc. HCl + 47.5ml of distilled 
H2O) + 950ml of absolute ethanol} for a minute, followed by washing with distilled water 
for two minutes. The plates were then subjected to the blueing agent (Scott’s tap water 
substitute - MgSO4.7H2O - 20g, NaHCO3 - 3.5g dissolved in 1l distilled water) for two 
minutes followed by washing with water for two minutes. The plates were then run through 
Eosin Y for 30 seconds followed by washing with water for two minutes. The plates were 
then taken back through water, 70% alcohol and absolute alcohol before applying the 
cover slip. 
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3.4.3 Results and Discussion 
H&E staining in the following images (Fig. 3.10) show the cells migrating in a radial 
direction when seeded into a circular monolayer. The image (a) of Fig. 3.10 shows the 
cells at the edge of the monolayer emigrating outwardly (blue arrows) and some cells 
within the monolayer undergoing proliferation (green circles). The proliferating cells 
appear to be undergoing mitotic division which in few hours would divide into daughter 
cells. H&E staining revealed the morphology of the HUVECs and HMVECad. The 
HUVECs resembled cobble stones in appearance, whereas the HMVECad were more 
spindle shaped. 
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a) 
 
 
 
b)      c) 
      
 
 
Fig. 3.10 Haematoxylin & Eosin staining The circular monolayers of HUVECs (a & b) 
and HMVECad (c) were stained with H&E staining. The blue arrows and green circles in 
photomicrographs indicate the migrating and proliferating cells respectively. The HUVECs 
are morphologically cobble stone shaped (b), whereas the some of HMVECad are spindle 
shaped (c). The images are representative of samples from 3 different occasions (n=3). 
The scale bar of photomicrograph represents 200 (a) and 50µm (b & c) (Magnification: 
100x & 400x). 
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3.5 Expression of PECAM-1 and actin in HMVECad 
3.5.1 Introduction 
Platelet endothelial cell adhesion molecule-1 (PECAM-1) or CD31, a glycoprotein 
belonging to IgG super family has a molecular weight of 130kDa and is expressed 
constitutively by endothelial cells and on the surface of immune cells, platelets, monocytes 
and neutrophils, some T cells and megakaryocytes (Woodfin, Voisin and Nourshargh 
2007). The role of PECAM-1 in leukocyte transmigration during the inflammatory reaction 
is well documented (Woodfin, Voisin and Nourshargh 2007). Apart from a role in 
inflammatory reaction, PECAM-1 has been implicated in modulating cell junctions, cell 
adhesion and cytoskeletal signalling pathways (Ilan and Madri 2003). PECAM-1 induces 
angiogenesis by enhancing tube formation by increasing the migration of endothelial cells 
(Cao et al. 2002). PECAM-1 knockout mice showed decreased angiogenesis due to low 
vascular density and less haemoglobin and laminin resulting in a fewer neutrophils 
accumulating at the site of foreign body implants (Solowiej et al. 2003). Further, PECAM-1 
knockout endothelial cells showed a lack of formation of filopodia, decreased wound 
healing and cell motility in in-vitro models and decreased angiogenesis in PECAM-1 
knockout mice (Cao et al. 2009). 
There are not many reports indicating the role of PECAM-1 in any of the vascular 
complications of diabetes. Hyperinsulinaemia has been implicated in exacerbating 
atherosclerosis through increased expression of PECAM-1 which increases 
transendothelial migration of leukocytes (Okouchi et al. 2002). The in vivo and in vitro 
models of embryonic vasculogenesis in mice and embryo cells of mice suggest that the 
failure of PECAM-1 tyrosine dephosphorylation leads to the vasculopathy in the presence 
of hyperglycaemia or diabetes (Pinter et al. 1999). HUVECs when treated with advanced 
glycated fibronectin in the presence of inflammatory stimulants such as IL-1α, TNF-α, 
lipopolysaccharide and AGE-albumin increased the expression of PECAM-1 suggesting 
the involvement of PECAM-1 in the advancement of atherosclerosis in diabetes 
(Sengoelge et al. 1998). The anti-oxidants and PKC inhibitors blocked the diabetic red 
blood corpuscles (RBC) induced oxidative stress leading to PECAM-1 phosphorylation 
and transendothelial migration of monocytes (Rattan et al. 1997). However the contrasting 
reports suggesting no role for PECAM-1 in the presence of diabetes also exist in equal 
numbers. It has been reported that the expression of PECAM-1 remained unchanged in 
the presence of elevated glucose levels in HUVECs (Baumgartner-Parzer et al. 1995a). 
The possible beneficial use of PPAR-γ agonist in preventing diabetes induced 
atherosclerosis may be mediated by inhibiting the expression of some of adhesion 
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molecules but not through PECAM-1, as its expression remained unchanged in HUVECs 
as well as in myocardial infarction patients (Khare et al. 2005, Pasceri et al. 2000). 
Actin rearrangement is central to the cell motility cycle. As hypoxia is central to 
angiogenesis, there are plenty of reports discussing the role of actin fibres in angiogenesis 
as discussed in section 1.8 of the chapter 1. However, the direct influence of diabetes or 
increased level of glucose on the actin filaments during migration of endothelial cells is 
very rare to find in the literature except for couple of reports. The increased levels of 
glucose impaired the cytoskeletal rearrangement through the prevention of 
phosphorylation of vasodilator stimulated phosphoprotein (VASP) which is a actin protein 
in HMVEC and EPC (Li Calzi et al. 2008). The higher glucose concentration is implicated 
in reduced migration by impairing the reorganization of actin fibres as a dense peripheral 
band in HMVEC (Hamuro et al. 2002). The metabolic products of glucose such as glyoxal 
and methylglyoxal have been reported to cause cytoskeletal rearrangement by increasing 
the formation of actin stress fibres and finally leading to the inhibition of tube formation in 
bovine pulmonary endothelial cells (Sliman et al. 2010).   
3.4.2 Materials and Methods 
HMVECad were stained for the expression of PECAM-1 and actin as a marker and 
to visualise the cytoskeletal arrangement in migrating cells respectively. The cells were 
stained for the expression of monoclonal anti-human CD31 (PECAM-1) (Sigma Aldrich, 
UK) and N-terminal polyclonal anti-actin (Sigma Aldrich, UK) primary antibodies at a 
dilution of 1:100. The detailed method of identification of proteins is explained in section 
2.4.2. Actin stained cells were counterstained with Harris haematoxylin for a minute 
followed by washing with distilled water for two minutes.  
3.4.3 Results and Discussion 
PECAM-1 was expressed in HMVECad (Fig. 3.11) in all the four conditions of 
N5mM, N20mM, H5mM and H20mM at cell junctions as it is an EC-EC adhesion molecule 
(Woodfin, Voisin and Nourshargh 2007). The intensity of the stain was uniform across the 
monolayers as shown in photomicrographs (Fig. 3.11). The intensity of the stain 
corresponding to the confluence of the endothelial cells was observed by Raychaudhury 
et al. (2001) with help of immunocytochemical staining and northern blotting for mRNA 
levels of PECAM-1 (RayChaudhury et al. 2001). The same authors also suggest that 
newly migrating and sparse cells lack the expression of PECAM-1 until they establish 
contact with other cells (RayChaudhury et al. 2001). This could possibly explain the stain 
of PECAM-1 antibody being uniform across the confluent monolayer of cells. However the 
intensity of the stain differed depending on the conditions in which the cells were cultured. 
Although the expression of PECAM-1 was found predominantly at the cell junctions in 
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normoxic conditions (Fig. 3.11b), the stain was less intense in N20mM condition 
(Fig.3.11c) compared to N5mM condition (Fig.3.10b). This result is in contrast to 
Baumgartner-Parzer et al. (1995) who did not find any change in the expression of 
PECAM-1 in HUVECs cultured in 30mmol/l glucose levels  (Baumgartner-Parzer et al. 
1995a). The staining of PECAM-1 was expected to be higher in the presence of hypoxia 
as it acts as a stimulant for angiogenesis (Cao et al. 2002). On the contrary, the stain was 
found to be less intense in hypoxic conditions (Fig.3.11d&e) and found predominantly 
within the cytoplasm of the cells. The role of PECAM-1 in the wound environment of 
diabetes needs to be probed further as it was reported to be involved in angiogenesis by 
playing an active role in cell proliferation and migration in PECAM-1 null mice and in 
HUVEC and H5V endothelial cells (Cao et al. 2009). 
The expression of actin was uniform across the different conditions hence only 
representative images are shown in Fig. 3.12 under lower magnification (Fig. 3.12a) and 
under higher magnification of intact edge (Fig. 3.12b) and wounded edge (Fig. 3.12c) of 
HMVECad monolayer. Migrating cells at the leading edge show intense staining for actin 
(yellow arrows in Fig. 3.12a) due to its accumulation and polymerization followed by 
protrusion (Vicente-Manzanares, Webb and Horwitz 2005). The localisation of the stain 
was less clear at the trailing edge and in cells at the centre of the monolayer. In the 
migrating cells of both the intact and wounded edge of the monolayer, the nucleus stained 
by haematoxylin can be clearly seen at the rear (yellow circular shapes in Fig. 3.12b&c). 
The movement of nucleus towards rear and the placement of the microtubule organising 
centre (MTOC) and Golgi apparatus (which were not visualized in the presented images 
of figure 3.12) at the front of the leading edge of a cell is indicative of the directionality of 
cell migration (Etienne-Manneville and Hall 2001). No difference in the expression of actin 
in cells migrating either at increased glucose levels and/or hypoxic conditions was 
expected as the cells migrated in all conditions with varying degree and actin is central to 
the cell motility. However it would be interesting to study the changes or regulation of actin 
involvement in the different aspects of cell motility due to increased glucose and/or 
hypoxic conditions. 
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a) 
 
b)      c) 
    
d)      e)     
    
 
Fig. 3.11 Expression of PECAM-1 in HMVECad The HMVECad grown as circular 
monolayers were exposed to either 5mM or 20mM glucose and either normoxic (20% O2) 
or hypoxic (5% O2) condition for 48h. The cells in photomicrographs a) were treated with 
control antibody (IgG1) in order to determine the antibody specificity. The expression of 
PECAM-1 protein was detected in cells treated with b) N5mM, c) N20mM, d) H5mM and 
e) H20mM conditions. The images are representative of samples from 3 different 
occasions (n=3). The scale bar of each photomicrograph represents 200µm 
(Magnification: 100x). 
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a) 
 
 
b)      c) 
    
 
 
Fig. 3.12 Expression of actin in HMVECad The wounded monolayer of HMVECad 
exposed to four different conditions for 48 h was stained for actin followed by 
counterstaining with haematoxylin. No difference in the stain was observed in different 
conditions. Cells at the edge of the monolayer in photomicrographs a) show the intense 
expression of actin (yellow arrows) compared to the cells of other region. Cells at the edge 
(b) or other region (c) of the monolayer show the actin expression concentrated at the 
leading edge of a cell. The yellow circular shapes show the movement of nucleus towards 
rear indicating the direction of cell migration. The images are representative of samples 
from 3 different occasions (n=3). The scale bar of photomicrograph a) and of b) & c) 
represents 1mm and 100µm respectively [Magnification: a) - 25x; b) & c) – 200x]. 
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4.1 Hypothesis 
 The varying concentration of glucose and oxygen tension has an effect on the 
migration of endothelial cells. 
4.2 Introduction 
 Hyperglycaemia and hypoxia characterise the wound environment of diabetes. 
Impaired angiogenesis during diabetes deprives the tissues of essential nutrients and 
oxygen supply immediately after the injury. Sprouting of new blood vessels at the site of 
injury requires the proliferation and migration of endothelial cells. The effect of high 
glucose on the migration of endothelial cells is origin specific. Increase in the retinal 
endothelial cell proliferation and migration in the presence of elevated glucose level is a 
causative factor for the development of diabetic retinopathy (Duffy et al. 2006, Huang and 
Sheibani 2008). On the other hand, in vitro migration of human aortic endothelial cells and 
endothelial progenitor cells was impaired in the presence of elevated levels of glucose 
(Hamuro et al. 2002, Chen et al. 2007). Myocardial microvascular and aortic endothelial 
cells isolated from the diabetic rats showed decrease and increase respectively in the 
migration and proliferation compared to the corresponding cells isolated from age 
matched normal Wistar rats (Wang et al. 2009). 
 Hypoxia is a well known stimulant common to angiogenesis during undesirable 
carcinogenesis or during desirable wound healing (Carmeliet 2005). Endothelial cell 
migration and proliferation are essential steps of angiogenesis (Carmeliet 2005). Hypoxia 
induced angiogenesis is mainly mediated by hypoxia inducible factor (HIF) - 1 system by 
activating the endothelial cell migration through various angiogenic stimuli which include 
various cytokines (Pugh and Ratcliffe 2003, Yamakawa et al. 2003). Few reports have 
examined the combined effect of hypoxia and hyperglycaemia on endothelial cell 
migration. In vivo evidences suggest that the presence of diabetes impairs the migration 
of endothelial cells in diabetic animals (Liu et al. 2008). The fibroblasts isolated from 
diabetic mice showed less migration in the presence of hypoxia compared to wild type 
cells on a type I collagen coated surface (Lerman et al. 2003). 
 Donatis et al. (2010) suggests an interesting hypothesis of either migration or 
proliferation being exclusive at one given time for a single cell (De Donatis, Ranaldi and 
Cirri 2010). The same authors suggest that the fibroblasts migrate at a lower 
concentration of PDGF and make a phenotypic switch from migration to proliferation once 
the dose of PDGF is sufficient enough for the cells to undergo the cell division (De Donatis 
et al. 2008). In some other incidences, the endothelial cells were treated with an anti-
proliferative agent in order to prevent the influence of proliferation on the migration of 
endothelial cells (Gade et al. 1997, Hamuro et al. 2002). 
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In this chapter an attempt is made to assess the migration in the presence of 
hyperglycaemia and/or hypoxia. An anti-proliferative agent was used to assess the 
influence of the proliferation on the migration itself. Finally, the migration was carried out 
in the presence of D-mannitol to address the possibility that osmolarity associated with the 
elevated glucose concentration was producing the observed effects. 
4.3 Materials and methods 
The migration assay and wound healing assay were carried out as detailed in 
section 2.2.3 and 2.2.4 respectively. Endothelial cells were supplemented with either 5 or 
20mM D-glucose in 20 (N) or 5% (H) oxygen tension conditions creating four conditions 
for cell migration viz. N5mM, N20mM, H5mM and H20mM. To overrule the influence of 
proliferation on migration, an anti-proliferative agent hydroxyurea at 5mM concentration 
was used as previously described (Hamuro et al. 2002). HMVECad were treated with 
either 5 or 20mM of D-mannitol which served as an osmotic control. The migration data is 
presented in microns as mean ± SEM. 
4.4 Results 
4.4.1 Effect of varying glucose concentration and oxygen tension on the migration of 
endothelial cells assessed by radial migration assay 
 HUVECs incubated in an increased concentration of glucose (N20mM) (24 h: 45 ± 
2.4; 48 h: 76.6 ± 2.8) resulted in a significant decrease (p<0.001) in the migration distance 
(µm) in comparison with normal glucose concentration (N5mM) (24 h: 73.7 ± 1.9; 48 h: 
119 ± 3.2) condition (Fig. 4.1a). The cells in hypoxia with a normal glucose concentration 
(H5mM) (24 h: 120.1 ± 2.1; 48 h: 192.2 ± 0.8) migrated significantly faster (p<0.001) than 
in N5mM glucose and hypoxia with an elevated glucose concentration (H20mM) (24 h: 
70.8 ± 1.8; 48 h: 141.2 ± 1.6). 
The migration (µm) of HMVECad (Fig. 4.1b) in N5mM (24 h: 82.6 ± 1.4; 48 h: 133 
± 1.2) was significantly higher (p<0.001) compared to N20mM (24 h: 57.2 ± 1.0; 48 h: 
105.2 ± 1.1) condition. The cells in H5mM (24 h: 105.8 ± 1.0; 48 h: 172.3 ± 1.1) condition 
migrated significantly faster (p<0.001) than in H20mM (24 h: 80.5 ± 0.9; 48 h: 124.5 ± 1.5) 
and N5mM conditions. The migration of HUVECs and HMVECad at 48 h was significantly 
higher (p<0.001) than at 24 h for all the test conditions (Fig. 4.1). 
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Fig. 4.1 Effect of glucose concentration and oxygen tension on endothelial cell 
migration The migration of HUVEC (a) and HMVECad (b) in conditions of 5 or 20mM 
glucose and 20 (Normoxia – N) or 5% (Hypoxia – H) oxygen tension was assessed by the 
radial migration assay. The results are presented as net migration (mean ± SEM) of cells 
at 24 and 48 h. The results between the conditions were analysed by analysis of variance 
(ANOVA) followed by Bonferroni post hoc test. Independent t test was employed to 
compare the results between the 24 and 48 h. 
(***p<0.001 when compared as indicated; †††p<0.001 when compared with 24 h of a 
respective condition)  
(HUVECs: n = 180 & 120 at 24 & 48 h respectively for every condition; 
HMVECad: n =160 for N5mM; n = 140 for N20mM; n =180 for H5mM & H20mM at both 24 
& 48 h)  
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4.4.2 Effect of hydroxyurea on the migration of endothelial cells 
To assess the effect of proliferation on migration, the endothelial cells were 
incubated with an anti-proliferative agent hydroxyurea at 5mM concentration along with 
varying concentrations of glucose and oxygen tension. Visual inspection indicated that the 
presence of hydroxyurea created gaps in the monolayers of both HUVEC and HMVECad 
at 48 h (Fig. 4.2). No major gaps in the monolayers were observed at 24 h. The migration 
with respect to each other conditions remained unaltered. 
Similar to untreated cells, the migration (µm) of HUVECs (Fig. 4.3a) in the 
presence of hydroxyurea in N5mM (24 h: 80.4 ± 1.7; 48 h: 139.6 ± 1.2) and H5mM (24 h: 
113.4 ± 2.8; 48 h: 152.4 ± 2.1) conditions was significantly higher (p<0.001) than in 
N20mM (24 h: 62.1 ± 1.5; 48 h: 120.3 ± 0.5) and H20mM (24 h: 75.5 ± 2.1; 48 h: 114.3 ± 
2.1) conditions respectively. The migration of cells in H5mM condition was significantly 
higher (p<0.001) than in N5mM condition. The migration of HUVECs (Fig. 4.3a) in the 
presence of hydroxyurea in H5mM and H20mM conditions was not significantly different 
than in the absence of it at 24 h (Fig. 4.1a). However, the migration in N5mM (p<0.01) and 
N20mM (p<0.001) at 24 h and in all conditions (p<0.001) at 48 h was significantly different 
between the presence (Fig. 4.3a) and absence (Fig. 4.1a) of hydroxyurea. 
The migration (µm) of HMVECad in the presence hydroxyurea (5mM) (Fig. 4.3b) 
was similar to the migration of cells in its absence. The migration in N5mM (24 h: 76.0 ± 
1.3; 48 h: 113.1 ± 1.2) and H5mM (24 h: 99.7 ± 1.8; 48 h: 149.4 ± 2.2) conditions was 
significantly higher (p<0.001) than in N20mM (24 h: 61.0 ± 1.2; 48 h: 96.7 ± 1.4) and 
H20mM (24 h: 70.1 ± 0.8; 48 h: 110.0 ± 0.9) conditions respectively. The migration of cells 
in H5mM condition was significantly higher (p<0.001) than in N5mM condition. The 
migration of HMVECad in N5mM (p<0.01), N20mM (p<0.05), H5mM (p<0.01) and H20mM 
(p<0.001) conditions at 24 h and in all above mentioned conditions (p<0.001) at 48 h was 
significantly less in the presence of hydroxyurea (Fig. 4.3b) compared to those migrating 
in absence (Fig. 4.1b) of it. 
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Fig. 4.2 Effect of hydroxyurea on the endothelial cell monolayer HMVECad were 
incubated in either 5mM or 20mM D-glucose and 20 or 5% oxygen tension in the 
presence of 5mM hydroxyurea. The images of the monolayer were captured at 0 h (a). 
After 48 h (b) of incubation, the hydroxyurea showed its effect by inhibiting the cell 
proliferation and thus creating the gaps in the monolayer. The gaps are marked by red 
circles and migrating cells are shown by blue arrow marks at the edge of the monolayer. 
Similar observation was also made from the monolayers of HUVECs. The images are 
representative of samples from 3 different occasions (n=3). The scale bar on each 
photomicrograph represents 500µm (Magnification: 25x). 
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Fig. 4.3 Effect of hydroxyurea on the migration of endothelial cells The migration of 
HUVECs (a) and HMVECad (b) in conditions of 5 or 20mM glucose and 20 (Normoxia – 
N) or 5% (Hypoxia – H) oxygen tension was assessed by the radial migration assay. The 
anti-proliferative agent hydroxyurea (5mM) was added to assess the relationship between 
proliferation and migration. The results are presented as net migration (mean ± SEM) of 
cells at 24 and 48 h. The results between the conditions were analysed by analysis of 
variance (ANOVA) followed by Bonferroni post hoc test. The independent t test was 
employed to compare the results between 24 and 48 h. 
(***p<0.001 when compared as indicated; †††p<0.001 when compared with 24 h of 
respective condition)  
(HUVECs: n = 180 & 120 at 24 & 48 h respectively for each condition; 
HMVECad: n = 180 for each condition except for N20mM, where n=160 at 24 & 48 h) 
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4.4.3 Effect of varying glucose concentration and oxygen tension on the migration of 
HMVECad assessed by wound healing assay 
 The migration experiments hereafter were studied using HMVECad only as the 
migration trend of HUVECs towards four different conditions was not different from that of 
HMVECad. The migration (µm) of HMVECad (Fig. 4.4) from the intact edge in N5mM (24 
h: 80.2 ± 1.4; 48 h: 153.7 ± 3.1) was significantly higher (p<0.001) than in N20mM (24 h: 
61.6 ± 1.3; 48 h: 129.9 ± 2.4) condition. The migration was significantly less (p<0.001) in 
H20mM (24 h: 81.8 ± 1.2; 48 h: 163.6 ± 2.1) compared to H5mM (24 h: 92.9 ± 1.9; 48 h: 
183 ± 2.8) condition. The migration was significantly higher (p<0.001) in H5mM condition 
compared to N5mM condition. 
 Similar to the intact edge, the migration (µm) of HMVECad from the wounded edge 
was significantly higher (p<0.001) in N5mM (24 h: 87.8 ± 1.8; 48 h: 170.5 ± 2.8) and 
H5mM (24 h: 105.1 ± 1.4; 48 h: 208.8 ± 2.8) conditions compared to N20mM (24 h: 70.4 ± 
1.7; 48 h: 143.4 ± 2.7) and H20mM (24 h: 87.4 ± 1.2; 48 h: 179.8 ± 2.3) conditions 
respectively. The migration in H5mM condition was significantly higher (p<0.001) 
compared to N5mM condition. The migration (µm) of cells from the wounded edge of the 
monolayer was significantly higher (p<0.001; except for N5mM and H20mM at 24 h where 
p<0.01) in all conditions compared to the migration from the intact edge of the monolayer. 
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Fig. 4.4 Effect of glucose concentration and oxygen tension on the migration of 
HMVECad The migration of HMVECad in conditions of 5 or 20mM glucose and 20 
(Normoxia – N) or 5% (Hypoxia – H) oxygen tension was assessed by the wound healing 
assay. The results are presented as net migration (mean ± SEM) of cells at 24 (a) and 48 
h (b). The results between the conditions were analysed by analysis of variance (ANOVA) 
followed by Bonferroni post hoc test. The independent t test was employed to compare 
the results between the intact and wounded edge of the monolayer. 
(***p<0.001 when compared as indicated; ††p<0.01 and †††p<0.001 when compared with 
respective condition of intact edge cells)  
(Intact edge: n = 90 for each condition at 24 & 48 h, except for H5mM where n=80 at 24 h; 
Wounded edge: n = 90 for each condition at 24 & 48 h)  
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4.4.4 Effect of varying D-mannitol concentration and oxygen tension on the migration of 
HMVECad assessed by wound healing assay 
 D-mannitol (5 or 20mM) was used in order to overrule the role of osmotic pressure 
producing any effect on the migration.  All the four conditions viz. N5mM, N20mM, H5mM 
and H20mM D-mannitol were incubated in medium containing 5.6mM D-glucose as this 
was already supplemented in the M131 medium. The migration (µm) of HMVECad (Fig. 
4.5) from the intact edge in N5mM (24 h: 91.2 ± 1.8; 48 h: 146.1 ± 2.1) was not 
significantly different than in N20mM (24 h: 92.4 ± 1.8; 48 h: 152.8 ± 2.3) condition. The 
migration was not significantly different in H20mM (24 h: 106.7 ± 1.1; 48 h: 165.8 ± 1.7) 
condition compared to H5mM (24 h: 108.3 ± 1.7; 48 h: 169.7 ± 2.0) condition. However, 
the migration was significantly higher (p<0.001) in H5mM condition compared to N5mM 
condition. 
 Similar to the intact edge, the migration (µm) of cells from wounded edge (Fig. 4.5) 
was not significantly higher in N5mM (24 h: 110.1 ± 2.2; 48 h: 174.2 ± 3.1) and H5mM (24 
h: 129.7 ± 1.8; 48 h: 203.8 ± 2.6) condition compared to N20mM (24 h: 113.3 ± 2.5; 48 h: 
180.4 ± 3.1) and H20mM (24 h: 132.6 ± 1.6; 48 h: 206.4 ± 2.8) conditions respectively. 
The migration in H5mM condition was significantly higher (p<0.001) compared to N5mM 
condition. The cells migrated significantly faster (p<0.001) in all conditions from the 
wounded edge than those from the intact edge of the monolayer. 
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Fig. 4.5 Effect of D-Mannitol on the migration of HMVECad The migration of 
HMVECad in conditions of 5 or 20mM D-Mannitol and 20 (Normoxia – N) or 5% (Hypoxia 
– H) oxygen tension was assessed by the wound healing assay. The results are 
presented as net migration (mean ± SEM) of cells at 24 (a) and 48 h (b). The results 
between the conditions were analysed by analysis of variance (ANOVA) followed by 
Bonferroni post hoc test. The independent t test was employed to compare the results 
between the intact and wounded edge of the monolayer. 
(***p<0.001 when compared as indicated; †††p<0.001 when compared with respective 
condition of intact edge cells and NS = not significant)  
(Intact and wounded edge: n = 80, except at N20mM where n=90 at 24 & 48 h) 
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4.5 Discussion 
 The results indicate that the hyperglycaemia and hypoxia have opposing effects of 
decrease and increase respectively in the migration of endothelial cells. The migration 
was less when hyperglycaemia was combined with hypoxia compared to the hypoxia 
alone. HMVECad migrated faster from the wounded side than from the intact side of the 
monolayer.  Osmotic control D-mannitol did not alter the emigrational trends of cells. The 
presence of an anti-proliferative agent reduced the migration at 48 h compared with the 
respective control. 
The decrease in the migration of both HUVECs and HMVECad due to elevated 
levels of glucose is consistent with earlier findings where hyperglycaemia has been 
reported to cause dose dependant decrease in the migration of endothelial cells (Gade et 
al. 1997, Hamuro et al. 2002, Mascardo 1988, Yu et al.  2006). Results also confirmed 
that the reduction in the migration was not a result of osmotic pressure (Fig. 4.5) as 
increased D-mannitol did not alter the migration distance compared to lower concentration 
of D-mannitol. Hyperglycaemia has been reported to cause the reduction in the migration 
of microvascular endothelial cells by dephosphorylation of vasodilator stimulated 
phosphoprotein (VASP) resulting in its decrease in the redistribution at the leading edge 
(Li Calzi et al. 2008). Carbon monoxide and NO lost their ability to induce phosphorylation 
of VASP at Ser-157 and Ser-239 respectively in the presence of elevated levels of 
glucose (Li Calzi et al. 2008). The role of NO has been implicated by other studies as well. 
The reduced migration of endothelial cells in elevated levels of glucose is attributed to NO 
mediated impairment in actin polymerization (Gade et al. 1997) and further eNOS 
expression and intracellular production of NO was shown to be mediated by NF-κβ 
(Hamuro et al. 2002, Murohara et al. 1999). Yu et.al. (2006) suggest that the reduction in 
the proliferation and migration of HUVECs in the presence of higher glucose concentration 
was a result of PI3K and Akt inhibition (Yu et al.  2006). Increased glucose is known to 
produce its deleterious effects by increasing the production of reactive oxygen species 
(Brownlee 2005). Hence, hyperglycaemia induced reduction in the migration of endothelial 
cells was overcome by the complementing the media with an anti-oxidant, thiamine 
(Ascher et al. 2001).   
HUVECs and HMVECad were used as a model of macro and microvascular cells 
to measure the migration. The migration response towards increased concentrations of 
glucose has been reported to be cell specific (Wang et al. 2009, Duffy et al. 2006). 
Contrary to these reports, HUVECs and HMVECad responded similarly to the elevated 
levels of glucose by decreasing the migration (Fig.4.1). These contradictory results could 
possibly be due to the difference in the experimental models, cell type used and/or origin 
of cells. Wang et al. (2009) used the scratch wound assay and transwell inserts to 
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measure the migration of myocardial microvascular and aortic endothelial cells isolated 
from diabetic rats (Wang et al. 2009). Doffy et al. (2006) did not measure migration but 
found that the cell viability and apoptosis to be different in response to elevated glucose 
levels in human aortic and retinal endothelial cells. 
In various cell culture systems the hypoxia starts from 5% to downward reaching 
anoxia at 0.1 to 0.2% (1% = 8mm Hg) (Pouyssegur, Dayan and Mazure 2006). Hypoxia 
inducible factor (HIF) system activates pleiotropic actions by inducing various genes 
controlling cell migration, angiogenesis, erythropoiesis, energy metabolism and others as 
a part of cellular adaptation in response to the oxygen deprivation (Wang and Semenza 
1995, Semenza 2004). Results clearly indicated that the hypoxia increased the migration 
of both HUVEC and HMVECad over the period of 48 h (Fig. 4.1). ECs adapt to the 
decreasing oxygen tension and accordingly increase the accumulation of HIF-1α and its 
target genes such as VEGF, angiopoietins and GLUT-1 (Abaci et al. 2010). Hypoxia 
induced HIF-1α dependant bFGF and VEGF autocrine activity could be responsible for the 
in vitro migration of endothelial cells as they have been implicated in vessel formation 
(Calvani et al. 2006, Takata et al. 2008). The effect of hypoxia through HIF-1α activation is 
well documented as HIF-1α gene therapy has proved to be beneficial in healing the 
wounds of diabetic mice (Liu et al. 2008, Mace et al. 2007). 
 The migration of HUVECs and HMVECad was reduced when hyperglycaemia was 
combined with hypoxia in comparison with hypoxia alone (Fig. 4.1). These results are 
consistent with clinical manifestations of the people with diabetes suffering from chronic 
wounds as they experience delayed wound healing due to impaired angiogenesis. 
Hyperglycaemia induced formation of free radicals impaired the formation of ischemia 
driven vessel formation in diabetic mice. Further, hyperglycaemia prevented the 
dimerization of HIF-1α with HIF-1β and thus reduced the HIF-1 dependant transcription of 
VEGF and stormal cell derived factor-1 (SDF-1) in hypoxic mouse fibroblasts (Ceradini et 
al. 2008). In another study in diabetic fibroblasts, hyperglycaemia interfered with the 
transactivational activity of HIF-1 by impairing the interaction of HIF-1α with the 
coactivator p300 (Thangarajah et al. 2009). Hyperglycaemia has been reported to 
decrease the hypoxia induced expression of HIF-1α and its target gene VEGF, VEGFR, 
HSP-90, SDF-1 and stormal cell factor (SCF) by destabilisation of transctivational 
domains of HIF-1α (Botusan et al. 2008, Catrina et al. 2004). 
 Hydroxyurea, an anti-proliferative agent was used to understand the influence of 
proliferation on the migration as both processes are essential for angiogenesis. The dose 
of hydroxyurea at 5mM has been found to be anti-proliferative but not cytotoxic by 
previous users (Hamuro et al. 2002). The results (Fig. 4.3) indicated that hydroxyurea 
reduced the migration only after 48 h of its introduction and did not completely prevent the 
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migration. These are consistent with previous reports where it was found that the 
cessation of proliferation did not adversely affect the migration of endothelial cells (Gade 
et al. 1997, Hamuro et al. 2002). Although there is scant evidence differentiating the 
proliferation from migration and vice versa with respect to angiogenesis, it has been 
known for some time now that migration precedes the proliferation of endothelial cells in in 
vitro wound healing models (Coomber and Gotlieb 1990). It has been suggested that the 
migration was initiated due to VEGFR2 present on long filopodia of migrating retinal 
endothelial cells at the edge (tip cells) of a monolayer which sense the angiogenic 
stimulant (Gerhardt et al. 2003). Further unlike stalk cells, tip cells failed to stain for either 
phospho-histone or Ki-67 (markers for mitosis) indicating that tip cells were not 
proliferating whereas stalk cells were (Gerhardt et al. 2003). It was also suggested that 
the place vacated within a monolayer by a migrating tip cell is filled with proliferation of 
stalk cells to maintain cell-cell contact (Farooqui and Fenteany 2005). This could be the 
reason we witnessed the gap in the monolayer in stalk cells region than in the region of tip 
cells due to inhibition of proliferation of stalk cells by hydroxyurea (Fig. 4.2). Further, cells 
in the presence of the right quantity of soluble cues are known to make a phenotypic 
switch from migration to proliferation (De Donatis et al. 2008). This could be the possible 
reason in spite of using an anti-proliferative agent the migration persisted; however, was 
not equivalent to the cells which did not receive hydroxyurea (Fig. 4.1 vs. 4.3) as stalk 
cells might have failed to proliferate to fill the gap in the monolayer and keep up the pace 
of migration. 
The wound healing assay (Fig.4.4) was carried out in order to bring the migration 
of cells from the wounded and intact edge in a single model to test the effect of wounding 
on the intact edge. The wound healing assay made use of only HMVECad and not the 
HUVECs as both exhibited similar migration trends under different conditions and 
treatments. The results (Fig. 4.4) clearly showed that cells from the wounded side migrate 
faster than those from intact edge. Although there is no direct explanation available in the 
literature to be compared, the faster re-endothelialization could be due to faster 
rearrangement of cytoskeleton at the wound edge (Lee and Gotlieb 2003). Similar to 
epithelial cells, the migration of endothelial cells as a sheet at the wounded edge may be 
helped by the formation of lamellopodia and active crawling of the cells behind the edge 
(Farooqui and Fenteany 2005). This could be further assisted by release of the 
mitogenic/angiogenic substances from the wounded cells acting as chemotactants and/or 
the denuded region acting as a coated surface inducing haptotaxis. 
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4.6 Conclusion 
It is clearly evident from the results that the basal migration was altered in the 
presence of high glucose and/or low oxygen tension. Although proliferation has not been 
shown to adversely affect the migration, the role of cell cycle regulator such as cyclin 
dependant kinase inhibitor p27Kip1 in the migration is explored in the next chapter. The role 
of transcription factor HIF-1α in carrying out the effect of hypoxia and hyperglycaemia 
along with any signalling pathways such as MAPK p42/44, PI3K and PKCβII are explored 
in next chapter. 
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5.1 Hypothesis 
 The expression of transcription factor HIF-1 and cyclin dependant kinase inhibitor 
p27Kip1 have a role to play in the migration of HMVECad. The effect of hypoxia and 
hyperglycaemia are mediated by HIF-1α and through various signalling molecules such as 
protein kinase C (PKC), mitogen activated protein kinase (MAPK) and/or 
phosphotidylinositol 3-kinase (PI3K) during the migration of microvascular endothelial 
cells. 
5.2 Introduction 
Cell division and migration, essential steps of angiogenesis during the wound 
healing process, are known to be regulated by around 1249 and 360 genes respectively 
(Neumann et al. 2010). Cyclin dependant kinase inhibitor (CKI) - p27Kip1 acts as a check 
point or negative regulator preventing cell cycle progression from G1 to S phase 
(Toyoshima and Hunter 1994). Although a great amount of evidence has been recorded 
regarding the role of p27Kip1 with respect to cancer development, there is little indicating 
the role of p27Kip1 in the development of diabetic complications. The granulation tissue 
consisting mainly of fibroblasts showed considerable decrease in proliferation due to up 
regulation of p27Kip1 delaying the wound healing in diabetic mice (Altavilla et al. 2010). 
Similarly, proliferation of retinal neuronal cells of hypertensive rats with diabetes 
decreased due to increased expression of p27Kip1 (Lopes de Faria et al. 2008). In another 
study, TGF-β induced a decrease in HUVEC number and impaired cell cycle progression 
in hyperglycaemia was attributed to the over expression of p27Kip1 (McGinn et al. 2003a). 
Most of the work involving p27Kip1 and diabetes has focussed on diabetic nephropathy. 
The p27Kip1 protein expression increased consistently in podocytes and mesangial cells 
and occasionally in glomerular endothelial cells of diabetic mice and in the mesangial cells 
of normal mice in the presence of hyperglycaemia causing cell cycle arrest and 
hypertrophy (Wolf et al. 1998). Further, it was suggested that the hyperglycaemia in 
mesangial cells increased the expression of p27Kip1 by activating ERK1/2 which directly 
phosphorylates p27Kip1 at Ser178 (Wolf et al. 2003). 
Increasingly the evidence for the role of cytoplasmic p27Kip1 in regulating cell 
migration particularly in the backdrop of metastasis of cancerous cells is emerging 
(McAllister et al. 2003). Cell cycle independent migratory stimulant role of p27Kip1 was 
illustrated when p27Kip1 was knocked out in mouse embryonic fibroblasts led to the 
reduced migration due to increased RhoA activation with subsequent increase in the focal 
adhesions and stress fibres (Besson et al. 2004). Over expression of p90 ribosomal S6 
kinase 1 (RSK1), a serine/threonine kinase activated downstream of MAPK and PI3K, 
increased cytoplasmic localisation of p27Kip1 which in turn increased the migration by 
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inhibition of RhoA activation (Larrea et al. 2009). In contrast, other reports suggest that 
p27Kip1 mediates decrease in the cell motility. Elevated glucose level has been implicated 
in the increased migration and proliferation of aortic smooth muscle cells mediated by 
decreased expression of p27Kip1 and increased production of ROS (Yoon et al. 2010). 
Vascular smooth muscle cells cultured in high glucose have shown an increase in the 
proliferation and migration and this was inhibited by the use of simavistatin, a lipid 
lowering drug by increased expression of p27Kip1 (Chan et al. 2010). The migration of 
HUVECs, tube formation by HUVECs and by coronary artery endothelial cells (HCAECs) 
and blood flow recovery and vessel density in mice were inhibited due to the over 
expression of p27Kip1 establishing its role not only on the cell cycle progression but also 
during in vitro as well as in vivo migration (Goukassian et al. 2001, Moss et al. 2010). 
Further, over expression of p27Kip1 resulted in the disruption of lamellopodia formation, 
actin re-organization and focal adhesions in vascular smooth muscle cells and fibroblasts 
leading to the decrease in the migration (Diez-Juan and Andres 2003). 
Transcription factor HIF-1 mediates many biological activities including cell 
proliferation, migration/angiogenesis or invasion and metastasis through a cocktail of 
cytokines and growth factors (Semenza 2007). Deletion of HIF-1α resulted in reduced 
proliferation and migration of endothelial cells and HIF-1α null mice exhibited delayed 
wound healing due to impairment in the angiogenesis owing to decreased expression of 
VEGF (Tang et al. 2004). On one hand if hypoxia is known to stabilize HIF-1α, on other 
hand hyperglycaemia is known to destabilize or inactivate the HIF-1α in diabetic wound 
environment (Botusan et al. 2008, Thangarajah et al. 2010). Hyperglycaemia has been 
reported to interfere with the stability of HIF-1α in multiple ways. In a recent work, 
Thangarajah et al. (2010) suggest that hyperglycaemia produces reactive oxygen species 
which subsequently impair the binding of HIF-1 complex with co-activator p300 by 
methylglyoxal, a glycolytic end product thus preventing the transcription of downstream 
target genes leading to impaired wound healing in diabetic mice (Thangarajah et al. 2009, 
Thangarajah et al. 2010). Hyperglycaemia has also been shown to cause the 
destabilisation of HIF-1α stability by proteasomal degradation (Catrina et al. 2004). In 
another study by Botusan et al. (2008), hyperglycaemia has been shown to interfere with 
a) the stability of HIF-1α by causing VHL dependant degradation and b) translational 
activity by modifying the caroboxy terminal transactivation domain of HIF-1 (Botusan et al. 
2008). Decrease in the hypoxia responsive element (HRE) promoter transactivation too 
has also been held responsible for producing the deleterious effects of glucose on HIF-1α 
expression (Gao et al. 2007). The effects of hyperglycaemia and hypoxia may also be 
mediated through various signalling pathways including PKCβII, p42/p44 MAPK and PI3K-
Akt. 
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5.2.1 Protein Kinase C (PKC) pathway 
Diacylglycerol (DAG)/Protein kinase C (PKC) activation is implicated in mediating 
the vascular complications of diabetes (Das Evcimen and King 2007). Ruboxistaurin 
(LY333531), a PKC β antagonist inhibited AGE induced expression of TGF-β1 and ICAM-
1 reducing macrophage adhesion to HUVECs via anti-oxidant property by increasing 
superoxide dismutase/malondialdehyde (SOD/MDA) level (Xu et al. 2010a). The same 
antagonist inhibited the VEGF induced proliferation, migration and tube formation by 
HUVECs and inhibition of VSMC too with partial inhibition of p42/p44 MAPK and Akt 
(Andrassy et al. 2005, Nakamura et al. 2010). Decrease in the glomerular endothelial cell 
numbers and VEGF over expression was over come by PKC β inhibitor in diabetic Ren-2 
rats proving its role in the prevention of nephropathic complication of diabetes as well 
(Kelly et al. 2007). Diabetes induced a decrease in sciatic motor and saphaneous nerve 
sensory conduction velocity with blood flow along with thermal hyperalgesia was 
overcome by the use of ruboxistaurin in streptozotocin induced diabetic rats (Cotter, Jack 
and Cameron 2002). Protein kinase C β has also been reported to be involved with wound 
healing by modulating the F-actin activity in HUVECs (Jensen and Larsson 2004). All the 
above mentioned evidence suggests that over activation of PKC β actively precipitates the 
vascular complication of diabetes. ROS mediated over expression of HIF-1α mRNA in 
cancerous cells is known to subsequently activate PI3K-Akt and PKC signalling pathways 
(Koshikawa et al. 2009). Hypoxia independent activation of HIF-1α by angiotensin II was 
dependent on the production of ROS and activation of PKC in VSMC (Page et al. 2002). 
However the role of PKC β in either mediating the effects of hypoxia or HIF-1α on wound 
healing or cell proliferation and migration is not completely elucidated. 
5.2.2 p42/p44 mitogen activated protein kinase (MAPK) 
 p42/p44, also known as extracellular regulated kinase (ERK) 1/2 MAPK is one of 
the evolutionarily conservative four MAPK cascades along with c-Jun N-terminal kinase 1-
3 (JNK1-3), p38MAPK α, β, γ, δ and ERK5 (Keshet and Seger 2010). Various mitogens 
such as growth factors activate the ERK cascade by an upstream kinase called 
MAPK/ERK kinase (MEK) in an order to initiate vital cell functions such as proliferation 
and differentiation (Keshet and Seger 2010). The evidence involving the role of MAPK in 
precipitating the complications of diabetes is accumulating. Advanced glycation end 
products (AGE) induce apoptosis in endothelial progenitor cells which was reversed by 
the use of MPAK inhibitors confirms the MAPK pathways involvement in deleterious 
effects of high glucose (Shen et al. 2010). The expression of phosphorylated ERK1/2 was 
found in the subcutaneous microvascular endothelial cells isolated from human tissue of 
T2DM patients (Gogg, Smith and Jansson 2009). The migration of human coronary artery 
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endothelial cells due to VEGF by inducing the formation of stress fibres and adhesion 
molecules was mediated by the activation of ERK 1/2 MAPK and Akt (Mahadev et al. 
2008). Glycated bFGF resulted in the reduced capillary formation by bovine aortic 
endothelial cells with a reduction in the activation of ERK 1/2, which suggests that high 
glucose produces its deleterious effect on angiogenesis and hence wound healing via 
deactivation of ERK 1/2 MAPK (Duraisamy et al. 2001). PD98059, a p42/p44 MAPK 
inhibitor blocked the high glucose induced stimulation of L-arginine transport, membrane 
hyperpolarisation and eNOS phosphorylation resulting in NO production in HUVECs which 
could lead to the vasodilation during gestational diabetes (Flores et al. 2003). Topical 
administration of rhPDGF on skin wounds of diabetic rats improved the wound healing 
with increased phosphorylation of ERK 1/2 at the wound site (Cheng et al. 2007). 
 ERK1/2 MAPK has also been implicated in mediating HIF-1α induced activities. 
Hypoxia induced the migration and proliferation in VSMC through the activation of HIF-1α, 
ROS and ERK (Fu et al. 2010). Hypoxia induced VEGF expression was mediated by the 
activation of ERK, whereas PI3K mediated hypoxia induced HIF-1α and VEGF expression 
confirming PI3K and ERK1/2 MAPK role as an upstream mediators for the expression of 
HIF-1α and VEGF in animals (Yang et al. 2009). HIF-1α was phosphorylated by p42/p44 
MAPK in vitro as well as in vivo and the activation of p42/p44 MAPK increased the 
transcription activity of HIF-1α (Richard et al. 1999). It has been suggested that p42/p44 
MAPK although may not have any effect either on the stabilization or DNA binding activity 
of HIF-1α, but mediates the transcriptional activity of HIF-1α (Hur et al. 2001). 
5.2.3 Phosphatidylinoisitol 3-Kinase (PI3K)/adenosine-triphosphate dependant 
tyrosine kinase (Akt) Pathway  
 The PI3K-Akt signalling pathway controls many cellular activities including cell 
proliferation and activation of angiogenesis by controlling the expression of VEGF in 
endothelial cells (Jiang et al. 2000). Further, inhibition of PI3K-Akt pathway has been 
implicated in the inhibition of VEGF induced HUVEC migration as well (Matsunaga et al. 
2008). Activation of PI3K-Akt pathway is also believed to mediate high glucose induced 
retinal endothelial cell migration contributing towards the proliferative retinopathy of 
diabetes (Huang and Sheibani 2008).  On the other hand, the PI3K-Akt signalling pathway 
was suppressed in the EPCs obtained from diabetic patients leading to a decrease in 
migration and cell count. The effect was more pronounced if EPCs were treated with both 
glucose and oxidized LDL (Hamed et al. 2010). Increased glucose levels caused a 
decrease in cell proliferation and an increase in apoptosis and senescent activity of 
HUVECs and this effect was associated with the inhibition of the PI3K-Akt pathway 
(Varma et al. 2005, Zhong et al. 2010).  Apoptosis induced by high glucose has been 
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reported to be due to an increase in the production of ROS mediated by PI3K-Akt pathway 
(Sheu et al. 2005). All this evidence made it clear that activation of PI3K-Akt pathway 
leads to increased migration and a reduction in the migration results due to its 
suppression in the presence of glucose. 
 Various studies have reported the involvement of PI3K-Akt pathway in regulating 
the expression of HIF-1α. Ferulic acid, a natural compound produced its angiogenic 
effects by increasing the expression of HIF-1α with subsequent increase in the production 
of VEGF and PDGF via activation of PI3K-Akt pathway along with p42/p44 MAPK 
pathway in HUVECs (Lin et al. 2010). Another natural product, apigenenin a dietary 
flavanoid inhibited the formation of tubes via decreasing the expression of HIF-1α and 
subsequent expression of VEGF via PI3K-Akt pathway (Fang et al. 2005). The choroidal 
blood vessel formation in rats and retinal pigment epithelial cells in vitro up regulated the 
expression of HIF-1α and VEGF production in the presence of hypoxia with the activation 
of PI3K-Akt pathway (Yang et al. 2009). In tumour cells, hypoxia stabilised the HIF-1α with 
simultaneous increased production of ROS and this was negated by the use of a PI3K 
inhibitor leading to the conclusions that the production of ROS and HIF-1α are mediated 
by PI3K-Akt pathway in cancer cells (Koshikawa et al. 2009, Zhong et al. 2000). However, 
the role of PI3K-Akt in regulating HIF-1α remains unclear as short duration hypoxia 
stabilized and accumulated HIF-1α depending on the activation of PI3K-Akt whereas 
prolonged hypoxia resulted in the inactivation of Akt and down regulation of HIF-1α via 
glycogen synthase kinase (GSK) 3β pathway (Mottet et al. 2003). 
5.3 Materials and methods 
5.3.1 Immunocytochemistry and wound healing assay 
Expression of the cyclin dependent kinase inhibitor p27Kip1 and hypoxia inducible 
factor–1α (HIF-1α) was carried out by immunocytochemistry as explained in chapter 2 
(section 2.4.2). Unconjugated polyclonal anti-phospho-p27 (Ser10) at 1:100 and 
monoclonal anti-HIF-1α at 1:50 were used for identifying p27Kip1 and HIF-1α in HMVECad 
after incubation of cells for 48 h in four conditions (viz. N5mM, N20mM, H5mM and 
H20mM). The expression of HIF-1α was assessed for HMVECad at 48 h in the presence 
of different signal inhibitors as mentioned in the relevant segments and legends of the 
figures. The quantification of the stain is explained below in section 5.3.2. 
The molecular mechanisms of hypoxia and/or hyperglycaemia mediated migration 
of HMVECad was assessed by the addition of signal inhibitors at the beginning of the 
wound healing assay. The wound healing assay was carried out as explained in section 
2.2.4 using HMVECad. Different signal inhibitors such as PKCβII/EGFR inhibitor 
(PKCβII/EGFRi) [4,5-bis(4-Fluoroanilino)-phthalimide] 1µM (Calbiochem, Merck Chemicals, 
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Nottingham), p42/p44 MAPK Inhibitor (P42/p44 MAPKi) (2′-Amino-3′-methoxyflavone) 
(PD98059) 2µM (Calbiochem, Merck Chemicals, Nottingham) and PI3K Inhibitor (PI3Ki) 
[2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] (LY294002) 10µM (Invitrogen, UK) 
were used. DMSO of molecular biology grade was used as a solvent for these signal 
inhibitors at a final concentration of ≤ 0.7% v/v and an equivalent concentration was used 
for each control. 
5.3.2 Quantification of the protein expression 
 The images stained for the expression of p27Kip1 and HIF-1α were quantified using 
the Image J freeware (Image J 2010) developed by the National Institute of Health of 
Bethesda, USA. The quantification of stained images involved four steps 
a) Changing the scale of measurement from pixels to micrometers 
b) Converting the image to gray scale 
c) Segmenting the red stained cells using the threshold 
d) Measuring the threshold area at a fixed value 
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Conversion of the scale from pixels to micrometers was done by using 
Analyse>Set>Scale command to set the scale to micrometers. As all the images were 
captured at the magnification of 100x, the conversion ratio was 0.74pixels/µm. This ratio 
was used for all the images. 
 
 
 
Fig. 5.1a Quantification of stain An image of which the stain was to be quantified was 
opened and the scale was converted to pixels 
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Conversion of the images to gray scale was done using the Image>Type>RGB 
stack command to split the image into red, green and blue channels. It is essential to 
stack the image in gray scale in order to measure the threshold. The green channel of the 
RGB stack was selected to get the best separation. 
 
 
 
Fig.5.1b Quantification of stain Image was converted to gray scale 
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Next Image>Adjust>Threshold tool was used for thresholding the image. As image 
J cannot correctly threshold the image, it was manually adjusted. Using the ‘Threshold’ 
tool, the upper level of the threshold was fixed at 150 for all images barring a few images 
whose maximum threshold was either equal to or less than 150. For such images the 
adjusted threshold was slightly less than 150. 
 
 
 
Fig.5.1c Quantification of stain Image was thresholded to reflect accurate staining 
 
 
 
 
 
 
 
 
 
Chapter 5 – Molecular mechanisms of cell migration 
- 138 - 
Analyse>Set Measurement dialog was used to select the ‘Area’, ‘Area Fraction’, 
‘Limit to threshold’ and ‘Display Label’ so that image J measured the percentage of 
stained area and displayed it as a result. 
 
 
 
Fig.5.1d Quantification of image Parameter such as area of a defined square was 
selected to be displayed 
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The rectangular selections icon on the image J tool bar was selected to draw a 
square of 229.7 x 229.7 µm2. These dimensions were drawn on the image with the aim of 
measuring the threshold within six identical sized areas along the edges of the monolayer. 
These squares (229.7 x 229.7 µm2) were drawn along the edges of the layer to quantify 
the expression of proteins in migrating cells. However while quantifying HIF-1α expression 
in the images captured from the radial migration assay (Fig. 5.6 from section 5.4.2), the 
squares were drawn randomly as the cells were stained uniformly across the image. After 
drawing each of the six squares, the Analyse>Measure command was selected to display 
the area and percent area in the ‘Results’ window. These results were copied to the excel 
worksheet for subsequent analysis. The results were expressed as mean ± SEM of 
percent of stained area of six observations for each image (n=6) from each condition. All 
the results were analysed using SPSS 15.0. 
 
 
 
 
Fig. 5.1e Quantification of stain Total of six squares of defined area were measured for 
each image 
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5.4 Results  
5.4.1 Expression of p27Kip1 protein in HMVECad  
HMVECad expressed p27Kip1 protein at N5mM, N20mM, H5mM and H20mM 
conditions at 48 h. The p27Kip1 was predominantly expressed in the nuclei of the cells at 
the migrating edges of the monolayer for all of the test conditions (Fig. 5.2c-f). It was very 
rarely found anywhere other than the edges of the monolayer. Interestingly, in some of the 
cells migrating in 5mM glucose in both normoxia and hypoxia the p27Kip1 expression was 
localised, along with nuclei, in the cytoplasm of cells (Fig. 5.2c&e). No difference in the 
intensity of the expression of p27Kip1 was found between N5mM and N20mM or between 
H5mM and H20mM conditions. However, the cells incubated in 5% oxygen (Fig. 5.2e&f) 
expressed more p27Kip1 than those of their normoxic (Fig. 5.2c&d) counterparts. 
 The expression of p27Kip1 was also assessed for migrating cells of the wound 
healing assay model at 48 h. Similar to those of the circular monolayer; the HMVECad 
migrating from the intact edge of the semicircular monolayer expressed p27Kip1 in the 
nuclei and in some cases (i.e. N5mM and H5mM) in the cytoplasm of cells at the leading 
edges (Fig. 5.3c&e).  The intact edge of HMVECad (Fig. 5.3) was more intensely stained 
for p27Kip1 in N5mM and H5mM compared to N20mM and H20mM conditions respectively. 
Cells migrating under N20mM and H20mM conditions showed only weak staining. On the 
other hand HMVECad migrating from the wounded edge expressed very little p27Kip1 for 
all the four conditions (Fig. 5.4). 
 The influence of varying glucose concentration and oxygen tension on the intensity 
of the p27Kip1 staining was quantified using image J freeware (Fig. 5.5). The intensity of 
p27Kip1 expression by HMVECad of the intact and wounded edge of the semicircular 
monolayer was assessed. The percent area of stained cells at the intact edge was found 
to be significantly less for N20mM (1.3 ± 0.7) and H20mM (3.2 ± 0.7) compared to those 
of N5mM (9.0 ± 2.3) and H5mM (18.9 ± 7.5) conditions respectively. The HMVECad of the 
intact edge under H5mM conditions expressed significantly higher quantities of p27Kip1 
when compared to the N5mM condition (p<0.001). However, the difference in the p27Kip1 
expression in cells migrating from the wounded edge was not found to reach statistical 
significance (p>0.05) for N5mM (3.0 ± 2.1), N20mM (1.5 ± 0.6), H5mM (2.2 ± 1.8) and 
H20mM (4.6 ± 2.2) conditions. 
When the intensity of the expression of p27Kip1 is compared between the intact and 
wounded edge, it was found to be significantly different for N5mM (p<0.05) and H5mM 
(p<0.001) only. The intensity of the stain for cells in both N20mM and H20mM was not 
significantly different between the intact and wounded edge. 
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a)      b) 
     
 c)      d) 
     
e)      f) 
     
Fig. 5.2 Expression of p27Kip1 in HMVECad of the circular monolayer The circular 
monolayers of HMVECad were exposed to four different conditions for 48 h. The cells of 
a) and b) were treated with control antibody (IgG1) and TBS alone in order to determine 
the antibody specificity and as buffer control respectively. The expression of p27Kip1 
protein was detected in the cells treated with c) N5mM, d) N20mM, e) H5mM and f) 
H20mM conditions. The arrows and circles indicate nuclear and cytoplasmic staining 
respectively. The images are representative of samples from 3 different occasions (n=3). 
The scale bar on each photomicrograph represents 200µm (Magnification: 100x). 
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Fig. 5.3 Expression of p27Kip1 in HMVECad of the intact edge The intact edges of the 
semicircular monolayer of HMVECad were exposed to four different conditions for 48h. 
The cells were treated with control antibody (IgG1) (a) and TBS alone (b) in order to 
determine the antibody specificity and as buffer control respectively. The expression of 
p27Kip1 protein was detected in cells treated with c) N5mM, d) N20mM, e) H5mM and f) 
H20mM conditions. The arrows and circles indicate nuclear and cytoplasmic staining 
respectively. The images are representative of samples from 3 different occasions (n=3). 
The scale bar on each photomicrograph represents 200µm (Magnification: 100x). 
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Fig. 5.4 Expression of p27Kip1 in HMVECad of the wounded edge The wounded edges 
of the semicircular monolayer of HMVECad were exposed to four different conditions for 
48 h. The cells were treated with a) control antibody (IgG1) and b) TBS alone in order to 
determine the antibody specificity and as buffer control respectively. The expression of 
p27Kip1 protein was detected in cells treated with c) N5mM, d) N20mM, e) H5mM and f) 
H20mM conditions. The images are representative of samples from 3 different occasions 
(n=3). The scale bar on each photomicrograph represents 200µm (Magnification: 100x). 
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Fig. 5.5 Expression of p27Kip1 in HMVECad in response to glucose concentration 
and oxygen tension The semicircular monolayers were incubated at 5mM or 20mM 
glucose concentration in either normoxic (20% O2) or hypoxic (5% O2) condition for 48 h. 
The cells were stained for the expression of p27Kip1 on both the intact and wounded edge 
of the semicircular monolayer. Intensity of the expression was quantified as percent area 
using Image J freeware. The results are presented as mean ± SEM of 6 identical sized 
regions (n=6) at either intact or wounded edge from a single monolayer. The results for 
different conditions were analysed by analysis of variance (ANOVA) followed by 
Bonferroni post hoc test. The comparison between the intact and wounded edge was 
analysed by Independent t test.   
(*p<0.05, **p<0.01, ***p<0.001 and NS = not significant when compared as indicated) 
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5.4.2 Expression of HIF-1α in HMVECad 
The circular monolayers of HMVECad in N5mM, N20mM, H5mM and H20mM 
conditions were stained for the detection of HIF-1α (Fig. 5.6) protein after measuring the 
migration at 48 h. The expression was found to be uniform across the given monolayer. 
The HIF-1α staining was more intense in cells exposed to hypoxic conditions compared to 
normoxic conditions (Fig.5.6e&f vs. c&d). The expression was weak in N5mM (Fig.5.6c) 
than in N20mM (Fig.5.6d) condition. Hypoxia induced expression of HIF-1α was 
predominantly found to be concentrated in the nuclei of the cells which were cultured in 
5mM glucose concentration (Fig.5.6c&e) and in the perinuclear region for those which 
were cultured in 20mM glucose concentration (Fig.5.6d&f).  
 The expression of HIF-1α in the migrating cells of the intact edge of the 
semicircular monolayer was found to be higher (Fig. 5.7) in hypoxic conditions than 
normoxic conditions at 48 h, similar to that of the circular monolayer. However, the cells 
sitting at the edge expressed more HIF-1α than any other part of the layer for all the 
conditions (Fig. 5.7). The distinction between the nuclear and perinuclear localisation of 
HIF-1α expression was not clear for N5mM and N20mM conditions. For cells migrating in 
H5mM conditions, the expression of HIF-1α was greater than any other conditions and 
was localised predominately in the nuclei. The cells incubated in H20mM expressed HIF-
1α more at the perinuclear region than within the nucleus. 
The cells migrating from the wounded edge of the semicircular monolayer (Fig. 
5.8) expressed HIF-1α across the layer uniformly for any given condition. The cells 
migrating under H5mM condition expressed more HIF-1α than those in any other 
conditions. 
HIF-1α expression in HMVECad located in the intact or the wounded edges due to 
the changes in concentration of glucose and oxygen tension was quantified by image J 
(Fig. 5.9). The cells migrating from the intact edge expressed significantly (p<0.001) more 
HIF-1α for H5mM (21.2 ± 8.3) than H20mM (7.2 ± 2.6) and N5mM (5.5 ± 2.4) conditions. 
However, no significant (p>0.05) difference in the percent area of stained cells was 
observed between N5mM and N20mM (3.8 ± 2.3) conditions. The HIF-1α expression 
pattern was similar for the wounded edge. The intensity of the stain was significantly 
higher (p<0.001) for H5mM (14.1 ± 3.5) than H20mM (2.5 ± 1.7) and N5mM (3.0 ± 1.0). 
No significant difference (p>0.05) was found between N5mM and N20mM (2.6 ± 1.2). 
No significant difference in the level of HIF-1α protein was found between the 
intact and wounded edge for any of the conditions except for H20mM, where cells of the 
intact edge expressed more (p<0.05) HIF-1α than those of wounded edge.  
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a)      b) 
    
 c)      d) 
     
e)      f) 
     
Fig. 5.6 Expression of HIF-1α in HMVECad of the circular monolayer The circular 
monolayer of HMVECad were exposed to four different conditions for 48 h. The cells were 
treated with a) control antibody (IgG1) and b) TBS alone in order to determine the 
antibody specificity and as buffer control respectively. The expression of HIF-1α protein 
was detected in cells treated with c) N5mM, d) N20mM, e) H5mM and f) H20mM 
conditions. The arrows and circles indicate nuclear and perinuclear staining respectively. 
The images are representative of samples from 3 different occasions (n=3). The scale bar 
of each photomicrograph represents 200µm (Magnification: 100x). 
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Fig. 5.7 Expression of HIF-1α in HMVECad of the intact edge The intact edges of the 
semicircular monolayer of HMVECad were exposed to four different conditions for 48 h. 
The cells were treated with a) control antibody (IgG1) and b) TBS alone in order to 
determine the antibody specificity and as buffer control respectively. The expression of 
HIF-1α protein was detected in cells treated with c) N5mM, d) N20mM, e) H5mM and f) 
H20mM conditions. The arrows and circles indicate nuclear and perinuclear staining 
respectively. The images are representative of samples from 3 different occasions (n=3). 
The scale bar of each photomicrograph represents 200µm (Magnification: 100x).  
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Fig. 5.8 Expression of HIF-1α in HMVECad of the wounded edge The wounded edges 
of the semicircular monolayer of HMVECad were exposed to four different conditions for 
48 h. The cells were treated with a) control antibody (IgG1) and b) TBS alone in order to 
determine the antibody specificity and as buffer control respectively. The expression of 
HIF-1α protein was detected in cells treated with c) N5mM, d) N20mM, e) H5mM and f) 
H20mM conditions. The arrows and circles indicate nuclear and perinuclear staining 
respectively. The images are representative of samples from 3 different occasions (n=3). 
The scale bar of each photomicrograph represents 200µm (Magnification: 100x). 
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Fig. 5.9 Expression of HIF-1α in HMVECad in response to altered glucose and 
oxygen concentration The semicircular monolayers were incubated at either 5mM or 
20mM glucose concentration and either normoxic (ambient O2) or hypoxic (5% O2) 
condition for 48 h. The cells were stained for the expression of HIF-1α. Intensity of the 
expression was quantified as percent area using Image J freeware. The results are 
presented as mean ± SEM of six identical sized regions (n=6) at either intact or wounded 
edge from a single monolayer. The results for different conditions were analysed by 
analysis of variance (ANOVA) followed by Bonferroni post hoc test. The comparison 
between the intact and wounded edge was analysed by Independent t test. 
(**p<0.01, ***p<0.001 and NS = not significant when compared as indicated) 
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5.4.3 Effect of intracellular signal inhibitors on the migration of HMVECad in 
hypoxia 
 The migration (µm) of HMVECad from the intact edge for H5mM condition 
(Fig.5.10) was greater than for the cells incubated in H20mM amongst all treatments viz. 
untreated cells (166.5 ± 3.9 vs. 147.0 ± 3.2), p42/p44 MAPKi (163.0 ± 4.1 vs. 118.0 ± 3.9) 
and PI3Ki treatment (124.8 ± 3.5 vs. 104.5 ± 3.8) except for PKCβII/EGFRi treated cells 
(169.0 ± 3.9 vs. 163.4 ± 4.1) at 48 h. However, the migration of cells from the wounded 
edge for H5mM condition was faster than those for H20mM condition for all the treatments 
(untreated cells: 212.7 ± 4.6 vs. 183.1 ± 4.2, p42/p44 MAPKi treated cells: 194.8 ± 4.1 vs. 
156.7 ± 7.4, PKCβII/EGFRi treated cells: 210.0 ± 4.0 vs. 193.0 ± 4.5 and PI3Ki treatment: 
169.7 ± 4.9 vs. 130.3 ± 5.0).  
 The PI3Ki treated cells of the intact edge (Fig. 5.10) migrated significantly lesser 
(p<0.001) than those of the other three treatments under H5mM condition. No difference 
(p>0.05) in the migration was recorded for either PKCβII/EGFRi treated or p42/p44 MAPKi 
treated cells when compared with those of untreated cells for H5mM condition. The PI3Ki 
treated cells were not significantly different (p>0.05) from p42/p44 MAPKi treated cells in 
the migration under H20mM condition. However along with PI3Ki treated cells, p42/p44 
MAPKi treated cells also migrated significantly less (p<0.001) than those of untreated and 
PKCβII/EGFRi treated cells for H20mM condition. 
 The cells of the wounded edge (Fig. 5.10) migrated significantly less when they 
received PI3Ki compared to no treatment (p<0.001) or p42/p44 MAPKi (p<0.05) or 
PKCβII/EGFRi (p<0.001) treatment for H5mM condition. No difference (p>0.05) was 
observed in the migration between untreated, p42/p44 MAPKi treated or PKCβII/EGFRi 
treated cells for H5mM condition. The inhibition of PI3K treatment significantly prevented 
the cells from migrating on par with the other treatments (p<0.001 against untreated and 
PKCβII/EGFRi, p<0.01 against p42/p44 MAPKi) under H20mM condition too. The p42/p44 
MAPKi treated cells also migrated significantly less than those of untreated (p<0.01) and 
PKCβII/EGFRi treated (p<0.001) cells under H20mM condition. However, like those from 
the intact edge, the cells from the wounded edge showed no significant (p>0.05) 
difference in the migration of PKCβII/EGFRi treatment from those of no treatment. The 
migration of the HMVECad (Fig. 5.10) from the wounded edge was significantly greater 
(p<0.001) than that from intact edge for all the treatments and both the conditions. 
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Fig. 5.10 Effect of specific intracellular signal inhibitors on the migration of HMVECad The semi circular monolayers of HMVECad were 
treated with either p42/p44 MAPK inhibitor (PD98059) (2µM) or PKCβII/EGFR inhibitor (1µM) or PI3K inhibitor (LY294002) (10µM). The 
migration of HMVECad of the semicircular monolayer in the presence of the above mentioned treatments due to the conditions induced by both 
5mM or 20mM glucose concentration and hypoxia (5% oxygen tension) at 48 h was assessed by the wound healing assay. The results 
represent 10 observations from each of 3 samples of one occasion (n=30, unless mentioned below). The results are presented as net migration 
(mean ± SEM) of cells. The comparison between treatments was analysed by analysis of variance (ANOVA) followed by Bonferroni post hoc 
test. The comparison among conditions and edges was analysed by Independent student’s t test. The migration was significantly lower 
(p<0.001) at the intact edge for both the conditions and all the treatments compared to respective condition and treatment of the wounded 
edge.  
(††p<0.01, ††† p<0.001 when compared with H5mM condition of respective edge; *p<0.05, **p<0.01, and ***p<0.001 when compared as 
indicated)  
(Intact and wounded edges: n = 20 for both PD98059 and LY294002 in H5mM and for PKCβII/EGFRi in H20mM) 
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5.4.4 Effect of intracellular signal inhibitors on the expression of HIF-1α 
 The HMVECad were treated with p42/44 MAPKi or PKCβII/EGFRi or PI3Ki to 
understand their role in regulating the expression of HIF-1α. The semicircular monolayers 
were incubated in H5mM and H20mM conditions for 48 h before staining for the 
expression of HIF-1α. The expression of HIF-1α was localised in the nucleus for H5mM 
treatments (Fig. 5.11Aa and 5.12Aa), and both nucleus and the perinuclear region in 
H20mM (Fig. 5.11Ba & 5.12Ba) and in PI3Ki treated cells (Fig.5.11d (A&B) & 5.12d 
(A&B)). HIF-1α was predominantly perinuclear in cells treated with p42/p44 MAPKi 
(Fig.5.11b (A&B) & 5.12b (A&B)) and PKCβII/EGFRi (Fig.5.11c (A&B) & 5.12c (A&B)) in 
H5mM and H20mM conditions. HIF-1α staining was more intense in untreated cells of the 
intact and wounded edge compared to treated cells in both H5mM (Fig. 5.11Aa & 5.12Aa) 
and H20mM (Fig. 5.11Ba & 5.12Ba) conditions. 
 The HIF-1α expression in the presence of different signal inhibitors was quantified 
using image J (Fig. 5.13). Untreated (7.6 ± 2.2) HMVECad of the intact edge expressed 
significantly more HIF-1α than p42/p44 MAPKi (2.1 ± 0.3) (p<0.001) or PKCβII/EGFRi (2.2 
± 0.4) (p<0.001) or PI3Ki (2.1 ± 0.4) (p<0.001) treatment for H5mM condition. No 
significant difference (p>0.05) was observed amongst the treated cells for H5mM 
condition. The H20mM conditions followed the trend of H5mM as the untreated cells (9.4 
± 1.2) expressed more of HIF-1α than p42/p44 MAPKi (2.1 ± 0.3) (p<0.001) or 
PKCβII/EGFRi (5.1 ± 0.7) (p<0.01) or PI3Ki (2.9 ± 0.5) (p<0.001) treatment. Among the 
different treatments, the level of HIF-1α protein was more (p<0.05) in PKCβII/EGFRi 
treated cells compared to p42/p44 MAPKi treated cells. There was no difference (p>0.05) 
between H5mM and H20mM condition for any of the treatments except for PKCβII/EGFRi. 
The PKCβII/EGFRi treated cells expressed more (p<0.01) HIF-1α in H20mM than in H5mM 
condition of intact edge. 
 The level of expression of HIF-1α in the wounded edge was different (p<0.01) 
between the untreated cells (9.4 ± 1.7) and PI3Ki treated cells (2.6 ± 0.5) for H5mM 
condition. No difference (p>0.05) was observed between the untreated cells and p42/p44 
MAPKi (6.1 ± 1.1) or PKCβII/EGFRi treated (5.1 ± 1.1) cells for H5mM condition. No 
difference (p>0.05) among the treatments was observed. For H20mM condition, p42/p44 
MAPKi treatment (2.4 ± 0.4) significantly reduced (p<0.001) the expression of HIF-1α 
compared to either no treatment (10.5 ± 1.1) or PKCβII/EGFRi treatment (8.3 ± 0.9). A 
significant difference (p<0.01) was also found between the untreated and PI3Ki treated 
cells (5.4 ± 0.9). The level of the protein was significantly less (p<0.01) for p42/p44 MAPKi 
and more (p<0.05) for PKCβII/EGFRi and PI3Ki treatment at H20mM compared to H5mM 
condition. 
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 The HMVECad of the wounded edge expressed more HIF-1α for p42/p44 MAPKi 
(p<0.01) and PKCβII/EGFRi (p<0.05) treatment than those of intact edge in H5mM 
condition. No difference (p>0.05) was detected for untreated and PI3Ki treated cells. 
However, for H20mM condition, PKCβII/EGFRi (p<0.01) and PI3Ki (p<0.05) treatment 
increased the expression of HIF-1α in the cells of the wounded edge compared to intact 
edge. No difference (p>0.05) between the two edges was observed in untreated as well 
as for p42/p44 MAPKi treated cells.  
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 c)      d) 
     
 
 
Fig. 5.11A Effect of inhibitors on the expression of HIF-1α in HMVECad of the intact 
edge The HMVECad of intact edges of the semicircular monolayer were treated with 
signal inhibitors and exposed to 5mM glucose under hypoxic (5% O2) condition for 48 h. 
The expression of HIF-1α protein was detected in cells treated with a) no treatment, b) 
p42/p44 MAPKi (PD98059) (2µM), c) PKCβII/EGFRi (1µM) and d) PI3Ki (LY294002) 
(10µM) treatment. The arrows and circles indicate nuclear and perinuclear staining 
respectively. The images are representative of 3 samples (n=3). The scale bar of each 
photomicrograph represents 200µm (Magnification: 100 x). 
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a)      b) 
     
 
 
c)      d) 
     
 
 
Fig. 5.11B Effect of inhibitors on the expression of HIF-1α in HMVECad of the intact 
edge The HMVECad of the intact edges of the semicircular monolayer were treated with 
signal inhibitors and exposed to 20mM glucose under hypoxic (5% O2) condition for 48 h. 
The expression of HIF-1α protein was detected in cells treated with a) no treatment, b) 
p42/p44 MAPKi (PD98059) (2µM), c) PKCβII/EGFRi (1µM) and d) PI3Ki (LY294002) 
(10µM) treatment. The arrows and circles indicate nuclear and perinuclear staining 
respectively. The images are representative of 3 samples (n=3). The scale bar of each 
photomicrograph represents 200µm (Magnification: 100 x). 
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a)      b) 
     
 
 
c)      d) 
     
 
 
Fig. 5.12A Effect of inhibitors on the expression of HIF-1α in HMVECad of the 
wounded edge The HMVECad of wounded edges of the semicircular monolayer were 
treated with signal inhibitors and exposed to 5mM glucose under hypoxic (5% O2) 
condition for 48 h. The expression of HIF-1α protein was detected in cells treated with a) 
no treatment, b) p42/p44 MAPKi (PD98059) (2µM), c) PKCβII/EGFRi (1µM) and d) PI3Ki 
(LY294002) (10µM) treatment. The arrows and circles indicate nuclear and perinuclear 
staining respectively. The images are representative of 3 samples (n=3). The scale bar of 
each photomicrograph represents 200µm (Magnification: 100 x). 
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c)      d) 
     
 
 
Fig. 5.12B Effect of inhibitors on the expression of HIF-1α in HMVECad of the 
wounded edge The HMVECad of the wounded edges of the semicircular monolayer were 
treated with signal inhibitors and exposed to 20mM glucose under hypoxic (5% O2) 
condition for 48 h. The expression of HIF-1α protein was detected in cells treated with a) 
no treatment, b) p42/p44 MAPKi (PD98059) (2µM), c) PKCβII/EGFRi (1µM) and d) PI3Ki 
(LY294002) (10µM) treatment. The arrows and circles indicate nuclear and perinuclear 
staining respectively. The images are representative of 3 samples (n=3). The scale bar of 
each photomicrograph represents 200µm (Magnification: 100 x). 
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Fig. 5.13 Expression of HIF-1α in HMVECad in response to the specific intracellular signal inhibitors Intensity of the stain for the 
expression of HIF-1α was quantified as percent area using Image J freeware. The semicircular monolayer was incubated at 5mM or 20mM 
glucose concentration and hypoxic (5% O2) condition for 48 h. The cells were treated with either p42/44 MAPK inhibitor (PD98059) (2µM) or 
PKCβII/EGFR inhibitor (1µM) or PI3K inhibitor (LY294002) (10µM) at the beginning of the incubation. The results are presented as mean ± SEM 
of 6 identical sized regions from 3 samples (n=18, unless mentioned below). The comparison between the treatments within a condition was 
analysed by analysis of variance (ANOVA) followed by Bonferroni post hoc test. Independent student’s t test was employed to compare 
amongst the conditions and edges. 
(†p<0.05, †† p<0.01 when compared with intact edge of the respective treatment, *p<0.05, **p<0.01 and ***p<0.001 when compared as 
indicated) 
(Intact & wounded edge: n = 12 for both p42/p44 MAPKi and PI3Ki in H5mM condition) 
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5.5 Discussion 
HMVECad incubated in hypoxia expressed more p27Kip1 compared to normoxia 
(Fig.5.2c&d vs. 5.2e&f) as hypoxia has been reported to activate various cell cycle 
regulators. The expression of p27Kip1 has been found to be activated in hypoxic cells 
(Gardner et al. 2001). The expression of p27Kip1 in the nuclei of some of HMVECad only at 
the migrating edge of a monolayer (Fig. 5.2) could indicate that those cells might be 
actively under the consideration of not transiting from G1 to S phase of cell cycle. However 
this observation, although correct might not have any bearing on the migration of cells, as 
the migration has been observed in the presence of anti-proliferative agent (Fig. 4.3). The 
expression of p27Kip1 in the cytoplasm (Fig. 5.2c&e, 5.3c&e) could indicate its role in the 
migration as the evidence has started emerging in its favour. It has been proved that 
MAPK/PI3K downstream effector p90 ribosomal S6 kinase (RSK1) increased the 
migration via accumulation of p27Kip1 in cytoplasm (Besson et al. 2004, Larrea et al. 2009). 
On the contrary, over expression of p27Kip1 is implicated in negatively regulating the 
migration along with proliferation (Diez-Juan and Andres 2003, Goukassian et al. 2001). It 
is also worth remembering that the cells might be making the phenotypic switch from 
migration to proliferation (De Donatis et al. 2008). However, there is a need to confirm this 
further. Surprisingly, either no difference in the p27Kip1 nuclear expression was found 
between the normal and elevated glucose concentration or cells incubated in low glucose 
concentration expressed more p27Kip1 protein compared to higher glucose level 
(Fig.5.2c&e vs. d&f). These observations are contrary to previous observation wherein 
high glucose leads to the induction of p27Kip1 mediated hypertrophy of mesengial cells 
(Wolf et al. 2003). The cells at the middle of the monolayer (Fig.5.2-5.4) have not, as 
expected, expressed the p27Kip1. This could be explained on the basis that the cells in the 
middle of the monolayer are neither at the forefront of the migration nor undergoing active 
proliferation irrespective of the conditions. 
The lack of expression of p27Kip1 in elevated glucose levels in intact edge cells was 
clearly demonstrated when the stain was quantified using image J freeware (Fig.5.5). 
Surprisingly, the intensity of the stain differed between the cells cultured in normal glucose 
levels of intact edge and wounded edge but not for those cultured in higher glucose levels 
(Fig.5.5). It is further surprising that the cells at the wounded edge failed to express p27Kip1 
either in nuclei or cytoplasm suggesting no role for it either in proliferation (expected) or 
migration (unexpected). As no difference in the expression of p27Kip1 between any of the 
conditions in HMVECad of wounded edge (Fig.5.5) was found, it is plausible to 
understand the lack of nuclear expression considering that the proliferation might be 
taking place and aiding the increased migration at the wounded edge. However the lack of 
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cytoplasmic expression of p27Kip1 in the cells of wounded edge raises the question about 
activated p27Kip1 having any role in the migration of cells. This dichotomy in the role of 
cytoplasmic p27Kip1 in regulating the migration of cells could be the reason behind the 
contradicting evidences being reported. Taken together there is a need for more work to 
elucidate the role of p27Kip1 in proliferation and/or migration of microvascular endothelial 
cells in diabetic milieu. 
The immunostain being more intense in the presence of hypoxia (Fig.5.6e, 5.7e 
and 5.8e) is very much expected as HIF-1α is a well known angiogenic stimulant under 
the control of oxygen tension. Hypoxia is essential not only for the stabilization of HIF-1α 
but also for the nuclear translocation and its accumulation in the nucleus, so that it can 
perform its transcriptional activity (Kallio et al. 1998). The expression of HIF-1α was found 
to be nuclei specific in large number of HMVECad cultured in normal glucose condition as 
against the perinuclear localisation in elevated glucose levels (Fig.5.6c&e vs. d&f). The 
perinuclear localization suggests that HIF-1α although stabilized due to hypoxia and 
hence getting expressed, might not be translocated into nuclei as the high glucose might 
be interfering with that process. Apart from this, there are reports suggesting the 
degradation of HIF-1α in the presence of higher glucose. Catrina et el. (2004) suggest that 
hyperglycaemia interferes with the stability of HIF-1α in hypoxia against the proteasomal 
degradation in spite of the inhibition of PHDs and with the transcriptional activity of HIF-1α 
(Catrina et al. 2004). Further, stabilization and activation of HIF-1α rectified the diabetes 
induced impairment of wound healing by restoring the activation of many essential target 
genes such as VEGF, VEGFR, HSP-90, SDF-1α, SCF and Tie-2 (Botusan et al. 2008). 
The degradation of HIF-1α and its failure to undergo nuclear translocation in the presence 
of high glucose could be the reasons for the decreased migration of HMVECad. The 
expression of HIF-1α in normoxia (Fig.5.6c&d) although weak could have been regulated 
not by oxygen tension but by other factors such as growth factors and cytokines which are 
also known to regulate HIF-1 (Webb, Coleman and Pugh 2009). It was interesting to note 
the uniformity of the stain across the circular monolayer as against the expectation of cells 
at the edge having more stain (Fig. 5.6). The expectation that the cells at the edge of 
monolayer express more HIF-1α was based on the proposition that HIF-1 being a 
transcription factor for many mitogenic agents such as VEGF would be instrumental in 
driving the migration up (Pugh and Ratcliffe 2003). 
HMVECad at the intact and wounded edge in hypoxia (Fig.5.7e&f and 5.8e&f) 
stained slightly more intensely than the cells at the centre of the monolayer. This could 
indicate that HIF-1α activation is essential for the migration of cells. The quantification of 
the intensity of the stain using image J freeware (Fig.5.9) found no difference among any 
of the conditions except in H20mM condition between the intact and wounded edge, 
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although the migration of the wounded edge was greater than the intact edge (chapter 4, 
Fig.4.4). Contrary to the expectation HIF-1α level was found to be more intense at the 
intact edge than at the wounded edge.  
 We wanted to assess the role of possible signalling pathway/s in mediating the 
HIF-1α and hyperglycaemia regulated migration of HMVECad. Hence, the migration was 
assessed using p42/p44 MAPK, PKCβII and PI3K signal inhibitors in hypoxia as it was well 
established that hypoxia not only stimulates the migration but also activates HIF-1 system. 
Further, HMVECad were stained in the presence of inhibitors for the expression of HIF-1α 
in order to understand how different signalling pathways regulated the expression of HIF-
1α in H5mM (Fig.5.11 A&B) and H20mM (Fig.5.12 A&B) conditions. HIF-1α was localised 
as expected in the nuclei of untreated cells (Fig.5.11Aa & 5.12Aa) in H5mM condition in 
both intact and wounded edges. Unlike previous set of experiments, equal number of cells 
if not more, expressed nuclear localisation than perinuclear localisation of HIF-1α in the 
presence of H20mM condition (Fig.5.11Ba & 5.12Ba). Further, when the stain was 
quantified (Fig. 5.13) no difference in the quantity of HIF-1α was observed between H5mM 
and H20mM conditions in untreated cells. 
The PI3Ki treated cells from both the intact and wounded edge, migrated 
significantly less than other treatments and untreated cells (Fig.5.10). This clearly 
indicates that PI3K activation is central to the migration and re-endothelialisation induced 
by hypoxia and this observation is consistent with previous reports (Fitsialos et al. 2008, 
Woodward et al. 2009). The involvement of PI3K in mediating the HIF-1α dependant 
migration of endothelial cells was confirmed by the consistent decrease in the expression 
of HIF-1α in PI3Ki treated cells compared to untreated cells (Fig.5.13). The mediatory role 
of PI3K in regulating the expression of HIF-1α has been reported by other workers as well 
(Mottet et al. 2003, Yang et al. 2009). Inhibition of PI3K-Akt pathway could be aggravating 
the decrease in the migration induced by high glucose through degrading the HIF-1α as 
few PI3Ki treated cells expressed HIF-1α in nucleus (Fig.5.11Bd &5.12Bd), not the extent 
of untreated cells (Fig.5.13). This observation is consistent with previous reports where 
the inhibition of PI3K pathway has been reported to be detrimental in mediating the effects 
of high glucose in migration of cells (Yu et al.  2006). Interestingly, more of HIF-1α was 
expressed by the re-endothelializing PI3K inhibited cells from the wounded edge in 
H20mM compared to their counterparts in H5mM condition (Fig.5.13). 
Although many reports support the role of p42/p44 MAPK pathway in mediating 
the effects of hypoxia and HIF-1α (Richard et al. 1999), p42/p44 MAPK inhibition did not 
impact the migration (Fig.5.10) in hypoxia alone in HMVECad. The presence of elevated 
glucose levels continued to decrease the migration further when treated with p42/p44 
MAPKi or PI3Ki (Fig. 5.10). This indicates that the inhibition of MAPK along with PI3K 
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pathway aggravates the deleterious effect of glucose on the migration in the presence of 
hypoxia. The decreased activation of p42/p44 MAPK has been implicated in reducing the 
tube formation by glycated bFGF (Duraisamy et al. 2001). The decrease in the migration 
due to inhibition of p42/p44 MAPK could be due to reduced production of VEGF and 
decreased activity of HIF-1α during hyperglycaemia (Gupta et al. 1999, Yun et al. 2009). 
The role of p42/p44 MAPK pathway in mediating the effects of hypoxia and/or 
hyperglycaemia remain unclear as it did not produce any conclusive effect either on the 
migration or on the expression of HIF-1α. These results are not surprising as p42/p44 
MAPK is known to mediate proliferation and differentiation effects and p38 MAPK pathway 
has been implicated in mediating the migration of cells (Rousseau et al. 1997). However, 
regulation of HIF-1α remained puzzling as it has been reported to be regulated by p42/p44 
MAPK (Richard et al. 1999). This population of cells could possibly were affected by 
different set of signalling pathways than p42/p44 MAPK. 
The inhibition of PKC pathway led to the reversal of high glucose effects in 
migration indicating that glucose caused HIF-1α degradation via activation of PKC 
pathway as PKCβII/EGFRi treated cells expressed HIF-1α in high glucose compared to 
normal glucose levels. These results confirm that the production of ROS via de novo 
synthesis of DAG and subsequent activation of PKC pathway is central to the harmful 
effects of high glucose (Brownlee 2005). The perinuclear HIF-1α expression in 
PKCβII/EGFRi treated cells suggests that the phopsphorylation of PKCβII may have a role 
in the nuclear translocation of HIF-1α into the nucleus. Hyperglycaemia is known to not 
only induce the activation of PKCβII pathway but also the formation of ROS in HUVECs 
(Gallo et al. 2005). Further, the beneficial effects of PKC inhibitor was demonstrated when 
it reduced the microvascular complications of hind limbs in STZ induced diabetic mice 
through the increased expression of PDGF (Tanii et al. 2006). Although the migration of 
PKCβII/EGFRi treated cells from wounded edge decreased, the expression of HIF-1α did 
not diminish in comparison to untreated cells in H20mM condition. This clearly indicates 
that deleterious effects of glucose in decreasing the migration were mediated at least 
partially through the activation of PKC pathway via HIF-1α. 
5.6 Conclusion 
Hyperglycaemia results in decreasing the migration compared to hypoxia alone 
due to retarded transcriptional activity of HIF-1 either because of failure in nuclear 
translocation or degradation of HIF-1α. This activity was mediated by PKCβII pathway. The 
p42/p44 MAPK pathway aggravated the effects of high glucose whereas PI3K pathway 
might be a mediator for either aggravating the effects of high glucose and/or for the 
inhibition of angiogenic stimulant effects of hypoxia. The role of cytoplasmic expression of 
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p27Kip1 during the migration of cells needs a further probing. As ROS are known to be a 
common source of both hypoxia and hyperglycaemia, in the next chapter effect of 
silymarin, an antioxidant on the migration of HMVECad is evaluated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 - Effect of silymarin on the migration of 
endothelial cells 
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6.1 Hypothesis 
 Antioxidant, silymarin [Silybum marianum (L.)] will have a beneficial effect on high 
glucose induced decrease in the migration of HMVECad. 
6.2 Introduction  
 Silymarin complex consisting of seven different flavonolignans and a flavanoid has 
been in use as a hepatoprotective agent and as an antioxidant for many years (Comelli et 
al. 2007, Post-White, Ladas and Kelly 2007).  Silymarin produces its anti-oxidant effects 
through various ways. It has been shown to increase many anti-oxidant enzymes such as 
superoxide dismutase (SOD), glutathione peroxidase (GSHPx), glutathione reductase 
(GR) and catalase (CAT) as well as decreasing the levels of serum alanine 
aminotransferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP) 
and total bilirubin which help in the elimination of ROS (Comelli et al. 2007, Eminzade, 
Uraz and Izzettin 2008). Silymarin has started to receive attention not only as a 
hepatoprotective adjuvant for cancer therapy but also because of its antiangiogenic 
effects (Ramasamy and Agarwal 2008, Singh, Gu and Agarwal 2008). Silibinin, the main 
component of silymarin has been shown to produce antiangiogenic effects by decreasing 
the expression of many angiogenic stimulants such as HIF-1α, iNOS, PECAM-1, VEGF, 
down regulation of VEGFR1 (Raina et al. 2008) and by increasing the expression of 
TIMP-1 and 2 which are inhibitors of MMPs and ANG-2 and Tie-2 (Tyagi et al. 2009). The 
anticancerous effects were mediated by the inhibition of the phosphorylation of p38, 
JNK1/2 and ERK1/2 MAPK and PI3K-Akt pathway (Garcia-Maceira and Mateo 2009, Gu 
et al. 2005). However, beneficial effects of silibinin in non-cancerous cells such as glial 
cells, cardiac myocytes and neutrophils are regulated by PKC activity along with other 
pathways (Tsai et al. 2010, Varga et al. 2004, Zhou et al. 2007). 
 The anti-diabetic effects of silymarin remain untested to a large extent. Silymarin is 
known to produce its anti-diabetic effects by acting as a cytoprotectant of pancreatic cells, 
as an anti-oxidant and by inhibition of hepatic glucose formation (Guigas et al. 2007, Soto 
et al. 2003, Soto et al. 2004 and Soto et al. 2010). Silymarin has also been proved to 
provide the cytoprotective effect to HUVECs against hypoxia as well as high glucose 
(Weidmann 2008). Hypoxia and high glucose are known to produce their effects by 
inducing the production of ROS (Li et al. 2010). As silymarin is a known antioxidant, the 
effects of silymarin on the migration of endothelial cells in the presence of high glucose 
and/or low oxygen tension are tested in this chapter. 
6.3 Materials and methods  
The migration of HMVECad was assessed in the presence of silymarin (SM) 
(50µM) (in 0.5% v/v of DMSO) and α-lipoic acid (aLA) (100 µM) (in 0.5% v/v of ethanol) 
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(Weidmann 2008). Alpha lipoic acid was used as a positive control to compare with 
silymarin treatment. DMSO and ethanol were used as a vehicle control for SM and aLA 
treatment respectively. The migration was assessed by both the radial migration assay 
and wound healing assay as explained in section 2.2.3 and 2.2.4 respectively. The 
migration of endothelial cells was assessed in 20% O2 tension and 5mM glucose (N5mM), 
20% O2 tension and 20mM glucose (N20mM), 5% O2 tension and 5mM glucose (H5mM) 
and 5% O2 tension and 20mM glucose (H20mM) conditions. All the results are presented 
as net migration (mean ± SEM) in micrometers and analysed using SPSS 15.0. 
6.4 Results 
6.4.1 Effect of silymarin on the migration of HMVECad by radial migration assay 
The vehicle control (DMSO) for silymarin, did not significantly alter endothelial cell 
migration (Fig. 6.1a & b) when compared to control. The migration pattern was found to be 
similar to that explained in section 4.4.1.; the migration (µm) of untreated endothelial cells 
was lower (p<0.001) for N20mM (24 h: 57 ± 1.3; 48 h: 117.2 ± 1.5) in comparison to that 
of N5mM (24 h: 78.4 ± 0.8; 48 h: 133.9 ± 0.9) condition for both 24 and 48 h. The 
migration was high (p<0.001) for H5mM (24 h: 101.4 ± 1.1; 48 h: 174.6 ± 1.5) compared to 
N5mM condition for 24 and 48 h. When hypoxia and high glucose concentration (H20mM) 
(24 h: 72.2 ± 1.1; 48 h: 136.3 ± 1.3) were combined the migration was lower (p<0.001) 
than that of hypoxic and normal glucose (H5mM) level for both 24 and 48 h. 
The results show that the addition of silymarin (50µM) increased the migration of 
cells in N20mM (24 h: 100.4 ± 1.0; 48 h: 178.3 ± 1.6) condition and was found to bring the 
migration (µm) level to those in N5mM (24 h: 99.9 ± 0.8; 48 h: 172.7 ± 2.0) condition. 
However, the migration of cells in H5mM (24 h: 117.9 ± 1.4; 48 h: 208.9 ± 5.6) condition 
was found to be more (p<0.001) than those in N5mM condition as with the untreated cells. 
Like in normoxia, the migration of cells in H20mM (24 h: 115.5 ± 1.3; 48 h: 198.5 ± 2.0) 
condition was brought to the level of H5mM condition and no significant difference was 
found between the two conditions. The number of observations (n = 40) recorded for 
H5mM and H20mM at 48 h was less due to the limitation of image size that could have 
been captured within the image frame, which was explained in section 3.2.3. The 
migration of untreated cells in all conditions was significantly (p<0.001) lower compared to 
respective condition of silymarin treated cells. The silymarin treatment increased the 
migration level of HMVECad in 20mM condition under both normoxia and hypoxia to that 
of 5mM condition. These results confirm the ability of the silymarin to overcome the high 
glucose induced decrease in the migration of microvascular endothelial cells. 
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Fig. 6.1 Effect of silymarin (50µM) on the migration HMVECad were cultured in 
conditions of 5 or 20mM glucose and 20 (Normoxia – N) or 5% (Hypoxia – H) oxygen 
tension. The migration was assessed by the radial migration assay. The silymarin 
significantly increased (p<0.001) the migration for all the conditions compared to 
respective condition of untreated cells. The results are presented as net migration (mean 
± SEM) of cells at 24 (a) and 48h (b) and analysed by analysis of variance (ANOVA) 
followed by Bonferroni post hoc test. 
(***p<0.001 when compared as indicated; NS = not significant)  
v.c. (DMSO) 24 & 48h: N5mM=160; N20mM=120; H5mM=180; H20mM=180 
SM 24 & 48h: N5mM=180 & 120; N20mM=180; H5mM=180 & 40; H20mM=140 & 40) 
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6.4.2 Effect of α - lipoic acid on the migration of HMVECad by radial migration assay 
The migration of HMVECad in the presence of vehicle control (ethanol) (Fig. 6.2a 
& b) was comparable to those found with DMSO. The migration (µm) in N20mM condition 
(24 h: 62.1 ± 1.3; 48 h: 110.5 ± 1.6) was lower (p<0.001) and that of H5mM (24 h: 105.9 ± 
1.9; 48 h: 175.5 ± 2.6) condition was higher (p<0.001) in comparison with the N5mM (24 
h: 73.7 ± 0.8; 48 h: 136.8 ± 1.7) condition for both 24 and 48 h. When hypoxia and high 
glucose concentration (H20mM) were combined (24 h: 74.1 ± 0.6; 48 h: 138.3 ± 0.9) the 
migration was lower (p<0.001) than that of hypoxic and normal glucose level (H5mM) at 
24 and 48 h. 
Unlike silymarin, aLA (100µM) failed to overcome the decrease in the migration 
(µm) of N20mM (24 h: 73.8 ± 0.8; 48 h: 129 ± 1.2) cells compared to those of N5mM (24 
h: 77.4 ± 0.8; 48 h: 144.4 ± 0.9) cells (24 h: p<0.05; 48 h: p<0.001). Similarly, there was a 
significant decrease (p<0.001) for both 24 and 48 h in the migration of cells incubated in 
H20mM (24 h: 82.5 ± 0.9; 48 h: 144.1 ± 1.3) condition compared to H5mM (24 h: 92.2 ± 
1.3; 48 h: 165.8 ± 2.0) condition. However, hypoxia (H5mM) was still able to drive the 
migration of the cells further (p<0.001) than those of normoxia (N5mM). 
Alpha lipoic acid treatment was found to significantly (N5mM: 24 h - p<0.01 & 48 h 
- p<0.001, N20mM: 24 & 48 h - p<0.001) increase the migration under normoxic condition 
when compared to those of untreated cells of same conditions. However, in H5mM 
condition the migration at 24 (p<0.001) and 48 h (p<0.01) was found to be less than that 
of untreated cells. For the cells incubated in H20mM condition, the migration due to aLA 
treatment was again found to be high at 24 (p<0.001) and 48 h (p<0.001) compared to 
those of untreated cells of the same condition. As aLA failed to overcome the high glucose 
induced decrease in the migration, it was decided to continue to work with silymarin and 
the aLA was not used any further. 
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Fig. 6.2 Effect of α- lipoic acid (100µM) (aLA) on the migration HMVECad were 
cultured in conditions of 5 or 20mM glucose and 20 (Normoxia – N) or 5% (Hypoxia – H) 
oxygen tension. The migration was assessed by the radial migration assay. Alpha lipoic 
acid significantly increased the migration of all conditions except H5mM condition, 
compared to the respective condition of untreated cells. The results are presented as net 
migration (mean ± SEM) of cells at 24 (a) and 48 h (b) and analysed by analysis of 
variance (ANOVA) followed by Bonferroni post hoc test. 
(*p<0.05, **p<0.01 & ***p<0.001 when compared as indicated)  
(v. c. (ethanol) 24 & 48 h: N5mM=180; N20mM=160; H5mM=140; H20mM=180 
aLA 24 & 48 h: N5mM = 180; N20mM = 180; H5mM = 160; H20mM = 160) 
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6.4.3 Effect of silymarin on the migration of HMVECad by the wound healing assay 
 The effect of silymarin (50µM) on HMVECad migrating from the intact and 
wounded edges of the semicircular monolayer was assessed by the wound healing assay. 
Like with the radial migration assay, the vehicle control (DMSO) for SM on its own 
did not alter the trends of endothelial cell migration (Fig 6.3a & b) from intact or wounded 
edge of the layer. The migration pattern for vehicle control was found to be similar to that 
explained in the earlier section (6.4.1) of this chapter. The migration (µm) of endothelial 
cells from the intact edge was lower (p<0.001) under N20mM (24 h: 82.4 ± 1.9; 48 h: 
160.3 ± 3.2) condition in comparison to that of N5mM (24 h: 100.2 ± 2; 48 h: 192.2 ± 4.7) 
condition for both 24 and 48 h. The migration was higher (p<0.001) in H5mM (24 h: 136.6 
± 2.7; 48 h: 237.6 ± 3.9) condition compared to that of N5mM condition at both 24 and 
48h. When hypoxia and high glucose level were combined (H20mM) (24h: 95.6 ± 3.9; 
48h: 191.5 ± 4.5) the migration was lower (p<0.001) than that of hypoxic and normal 
glucose level (H5mM) for 24 and 48 h. 
The migration (µm) of cells from the wounded edge of the same monolayer was 
measured. The same patter of migration (N5mM; 24 h: 131.9 ± 4.2; 48 h: 227.9 ± 4.6, 
N20mM; 24 h: 107.5 ± 2.9; 48 h: 187.7 ± 4.2, H5mM; 24 h: 165 ± 3.3; 48 h: 262.7 ± 4.3 
and H20mM; 24 h: 125.5 ± 4.3; 48 h: 224.2 ± 4.5) was observed for cells migrating from 
the wounded edge of the layer (Fig. 6.3a & b). When the migration of untreated cells were 
compared between the intact and wounded edges of the monolayer, it was observed that 
the wounded edge cells migrated significantly (p<0.001) faster than those on non 
wounded edge for all the conditions and time points. 
The results (Fig. 6.3a & b) for the intact edge of the layer show that the silymarin 
treatment increased the migration (µm) in N20mM condition (24 h: 95.9 ± 3.3; 48 h: 190.5 
± 4.2) and was found to be on par with those of N5mM (24 h: 97.4 ± 3.9; 48 h: 169.1 ± 
5.3) at 24 h. However, the migration of cells from the intact edge in N20mM condition was 
significantly increased (p<0.01) beyond the migration in N5mM condition after 48 h. The 
migration of cells incubated in H5mM (24 h: 120.2 ± 2.6; 48 h: 208.6 ± 3.9) condition was 
found to be significantly higher (p<0.001) than those of N5mM condition. Under hypoxic 
conditions, silymarin halted the effect of hyperglycaemia on the migration of cells in 
H20mM (24 h: 122.2 ± 3.1; 48 h: 221.5 ± 4.3) condition at 24 and 48 h and brought it to 
the level of H5mM condition. 
The silymarin treated cells migrating from the wounded edge of the layer followed 
the same pattern as those from the intact edge for all the conditions and time points 
(N5mM; 24 h: 122.4 ± 2.1; 48 h: 215.1 ± 3.5, N20mM; 24 h: 129.5 ± 3; 48 h: 235.5 ± 3.1, 
H5mM; 24 h: 148.7 ± 2.8; 48 h: 266.5 ± 4.1 and H20mM; 24 h: 159.6 ± 4; 48 h: 269.1 ± 
4.3). Like with the cells of intact edge, the silymarin treatment caused an increase in the 
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migration of cells in N20mM condition beyond that in N5mM condition of the wounded 
edge at 48 h. Like untreated cells, it was observed that the silymarin treated cells of the 
wounded edge migrated faster (p<0.001) than those of unwounded edge of the same 
monolayers for all conditions and time points. 
The difference in the migration of the untreated and silymarin treated cells from 
intact edge did not reach significance at 24 h in N5mM condition. However by the end of 
48 h the silymarin treated cells from the intact edge had migrated less (p<0.01) than those 
of untreated cells. The difference in the migration of the untreated and treated cells 
migrating from the wounded edge did not reach significance at both time points. In 
N20mM condition, the migration of cells in the presence of SM was significantly higher 
than those of untreated cells for both the intact (24 h: p<0.01 48 h: p<0.001) and wounded 
edges (24 & 48 h: p<0.001) and for both time points. In H5mM condition at 24 and 48 h, 
SM treated cells migrated slower from the intact edge (24 h: p<0.01, 48 h: p<0.001) 
compared to those of untreated cells. Surprisingly, SM treated cells from the wounded 
edge migrated slower at 24 h (p<0.01), but covered more distance in the next 24 h hence 
no difference was found between the treated and untreated cells at the end of 48 h. 
Similar to N20mM condition there was a significant difference (p<0.001) between the 
untreated and treated cells at H20mM condition at both time points as silymarin negated 
the effect of hyperglycaemia on reducing migration distance. It was noted that the 
migration of untreated cells from the intact edge of the wounded semicircular monolayer 
(Fig. 6.3a & b) was significantly (p<0.001) higher than that of intact circular monolayer 
(Fig. 6.1a & b) 
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Fig. 6.3 Effect of silymarin (50µM) on the migration of HMVECad from intact and 
wounded edges Migration in conditions of 5 or 20mM glucose and 20 (Normoxia – N) or 
5% (Hypoxia – H) oxygen tension was assessed by the wound healing assay. The 
silymarin significantly increased (p<0.001) the migration of 20mM conditions compared to 
respective conditions of untreated cells. The results are presented as net migration (mean 
± SEM) of cells at 24 (a) and 48 h (b) and analysed by analysis of variance (ANOVA) 
followed by Bonferroni post hoc test. 
(**p<0.01, *** p<0.001 when compared as indicated; NS = not significant)  
(v.c. intact edge and wounded edge (24 & 48h): N5mM = 60 & 90; N20mM = 60 & 90; 
H5mM = 60 & 90; H20mM = 40 & 70 
SM intact edge (24 & 48h): N5mM = 40 & 70; N20mM = 40 & 60; H5mM = 50 & 70; 
H20mM = 50 & 70 
SM wounded edge (24 & 48h): N5mM = 50 & 70; N20mM = 40 & 70; H5mM = 60; H20mM 
= 60 & 80)  
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6.5 Discussion 
Silymarin successfully restored the high glucose induced decrease in the migration 
of HMVECad in the presence of both normoxia and hypoxia. This observation was true for 
both radial migration and the wound healing assay. The migration of silymarin treated 
HMVECad in hypoxia compared to normoxia was not consistent as it was contradictory 
between the radial migration and wound healing assay. Further, the results indicated that 
α-lipoic acid was not sufficiently effective in restoring the negative trend of migration due 
to high glucose. 
It has been proven from the data presented in chapter 4 that high glucose and low 
oxygen tension have opposing effects on the migration of HMVECad. The migration of 
cells treated with vehicles (untreated) (Fig.6.1 & 6.2) resembled the trends explained in 
chapter 4. However, there are no reports to the best of our knowledge, detailing the role of 
silymarin in endothelial cell migration or angiogenesis during diabetes, although it has 
been proved to have beneficial effects in diabetes (Soto et al. 2010). It has been 
confirmed from chapter 5 that the over activation of PKC pathway mediated the 
deleterious effects of high glucose whereas activation of PI3K is essential to induce the 
migration in hypoxia. 
Hyperglycaemia is known to cause the production of ROS which in turn over 
activates different pathways including DAG dependant PKC pathway which leads to 
glucotoxicity (Brownlee 2001). High glucose causes not only the production of ROS via 
over activation of PKCβII but also its translocation from cytosol to the membrane (Gallo et 
al. 2005). Silibinin has been proved to produce its anti-oxidant activity by inhibition of DAG 
dependant PKC translocation and NADPH activity (Varga et al. 2004). It is also known 
that the inhibitors of PKC prevent the formation of various ROS in endothelial cells (Pricci 
et al. 2003). Further, increased production of ROS in hyperglycaemia leads to the 
dysfunction of HIF-1α with subsequent impairment in the expression of target genes such 
as VEGF and PDGF (Thangarajah et al. 2010). This could possibly suggest that silymarin 
restored the migration of HMVECad (Fig.6.1 &6.3) in high glucose by inhibition of the 
production of ROS via reduced activation of PKCβII pathway and restoration of HIF-1α 
activity. However, it was surprising to note the inability of aLA (Fig.6.2) to produce any 
effect on the high glucose induced decrease in the migration, as it is a established strong 
anti-oxidant capable of interfering with the production of ROS and subsequent activation 
of PKCβII along with other oxidative markers (Ihnat et al. 2007). 
The results (Fig.6.1) suggest that silymarin treated cells increased the migration 
compared to untreated cells in both normoxia and hypoxia. Hypoxia causes an increase in 
the production of ROS and activation of PI3K leading to the increase in the migration of 
cancer cells due to increased transcriptional activity of HIF-1α (Koshikawa et al. 2009). 
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However, during the normal wound healing process hypoxia is desirable as it stimulates 
angiogenesis in order to re-establish the supply of oxygen and nutrients to the wounded 
tissue (Falanga 2005). The inhibition of PI3K attenuated hypoxia induced migration as 
noticed in chapter 5. Hence, silymarin could be causing the increase in the migration by 
either by its ability to scavenge the free radicals or through the mechanisms other than 
PI3K-Akt pathway. However, the increased migration was not consistent when the 
wounded monolayers were treated with silymarin (Fig.6.3). The cells in hypoxia from intact 
and wounded edge migrated significantly lesser than untreated cells. These conflicting 
results make the interpretation difficult. Further, there are no reported evidences about the 
pro-angiogenic effects of silymarin. On the contrary, the anti-angiogenic effects of 
silymarin find reasoning in the literature, which suggest that silymarin or its main 
constituent silibinin decreases the migration. Singh et al. (2005) suggests that silibinin 
produces its anti-angiogenic effects through multiple ways in both HUVEC and HMVEC 
(Singh et al. 2005). It has been suggested that silibinin inhibits the proliferation of 
HUVECs by the over expression of p27Kip1, p21Cip1 and p53 and causes apoptosis by 
increasing the activity of caspase 3 and 7 and decreasing survivin activity (Singh et al. 
2005). Further, silibinin has also been shown to cause a decrease in angiogenic stimuli by 
decreased MMP-2 mediated migration and tube formation through the inhibition of the Akt 
pathway and NF-κβ pathways (Singh et al. 2005). Anti-angiogenic effects of silymarin or 
silibinin are attributed to inactivation or inhibition of HIF-1α, PI3K-Akt pathway, ERK1/2, 
JNK1/2 and p38 MAPK (Chen et al. 2005, Garcia-Maceira and Mateo 2009, Gu et al. 
2005). 
6.6 Conclusion 
It could be possible that silymarin is restoring the high glucose induced decrease 
in the migration through its free radical scavenging activity via PKCβII inhibition and 
restoration of HIF-1α activity. Successful restoration of the migration in high glucose by 
silymarin suggests that it could be a candidate for therapeutic angiogenesis, hence 
formulated as a topical application with an aim of developing it as a therapeutic agent for 
delayed wound healing of diabetes. 
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7.1 Hypothesis 
 Gamma ray irradiated lyophilised wafer discs containing silymarin restore the high 
glucose induced reduction of endothelial cell migration compared to control wafer discs. 
7.2 Introduction 
 Wound dressings developed over many years are classified into different 
categories depending on their content, physical form and their function (Boateng et al. 
2008). Different agents such antimicrobials, growth factors and supplements are used to 
medicate the wound dressings (Boateng et al. 2008). Freeze-dried fibrin discs containing 
growth factors were reported to enhance endothelialisation (Kumar and Krishnan 2002) 
and those containing tetracyclins were successfully used as subcutaneous implants to 
control infection during wound healing in mice with steady release of the drug into the 
serum (Kumar, Vasantha Bai and Krishnan 2004). Similarly topical application of vitamins 
A, E and C has shown to improve wound healing in rats (Porto da Rocha et al. 2002). 
Lyophilised or freeze-dried formulations are a promising topical drug deliver system for the 
application of therapeutic agents used to treat recalcitrant diabetic wounds. Wafers can be 
developed to contain a variety of medication using freeze-dried polymers as topical 
vehicles (Matthews et al. 2005, Matthews et al. 2008). Silymarin or silibinin has been used 
topically to treat contact dermatitis and photocarcinogenesis in experimental animals (Han 
et al. 2007, Mallikarjuna et al. 2004). However, freeze-dried products containing silymarin 
for the topical treatment of diabetic wounds has not been reported. 
Natural polymers are widely used as vehicles in many different formulations. 
Selection of a vehicle is critical as some vehicles themselves may have a therapeutic 
effect. A freeze-dried chitosan film with and without bFGF was beneficial when applied on 
full-thickness wounds created on the backs of genetically diabetic mice until day five 
indicating that the vehicle itself may also have an effect on the wound healing (Mizuno et 
al. 2003). TGF- 1 was incorporated in phosphate buffered saline/poloxamer gel 
formulations, duoDERM hydroactive paste and in a poly (ethylene oxide) hydrogel and 
tested for wound healing activity in diabetic rats. Poloxamer gel formulations containing 
TGF- 1 showed improved wound healing in diabetic rats with sustained release of drug 
suggesting the importance of the carrier used in drug delivery (Puolakkainen et al. 1995). 
Polymers can also be used as vehicles for RNA interference constructs (Werth et al. 
2006). Xanthan gum and sodium alginate with methylcellulose have been successfully 
used to prepare freeze-dried wafers for wound models (Matthews et al. 2005, Matthews et 
al. 2006). 
Characterisation of physical properties of freeze-dried formulations is essential in 
order to understand drug/vehicle interactions, flow properties and drug release profile. 
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Some of the procedures such as thermal analysis and rheology are helpful in 
understanding the physical properties of freeze dried wafers and their contents (Matthews 
et al. 2008). The flow properties of the vehicle and other contents of topical applications 
determine the residence time of a drug when applied to the wound surface. The 
formulations for wound treatment would be effective if they establish an adherence to the 
wound site with prolonged residence time (Jones, Lawlor and Woolfson 2003). Other 
physical properties such as water vapour transmission, gaseous exchange, water 
absorption (from the wound surface) and adherence (to the wound site) are also of 
interest (Gatti, Pinchiorri and Monari 1994). These properties also serve as valuable 
guidance dictating the selection of materials.  
Therapeutic agents used in the treatment of chronic wounds of diabetes needs to 
be sterile in order to keep the bacterial load to the minimum at the wound site. Any topical 
application desirous of containing either anti-bacterial or proteinaceous growth factor or 
any other medication sensitive to heat can not be autoclaved or heat sterilised as the 
contents may not remain stable after sterilisation (Traub and Leonhard 1995). However 
the preparations can be sterilised by other method such as gamma irradiation while 
maintaining the stability of heat labile contents (Matthews et al. 2006). Gamma rays 
generated from Co-60 are widely used in industry to sterilise many pharmaceutical 
preparations, surgical instruments and cell culture materials. Gamma irradiation has been 
reported to affect stability and properties of few materials. The viscosity of extruded 
products containing xanthan gum increased when irradiated and those containing starch 
displayed increased expansion when exposed to ionising radiation (Hanna et al.  1997). 
The viscosity and molecular weight was reduced and chain breaking increased, with a 
change in colour, when alginate solution was exposed to gamma rays (Lee et al. 2003). 
The rheological properties of freeze-dried wafers containing xanthan gum remained 
largely unaffected when exposed to 40kGy of gamma radiation where as those composed 
of sodium alginate displayed reduced viscosity (Matthews et al. 2006). The ability of 
xanthan gum to withstand ionising radiation and its ability to potentially produce enhanced 
residence time at a wound site due to its viscous nature makes it an ideal vehicle for 
freeze dried products. 
This chapter deals with the preparation of freeze dried wafer discs composed of 
xanthan gum as a vehicle and silymarin and α-lipoic acid as active ingredients. The pre- 
and post-lyophilised gels were rheologically characterised by continuous flow 
measurements. Freeze dried wafer discs were tested on the wound healing model 
following gamma ray sterilisation. 
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7.3 Materials and methods 
7.3.1 Preparation of lyophilised wafers 
Polymer gels of xanthan gum (XG), guar gum (GG), ghatti gum (GhG), locust bean 
gum (LbG), karaya gum (KG) and sodium alginate (SA) were prepared at concentrations 
of 1.5, 2, 7, 1.5, 3 and 5% (w/v) respectively. The gels containing these polymers were 
prepared by dissolving them in pre-heated (~ 40 0C) distilled water in a stainless steel 
beaker. Distilled water was heated by placing the beaker on a hot plate and the polymer 
was added and stirred with a mechanical overhead stirrer at 500rpm. The resulting gel 
was used for rheological characterisation as explained in 7.3.2.  
XG (1.5% w/v) was chosen as a vehicle to prepare the lyophilised wafers 
containing silymarin (SM) or α-lipoic acid (aLA). Wafers were prepared at concentration of 
50 and 100 µM of SM and aLA respectively, for further testing with endothelial cells. 
Pluronic F68 was used to aid suspension of SM and aLA as they are insoluble in water. 
Gels were prepared by dissolving Pluronic F68 (0.2% w/v) in distilled water in a stainless 
steel beaker, followed by the addition of SM (0.07% w/v) or aLA (0.06% w/v). Different 
components and their ratio in gels used for the preparation of the wafers are tabulated in 
Table 7.1. The contents were stirred using a Silverson turbine mixer for 0.5 h at room 
temperature (22 0C). XG (1.5% w/v) was added and the beaker was left overnight in the 
fridge at ~4 0C to form a weak gel. Roller mixture was used to get homogenous 
suspension of SM and aLA gels. 
Samples of prepared gel suspensions (4g) were poured to each well of a 6-well 
plate, avoiding the formation of bubbles for freeze drying. Gel suspensions were 
lyophilised in a laboratory scale freeze drier (VirTis adVantage, Biopharma Process 
Systems, Hampshire, UK) with shelf cooling. Gels were cooled to -50 0C and then heated 
to room temperature by a series of thermal ramps under reduced pressure. Primary drying 
removed the frozen water by sublimation and the remaining non-freezing water was 
removed by desorption to the gas phase. The freeze drying process was carried out over 
26 hours and a temperature profile of the process is charted in Fig. 7.1 Resulting 
lyophilized wafers were pressed to a paper-thin size and punched to make discs using a 
paper punch. Wafer discs (~5mm in size and ~1.5mg in weight) were placed in self-
sealable polythene bags and stored at room temperature. 
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Table 7.1 Contents of gels used to prepare lyophilised wafers The wafers containing 
silymarin (SM) or α-lipoic acid (aLA) as active pharmaceutical ingredient (API) were 
prepared using xanthan gum (XG) as a vehicle and non-ionic surfactant Pluronic F68 as a 
suspending agent. Vehicle control (v.c.) wafers contained no API. 
 
Batch 
No. 
Component ratio 
(%) in gels 
XG : F68 : API 
(API=SM/aLA) 
Calculated solids in  each wafer 
gel (4g) (mg) Mean (± S.D) weight 
of wafer (mg) (n=6) 
XG F68 API Total 
1 (v.c.) 1.5 : 0.2 : 0.0 60 8 - 68 65.7 (±2.6) 
2 (v.c.) 1.5 : 0.2 : 0.0 60 8 - 68 67.7 (±1.1) 
3 (SM) 1.5 : 0.2 : 0.07 60 8 2.8 70.8 67.7 (±0.6) 
4 (SM) 1.5 : 0.2 : 0.07 60 8 2.8 70.8 68.8 (±1.5) 
5 (aLA) 1.5 : 0.2 : 0.06 60 8 2.4 70.4 68.5 (±0.8) 
6 (aLA) 1.5 : 0.2 : 0.06 60 8 2.4 70.4 69.2 (±0.5) 
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Fig. 7.1 Freeze-drying cycle The temperature profile of the freeze drying cycle for 26h 
was obtained during the preparation of the wafers. The pre-lyophilised gels were cooled to 
-50 0C and then heated to room temperature by a series of thermal ramps under reduced 
pressure. 
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7.3.2 Rheological properties of polymer gels 
The rheological properties of pre-lyophilised polymer gels were measured using a 
dynamic rheometer (AR1000, TA Instruments). Gels formed from lyophilised wafers by the 
addition of volumetric amounts of distilled water to their original weight (i.e. 4g per well) 
were also rheologically characterised. Continuous flow rheometry tests were conducted at 
25 0C. This test depends on the viscous drag exerted on the geometry, when it is rotated 
on the fluid to determine the apparent viscosity of the fluid.  The geometry is composed of                                                                                                                                                                                                                                                                                                                                                                                                                                            
a wide-angle cone which spins centrally above a stationary plate giving torsional shear.  A 
cone and plate geometry of 40mm/20 (steel) and truncation value of 57µm was used. Flow 
measurements were carried out at continuous shear rates ranging from 0 to 600s-1. The 
results (rheograms) were a plot of shear rate vs. shear stress. The rheograms were 
analysed by the system software using the Herschel-Bulkley equation  
 
    σ = η’γn + σ0 
 
where ζ is shear stress (Pa), ε’ the viscosity coefficient or consistency (Pa.s), γ the shear 
rate (s-1), n the rate index (flow behaviour index) and ζ0 the yield stress (Pa). 
7.3.3 Sterilisation of wafers 
Wafers prepared as detailed in section 7.3.1 were irradiated with ultra violet rays 
(UVitec CROSSLINKER CL-500). Wafers were irradiated with UV rays at 0.36, 0.72, 1.5, 
3.0, 6.0 and 12.0 J/cm2. As the UV rays failed to sterilise the wafers, they were sterilised 
by gamma irradiation. Each batch of the control, SM and aLA wafers was divided into 
three lots packed as wafer discs in self-sealable plastic pouches. One lot was not 
irradiated to compare with other irradiated lots. One lot was irradiated with 25KGy, 
another with 40KGy of gamma rays (Isotron Plc, Swindon, UK) using Cobalt-60 as a 
source with an approximate dose rate of 5kGy/h.  
After irradiation wafers were tested for the presence of bacteria and fungi. To test 
for the presence of bacteria, wafers were incubated in tryptone soya agar (TSA) (Oxoid, 
UK)[40g/l of TSA made up of tryptone 15g/l, soyapeptone 5g/l, sodium chloride 5g/l and 
agar 15g/l poured into Petri dishes and sterilised at 1210C for 15 minutes] plates for 24h 
(Landry et al. 2001). To test for the presence of fungi wafers were incubated with 
sabouraud dextrose agar (SAB) (Oxoid, UK)[65g/l of SAB made up of mycologicalpeptone 
10g/l, glucose 40g/l and agar 15g/l is poured into Petri dishes and sterilised at 1210C for 
15 minutes] plates for 48h (Landry et al. 2001). 
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7.3.4 Quantification of silymarin in the wafers 
 High performance liquid chromatography (HPLC) was used to quantify SM 
(Quaglia et al. 1999) present in non-irradiated, 25 and 40kGy irradiated wafer discs. The 
HPLC system used for the quantification of silymarin content was as follows: 
 
Table 7.2 Components of HPLC equipment  
 Components Make 
1 Pump Jasco PU-1580 
2 Column Agilent Eclipse XDB-C18 
3 Degasser Jasco DG-980-50 
4 Gradient Unit Jasco – 1580 -02 
5 UV-Visible Detector Jasco UV-1500 
6 Data acquisition and evaluation Jasco Borwin 15.0 
 
The standard (or calibration) curve was obtained by running SM solution, prepared 
by dissolving 0.0112g of silymarin in 50ml of solvent in a volumetric flask. The solvent 
(50ml) was composed of 32ml of solvent A (0.01% formic acid in deionised water), 6ml of 
solvent B (HPLC grade methanol) and 12ml of solvent C (HPLC grade acetonitrile). 
Solution was injected into a valve using a 50µl sample loop. Analyte produces five well 
defined peaks at λ value of 289nm and a flow rate of 1ml/min using the following gradient 
elution: 
 
Table 7.3 HPLC gradient elution used to analyse silymarin 
Time % water % methanol % acetonitrile 
0 68 12 20 
10 68 12 20 
15 50 20 30 
20 50 20 30 
25 68 12 20 
  
 Standard solution from SM neat and sample solutions of non-irradiated, 25 and 
40kGy irradiated SM wafer discs were prepared in the above mentioned HPLC solvent to 
carry out the quantification of SM. 
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7.3.5 Effect of silymarin wafers on the migration of HMVECad 
 Gamma irradiated sterile wafer discs with and without silymarin were tested for 
their effect on the migration of human microvascular endothelial cells of adult dermis 
(HMVECad). The migration of cells in the presence of discs in four different conditions of 
normoxia in absence and presence of elevated glucose (N5mM and N20mM) and in 
hypoxia in absence and presence of elevated glucose concentration (H5mM and H20mM) 
was measured according to the method explained in 2.2.4. The results are expressed as 
net migration in microns (µm) and expressed as mean ± SEM. 
7.4 Results 
7.4.1 Rheological characterisation of the gels 
 The gels made from 2% GG and 1.5% XG exhibited plastic (i.e. a clear yield stress 
followed by a decrease in apparent viscosity as a function of increased shear rate) flow 
(Fig. 7.2a). The viscosity coefficient (consistency) and yield stress (inability of the gel to 
flow at lower shear rate) of the GG was found to be more than that of XG (table 7.4). 
Plastic flow exhibits a dramatic ‘shear thinning’ effect when a shear stress in excess of the 
minimum yielding stress is applied. The gels from other gums viz. 5% SA, 3% KG, 1.5% 
LbG and 7% GhG exhibited pseudoplastic (i.e. decreased apparent viscosity with 
increasing shear rate) flow (Fig. 7.2b). The flow charts of these polymer gums suggest 
that the gels exhibited pseudoplastic flow as they started to flow as soon as the shear 
stress was applied, making the flow curves pass through the origin. Pseudoplastic flow 
also exhibits shear thinning although less dramatically than plastic flow. The viscosity 
coefficient of 5% SA was found highest whereas 7% GhG exhibited the lowest (table 7.4). 
The freeze dried wafer discs of SM and aLA were prepared using 1.5% XG and sterilised 
by gamma rays. The freeze drying process did not change the flow properties of the post-
lyophilised reconstituted wafer gels from that of corresponding pre-lyophilised gels (Fig. 
7.3). Sterilisation by gamma rays increased the viscosity coefficient and yield stress of 
post-lyophilised control and SM wafers. On the contrary, viscosity coefficient decreased 
for sterilised aLA wafers and yield stress remained unchanged. Alpha lipoic acid pre- and 
post-lyophilised gels before sterilisation were more viscous with higher viscosity 
coefficient values and exhibited a higher yield stress compared to either control or SM 
wafer gels (table 7.4).  
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a) 
 
b) 
 
 
 
Fig. 7.2 Rheograms of gels The flow charts were obtained from gels composed of a) 2% 
GG and 1.5% XG and b) 5% SA, 3% KG, 1.5% LbG and 7% GhG. The XG and GG 
exhibited (a) plastic flow and the others (b) pseudoplastic flow. Arrows indicate ascending 
(      ) and descending (      ) cycles. 
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a) 
 
b) 
 
c) 
 
Fig. 7.3 The rheograms of pre-lyophilised and post-lyophilised wafer gels Flow 
charts of gels of irradiated and non-irradiated reconstituted post-lyophilised a) control 
wafers, b) silymarin (SM) wafers and c) α-lipoic acid (aLA) wafers. The wafers were 
composed of 0.07%w/v of SM or 0.06% w/v of aLA, 1.5% w/v of xanthan gum (XG) as a 
vehicle and non-ionic surfactant, Pluronic F68. Arrows indicate ascending (   ) and 
descending (      ) cycles. 
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Table 7.4 Viscosity coefficients and yield stress The viscosity coefficients 
(consistency) and yield stress (inability to flow at lower shear rates) of polymer gels, pre-
lyophilised wafer gels and post-lyophilised wafer gels were calculated using the Herschel-
Bulkley model. 
 
Fig. 
No. 
Gels Viscosity 
coefficient (Pa.s) 
Rate index Yield stress 
(Pa.s) 
7.2a 2.0% GG 
1.5% XG 
74.9 
1.8 
0.11 
0.39 
139.8 
24.6 
7.2b 5.0% SA 
3.0% KG 
7.0% GhG 
1.5% LbG 
31.9 
23.7 
2.7 
4.7 
0.44 
0.33 
0.51 
0.34 
- 
- 
- 
- 
7.3a Pre-lyophilised control gel 
Post-lyophilised control wafer gel 
Gamma (25kGy) irradiated gel 
Gamma (40kGy) irradiated gel 
2.5 
2.3 
2.9 
3.2 
0.31 
0.32 
0.29 
0.28 
18.9 
18.4 
20.2 
20.3 
7.3b Pre-lyophilised SM gel 
Post-lyophilised SM wafer gel 
Gamma (25kGy) irradiated gel 
Gamma (40kGy) irradiated gel 
2.2 
1.9 
2.8 
3.6 
0.33 
0.35 
0.31 
0.32 
19.3 
19.2 
23.2 
33.0 
7.3c Pre-lyophilised aLA gel 
Post-lyophilised aLA wafer gel 
Gamma (25kGy) irradiated gel 
Gamma (40kGy) irradiated gel 
3.3 
3.0 
1.7 
1.9 
0.31 
0.33 
0.39 
0.38 
25.2 
24.8 
25.0 
26.5 
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7.4.2 Sterilisation of wafers 
Lyophilized wafers composed of 1.5% XG, 5% SA, 2% hydroxypropyl methyl 
cellulose (HPMC) and 4% methyl cellulose (MC) were subjected to UV irradiation from 0 
to 12 J/cm2. Gels of HPMC and MC were prepared by slowly adding these polymers with 
continuous stir to pre-heated (~70 0C) distilled water in a glass beaker. The wafers were 
prepared by the same method to that of XG wafers. After UV irradiation, these wafers 
were tested for the presence of bacteria and fungi (table 7.5). Microbial colonies were 
counted to grade the level of contamination. The complete absence of colonies was 
considered as no contamination. One to 5 colonies, 6 to 20 colonies and more than 20 
colonies were graded as +, ++ and +++ respectively. Bacteria were found to be present in 
all wafers and the presence of fungi was detected in all wafers except in those made from 
MC. Gamma irradiated wafers were also tested for the presence of bacteria and fungi 
(Fig. 7.4). Bacteria and fungi were both absent in wafers irradiated with 25 and 40kGy of 
gamma rays, but present in non-irradiated control samples. 
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Table 7.5 UV irradiation Wafers prepared from different polymers were treated with UV 
radiation of different strengths and tested for the presence of a) bacteria and b) fungi. 
 
a) 
 Control 
(0J/cm2) 
0.36 
J/cm2 
0.72 
J/cm2 
1.5 
J/cm2 
3.0 
J/cm2 
6.0 
J/cm2 
12.0 
J/cm2 
XG +++ ++ ++ ++ ++ ++ ++ 
HPMC + + ++ + +++ +++ + 
MC + ++ ++ - - - + 
SA +++ +++ +++ + +++ +++ + 
 
 
 
b) 
 Control 
(0J/cm2) 
0.36 
J/cm2 
0.72 
J/cm2 
1.5 
J/cm2 
3.0 
J/cm2 
6.0 
J/cm2 
12.0 
J/cm2 
XG ++ - - + - - - 
HPMC - - + - - - - 
MC - - - - - - - 
SA - - + + - - - 
 
 
- No contamination (0 colonies)       
+       -      1 – 5 colonies 
++     -     6 – 20 colonies  
+++   -     >20 colonies 
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a) 
 
      25kGy      0kGy   40kGy 
 
 
 
b) 
 
     25kGy   0kGy    40kGy 
 
 
Fig. 7.4 Sterilisation by gamma irradiation The control, silymarin and α-lipoic acid 
wafers were prepared using 1.5% w/v of XG as a vehicle with 0.2% w/v of Pluronic F68 as 
non-ionic surfactant. They were successfully sterilised by treating with 25 and 40kGy 
gamma radiation. The gamma irradiated wafer discs did not show any presence of either 
a) bacteria or b) fungi, whereas untreated (0kGy) wafer discs were contaminated. 
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7.4.3 Quantification of silymarin in the wafers by HPLC 
 The concentration of silymarin present in gamma irradiated wafer discs was 
quantified by HPLC. The standard reference solution of silymarin was prepared by 
dissolving 0.0112g neat silymarin in 50ml of HPLC solvent as explained in 7.3.4. A series 
of solutions at different concentrations was prepared by diluting a standard reference 
solution. The range of standard solution concentrations obtained by a series of dilutions 
was between 8.96 and 89.6µg/ml. These standard solutions were used to obtain 
chromatograms with five distinguishable peaks (Fig. 7.5). The area under the curve (AUC) 
for each of the five peaks and total peak area was measured using the software (Table 
7.6). The AUC of peak 2 obtained from the different standard solutions was used to plot 
the calibration curve (Fig. 7.6). Peak 2 data was used as it was the most prominent of all 
peaks. The calibration curve of the standard solutions showed good linearity (correlation 
coefficient = 0.986). 
The molecular weight of SM and aLA is 482.44 and 206.33Da respectively. Each 
small disc added to 2.5ml of medium in a well weighs ~1.5mg. This 1.5mg wafer disc 
contained either 0.06mg of SM or 0.052mg of aLA in order to achieve the final 
concentration of 50 or 100µM respectively in 2.5ml of media. Silymarin alone was 
quantified as it was used in measuring the migration of HMVECad (Chapter 6). 
 The sample solutions were prepared by dissolving SM wafer discs in HPLC 
solvent. Weight of two each of non-irradiated, 25 and 40kGy irradiated wafer discs was 
noted and dissolved in 5ml of HPLC solvent so that they have a theoretical or expected 
concentration of 79.7, 78.05 and 85.37µg/ml respectively (Table 7.7). These sample 
solutions were run through the HPLC and AUC of peak 2 was used to quantify the 
silymarin present. The regression equation (y = 15994x – 45718) obtained from the 
calibration curve suggests that the silymarin present in non irradiated, 25 and 40kGy 
irradiated wafer discs was 71.7, 69.5 and 76.5µg/ml respectively. 
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Fig. 7.5 Chromatogram obtained from silymarin by HPLC The chromatogram was 
obtained by running a volumetric solution of silymarin (0.0112g) dissolved in 50ml of a 
solvent composed of 0.01% v/v formic acid in deionised water (32ml); methanol (6ml); and 
acetonitrile (12ml). The silymarin (50µl) solution was injected at a flow rate of 1ml/min to 
obtain five clear and distinguishable peaks at 289nm by the UV Visible detector. Numbers 
at each peak indicate the retention time (minutes) at which a peak appears on the 
chromatogram.  
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Table 7.6 Calculation of area under curve (AUC) The chromatograms obtained by 
HPLC contain five peaks due to standard and sample wafer disc solutions. The AUC for 
these peaks was calculated using Jasco Borwin 15.0 software.  
 
 
Concentration of 
silymarin (µg/ml) 
AUC (data in thousands) 
Total 
area 
Peak 
1 
Peak 
2 
Peak 
3 
Peak 
4 
Peak 
5 
Std 1 8.96 449.1 31.9 155.6 24.4 86.8 150.4 
Std 2 17.92 602.9 30.4 262.1 27.2 91.4 191.8 
Std 3 26.88 860.9 50.4 378.1 44.5 125.0 262.6 
Std 4 35.84 1164.2 72.9 489.4 66.4 180.1 355.4 
Std 5 44.8 1382.4 82.7 586.8 77.2 209.7 425.9 
Std 6 89.6 3570.5 234.7 1436.4 219.8 579.4 1100.0 
Sample 1 
0kGy 
- 3271.6 217.9 1102.3 173.4 544.6 1233.4 
Sample 2 
25kGy 
- 2934.0 142.1 1066.1 103.3 679.7 942.6 
Sample 3 
40kGy 
- 3503.8 183.2 1178.2 150.2 676.4 1315.8 
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Fig. 7.6 Quantification of silymarin in lyophilised wafer discs The calibration curve 
was obtained from silymarin standard solutions. The data from peak 2 was used to plot 
the calibration curve. The concentration of the silymarin present in the sample wafer discs 
was calculated from the regression equation. 
(Key: ● standard solutions, ▲ 25kGy irradiated SM wafer discs, x non-irradiated wafer 
discs and ж 40kGy irradiated wafer discs) 
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Table 7.7 Quantification of silymarin Peak 2 AUC was used to quantify the silymarin 
present in sample wafer disc solutions. The sample wafer disc solutions were prepared 
from non-irradiated, 25 and 40kGy irradiated wafer discs.   
 
 
Weight of the 
wafer discs in 
solvent 
(mg/ml) 
Measured 
concentration of 
silymarin  (µg/ml) 
(y = 15994x – 45718) 
Theoretical 
concentration of 
silymarin (µg/ml) 
Area under 
the curve for 
peak 2 
Std 1 - - 8.96 155644.2 
Std 2 - - 17.92 262053.5 
Std 3 - - 26.88 378076 
Std 4 - - 35.84 489391.8 
Std 5 - - 44.8 586805 
Std 6 - - 89.6 1436422 
Sample1 
(0kGy) 
2.0 71.7 79.7 1102258 
Sample2 
(25kGy) 
1.9 69.5 78.1 
1066145 
 
Sample3 
(40kGy) 
2.1 76.5 85.4 
1178273 
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7.4.4 Effect of silymarin wafer discs on the migration of HMVECad 
 The control and silymarin wafer discs were prepared as detailed in 7.3.1. Gamma 
irradiated wafer discs were used to assess their effect on the migration of HMVECad. The 
effect of the control wafer discs on the migration was assessed by placing 1 or 3 or 5 
discs in each well of a 6 well plate seeded with a circular monolayer of HMVECad. 
The net migration (µm) of endothelial cells (Fig. 7.7) in N5mM condition with no 
discs (24 h: 105.8 ± 0.6, 48 h: 160.9 ± 1.7), 1 disc (24 h: 101.4 ± 1.1, 48 h: 175.1 ± 1.1), 3 
discs (24 h: 101.9 ± 0.6, 48 h: 165.2 ± 1.2) and 5 discs (24 h: 111.8 ± 1.9, 48 h: 172.9 ± 
1.2) was found to be significantly (p<0.001) more than that of N20mM condition for no 
discs (24 h: 96.6 ± 1.1, 48 h: 138.7 ± 1.1), 1 disc (24 h: 92.6 ± 0.9, 48 h: 155.3 ± 0.7), 3 
discs (24 h: 86.1 ± 0.9, 48 h: 155.9 ± 0.5) and 5 discs (24 h: 90.9 ± 1.3, 48 h: 146.5 ± 1.1). 
These results confirm that the control wafers (i.e. 1.5% w/v XG + 0.2% w/v F68) on their 
own did not alter the migration when glucose concentration was altered. 
The migration (µm) of cells (Fig. 7.8) from the intact edge in the presence of 
silymarin wafer discs in N5mM (24 h: 82.7 ± 2.1, 48 h: 143.3 ± 3.0) condition was not 
different (p>0.05) than in N20mM (24 h: 89.7 ± 1.7, 48 h: 156.7 ± 3.1) condition. Similarly, 
the migration of cells was not different (p>0.05) in H5mM (24 h: 103.7 ± 1.9, 48 h: 168.7 ± 
2.5) condition compared to H20mM (24 h: 98.7 ± 1.7, 48 h: 171 ± 2.5) condition. However, 
the migration in H5mM condition was significantly higher (p<0.001) than in N5mM 
condition. A similar pattern of migration was observed for cells migrating from the 
wounded edge of the same monolayer (N5mM; 24 h: 101.6 ± 2.6, 48 h: 194 ± 4.6, 
N20mM; 24 h: 109.6 ± 2.3, 48 h: 184.6 ± 2.8, H5mM; 24 h: 132.4 ± 2.9, 48 h: 207.8 ± 3.6 
and H20mM; 24 h: 129.7 ± 2.4, 48 h: 203.4 ± 2.8). Unlike the intact edge, the migration 
from the wounded edge in N20mM condition was higher (p<0.05) compared to N5mM 
condition. 
Control wafer discs produced a migration (µm) similar to that of the vehicle 
controls detailed in previous chapter 6. The migration of HMVECad (Fig. 7.8) from the 
intact edge of the semicircular monolayer in N5mM condition (24 h: 89 ± 2.1, 48 h: 139.8 ± 
1.9) was significantly (p<0.001) higher than in N20mM (24 h: 77.4 ± 1.8, 48 h: 125.6 ± 2.6) 
condition. The migration in H5mM (24 h: 112.1 ± 3.1, 48 h: 165.5 ± 4.9) condition was 
much higher (p<0.001) than in N5mM condition. High glucose concentration combined 
with hypoxia (H20mM) (24 h: 93.9 ± 1.8, 48 h: 145.1 ± 2.8) significantly reduced (p<0.001) 
the migration of cells compared to those in H5mM condition. The migration of endothelial 
cells from the wounded edge of the monolayer (N5mM; 24 h: 115.7 ± 2.6, 48 h: 174.1 ± 
3.6, N20mM; 24 h: 100.8 ± 2.3, 48 h: 152.7 ± 2.6, H5mM; 24 h: 136.2 ± 2.9, 48 h: 203.4 ± 
4.5 and H20mM; 24 h: 117.6 ± 1.8, 48 h: 172.5 ± 2.2) was similar to that from the intact 
edge with similar levels of significance. 
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Fig. 7.7 Effect of control wafer discs on the migration of HMVECad The migration due 
to control wafer discs (1.5%w/v XG + 0.2%w/v Fluronic F68) was carried out in conditions 
of 5mM or 20mM glucose and 20% (Normoxia – N) oxygen tension. The migration was 
assessed by the radial migration assay. The control wafer discs did not alter the migration 
when the glucose level was increased. The results are presented in microns as net 
migration (mean ± SEM) (n=60) of cells at 24 (a) and 48 h (b) and analysed by 
independent t test. 
(***p<0.001 when compared with N5mM condition of respective disc numbers) 
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Fig. 7.8 Effect of silymarin wafer discs on the migration of HMVECad The migration 
of cells from intact and wounded edges in conditions of 5mM or 20mM glucose and 20% 
(Normoxia – N) or 5% (Hypoxia – H) oxygen tension was assessed by the wound healing 
assay. The silymarin wafer discs successfully overcame the negative effects of high 
glucose. The cells migrating from the wounded edge were significantly faster (p<0.001) 
than their counterparts from the intact edge for all the conditions and treatments. The 
migration due to control wafer discs resulted in trends similar to those of vehicle control 
wherein high glucose resulted in the reduction during both normoxia and hypoxia. The 
results are presented in microns as net migration (mean ± SEM) (n=90) of cells at 24 (a) 
and 48 h (b) and analysed by analysis of variance (ANOVA) followed by Bonferroni post 
hoc test. 
(*p<0.05 and NS = not significant when compared as indicated) 
(Control wafers: Intact & wounded edge, 24&48 h, N5mM = 80, H5mM = 60, H20mM = 80; 
SM wafers: Intact & wounded edge; 24&48 h, N5mM = 60, H5mM = 80 and H20mM = 80) 
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7.5 Discussion 
 The viscosity coefficient and yield stress of freeze dried silymarin wafers increased 
after gamma ray sterilisation. Sterilised wafers containing silymarin exhibited plastic flow 
and the drug content remained largely unaffected by ionising gamma rays. High 
performance liquid chromatography was used to quantify the silymarin present in sterile 
and non-sterile wafer discs. The migration due to silymarin present in the wafer discs was 
comparable to that of neat drug. 
The preparation of freeze dried wafer discs involved XG as a vehicle and non-ionic 
surfactant Pluronic F68 as both silymarin and aLA are water insoluble drugs (table 7.1). 
Matthews et al. (2008) successfully used XG along with non-ionic surfactant to prepare 
the freeze dried wafers of a water insoluble MMP-3 inhibitor (Matthews et al. 2008). The 
discrepancies observed between the calculated contents with that of mean weight of each 
(table 7.1) freeze dried wafer might be due to either a combination of residual water 
content and absorbed moisture as observed in a previous study (Matthews et al. 2005) or 
due to the loss of a part of wafer while peeling the wafer out of a well in which they were 
cast. The doses were calculated so that each wafer disc of SM and aLA produced 50 and 
100µM respectively when placed in 2.5ml of medium of a well of six well plate. 
 The rheological studies help to design the freeze dried products to achieve 
suitable consistency when applied to the wound site. Gels prepared from XG and GG 
exhibited plastic flow whereas other gums including SA exhibited psuedoplastic flow (Fig. 
7.2). This is consistent with earlier findings where flow curves of XG gel alone and in 
combination with varying concentration of methyl cellulose have a small yield value and 
flow curves of SA pass through origin (Matthews et al. 2005). Although the viscosity 
coefficient and yield stress exhibited by XG was much lower than that of GG, XG was 
used as a vehicle to prepare the lyophilised wafers. Xanthan gum was chosen over other 
natural polymers as it produces the right amount of consistency so that the topical 
application will have sufficient residence time at the wound site. Sufficient residence time 
of topical application is critical in the delivery of a drug (Jones, Lawlor and Woolfson 
2003). The expected enhancement in residence time by XG could be due to yield stress 
exhibited by XG which delays or inhibits viscous flow (Matthews et al. 2006). The pre-
lyophilised gel of the control wafer containing XG and Pluronic F68 was more viscous than 
XG alone but the yield value was lower. This indicates that non-ionic surfactant could be 
acting as a viscosity enhancer. Another added advantage of using XG as a vehicle in the 
preparation intended for wound management is its ability to withstand ionising gamma 
rays while undergoing sterilisation. 
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Sterilisation of potable water and clothing in operating theatres by UV irradiation 
has been in use for some time now (Taylor, Bannister and Leeming 1995, Zimmer and 
Slawson 2002). Attempts to sterilise the wafers by UV rays however, did not yield the 
desired results (table 7.5). The reason for this needs further assertion. This could possibly 
be due to either the failure of UV rays to penetrate wafers or the failure of polysaccharides 
to absorb UV rays and disrupt the microbes. This necessitated the search for other 
sterilisation methods. 
Silymarin and aLA wafer discs (Fig. 7.4) were sterilised at 25 and 40kGy of 
gamma rays which are normal dose rates for sterilising medical devices. However, lower 
doses used in sterilising products such as bone allografts can be explored (Nguyen, 
Morgan and Forwood 2007). The flow properties were investigated after gamma ray 
sterilisation in order to understand the possible changes ionisation might inflict on the 
polymers and active constituents. It is evident from the results (Fig. 7.3 & table 7.4) that 
reconstituted gels from XG wafers and SM wafers showed a small dose dependant 
increase in their viscosity coefficient and yield stress values upon gamma irradiation. 
These observations are in agreement with previous observations where gamma irradiation 
of XG resulted in a small increase in yield stress (Hanna et al.  1997). The antioxidant 
activity of SM might be acting synergistically in avoiding polymer chain scission by gamma 
rays, as antioxidant such as ascorbate are known to protect blood products against 
degradation by gamma rays (Zbikowska, Nowak and Wachowicz 2006). In contrast, the 
viscosity coefficient of reconstituted gels of sterile aLA wafers was decreased compared 
to non-sterile gels, but yield stress remained unchanged. This anomaly, along with the full 
potentials of other polymers as a suitable vehicle in preparing freeze dried products and 
their ability to remain stable during the sterilization process remains to be explored. 
It has been observed from chapter 6 that silymarin produces its effects against 
glucose induced decrease in cell migration at 50µM concentration. The quantity of 
silymarin present in individual wafer discs was assessed by comparing the sample 
solutions against the standard curve of known concentrations of silymarin by HPLC (Table 
7.6 & 7.7). HPLC has been used to quantify the different components of silymarin and 
further to establish its pharmacokinetic profile in human plasma in conjunction with other 
analytical methods (Quaglia et al. 1999, Wen et al. 2008). The different components of 
silymarin were separated and detected as five separate peaks (Fig. 7.5) at retention times 
of 3-18min which was different from earlier observations at 289nm (Quaglia et al. 1999). 
Peaks were not assigned to the components of silymarin due to their complex chemical 
nature and were simply referred as peak 1 to 5. Area under the curve of peak 2 was used 
to establish the standard curve and to calculate the concentration of silymarin in samples 
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as it was a predominant peak among others even at lower concentrations (Table 7.6, 7.7 
and Fig. 7.6). 
 Neither the presence of a single control wafer disc or an increase in their number 
altered the migration trends as the presence of high glucose continued to decrease the 
migration (Fig. 7.7 & 7.8). This confirms that unlike chitosan which has been reported to 
induce changes in wound healing (Mizuno et al. 2003), XG did not produce any effect on 
its own. The silymarin wafer discs were prepared so that each disc contained silymarin 
equivalent to 50µM when placed in a well containing 2.5ml of medium. However, the 
concentration of silymarin present in the wafer discs quantified by HPLC (table 7.7) 
suggested that one disc with an average weight of 1.5mg contained 10-11% less silymarin 
than expected. This could possibly be due to faulty readings obtained by HPLC as a result 
of non-homogenous dispersion of silymarin in xanthan gel or due to water content of 
wafers. It has been proved that water or moisture content in lyophilised wafers could be as 
high as 10-15% w/w (Matthews et al. 2005). This would mean that silymarin content could 
possibly be 10-15% less than expected. However, this decrease in the dose of silymarin 
did not adversely affect the migration of cells (Fig. 7.8). Similar to neat silymarin, as found 
in chapter 6, wafer discs containing the drug successfully prevented the decrease in 
endothelial cell migration due to elevated glucose levels both in normoxia and hypoxia. 
7.6 Conclusion 
Silymarin was successfully formulated as freeze dried wafer discs and sterilized by 
gamma radiation. The sterile freeze-dried discs containing silymarin retained their effect of 
restoring the migration of cells against the elevated glucose concentration both in 
normoxia and hypoxia. 
7.7 Further work 
 This pilot study established the method of formulating the silymarin into a freeze 
dried product. Qualitative and quantitative analysis of silymarin would be aided further by 
characterisation of wafers and gels by the use of differential scanning calorimetry (DSC) 
for thermal analysis, particle size distribution, vapour content and physical structure of 
wafers by scanning electron microscopy. The project would also benefit from studies on 
long term stability and drug release profile of silymarin in the freeze dried form. 
Furthermore, the effect of gamma sterilisation on the stability of the active ingredients 
needs further investigation by different analytical methods such as nuclear magnetic 
resonance (NMR) and liquid chromatography - mass spectra (LC-MS). 
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8.1 Discussion 
 The Diabetes Control and Complication Study (DCCT) and the United Kingdom 
Prospective Diabetes Study (UKPDS) have established that elevated glucose 
concentration is responsible for the onset and progression of the vascular complications of 
diabetes (DCCT Group 1993, UKPDS Group 1998). The presence of elevated glucose 
concentration interferes with hypoxia induced angiogenesis leading to a delay in wound 
healing for patients suffering from diabetes mellitus (Falanga 2005). Hypoxia is an 
essential stimulant for angiogenesis including endothelial cell migration during wound 
healing as well as cancer (Carmeliet 2005). The findings of this thesis suggest that the 
hypoxia and hyperglycaemia have opposing effects on the migration of endothelial cells. 
Hypoxia, as expected, increased the migration whereas the presence of higher 
concentration of glucose hindered the migration of endothelial cells. The deleterious 
effects of high glucose were mediated through HIF-1α protein and the migration was 
restored by the use of an anti-oxidant, silymarin. The strategy of developing a topical 
application resulted in a successful development of freeze dried wafer discs containing 
silymarin which prevented the deleterious effects of high glucose on migration.   
 In vitro migration of cells can be investigated using different methods (Auerbach et 
al. 2003, Eccles, Box and Court 2005). The scratch wound assay is one of the most 
widely used assays. We were interested in developing a method which would help to 
understand the influence of wounding a cell monolayer on the migration of cells not only 
from the wounded edge but also from the intact edge. A scratch wound assay is of no help 
in this regard as there is no intact edge as the scratch wound would be made on a 
confluent monolayer. Recently Dolle et al. (2005) used an omni-directional migration 
assay which was an improvement of previously designed assays by others (Dolle et al. 
2005). The omni-directional assay depends on the accuracy of placing glass rings on pre-
marked circles underneath each well of a six well plate and any changes would lead to 
non usability of the data generated. This omni-directional assay was based on optimising 
a method explained by Dixit and co-workers (Dixit et al. 2001). Dixit et al. (2001) 
measured the area of a circularly seeded monolayer at the starting time point and seven 
days later at an end time point. The radii were calculated from the difference in the 
approximate area of a monolayer at an end time point and area of a steel ferrule (used to 
cast the cells into a circular monolayer) at a starting time point (Dixit et al. 2001). The 
authors considered the approximation of area of a circular monolayer at an end time point 
possibly due to the lack of image analysis tools to analyse the exact area during the time 
of their study. The radial migration assay detailed in section 2.2.3 of chapter 2 of this 
study is a further improvement of the omni-directional assay explained by Dolle et al. 
(2005) and Dixit et al. (2001). Unlike the earlier methods, the radial migration assay 
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method developed in this thesis provides the flexibility of seeding the cells anywhere 
within a confined area of a glass ring and allows the measurement of an exact area or 
radii of monolayer using image analysis software. Once the radial migration assay was 
developed (after numerous trials and errors as discussed in chapter 3), it easily lent itself 
to develop the wound healing assay as explained in section in 2.2.4 of chapter 2. The 
wound healing assay explained in this thesis was able to not only determine the migration 
of cells from the intact and wounded edge together in one model as envisioned but to the 
best of our knowledge is also a novel method. Furthermore, the choice of 5% oxygen 
tension for the hypoxic conditions used in this study was chosen as the upper limit at 
which hypoxia mediated responses were operating and prior to induction of anoxia 
(Pouyssegur, Dayan and Mazure 2006). The results presented here demonstrate that this 
was sufficient to enhance cell migration and also activate HIF-1α. So these conditions 
were used throughout the study. 
The results of all the chapters clearly suggest that the ECs from the wounded edge 
migrated faster than their counterparts from the intact edge. In the light of these results, it 
could be argued that the wounded surface and un-wounded surface on which cells 
migrate, influences the rate and direction of migration. The migration of cells from the 
intact edge resembles endothelialisation simulating neo-angiogenesis or vasculogenesis 
whereas that from the wounded edge resembles re-endothelialisation simulating 
angiogenesis. Endothelial cells participating in endothelialisation demonstrated 
directionality with a basal speed (i.e. velocity) whereas those participating in re-
endothelialisation have directionality and increased speed (i.e. increased velocity). The 
increased velocity in endothelial cell migration from the wounded edge could be due to 
active crawling of stalk cells lining up behind tip cells at the edge, faster formation of 
lamellopodia and rearrangement of cytoskeletal structure in the leading edge of the 
migrating tip cells (Farooqui and Fenteany 2005, Lee and Gotlieb 2003). Along with these 
factors we suspect that the denuded surface might be acting as a ‘matrix’ and induces or 
enhances the haptotaxis. Furthermore, the release of soluble cues from ‘wounded’ cells 
might also be influencing the chemotaxis which needs further exploration. Chemotaxis 
and haptotaxis could be acting additively to increase the migration from the wounded 
edge compared to that from the intact edge. It would of interest to develop this by 
characterisation of the factors involved in inducing cell migration. 
The glucose dependent decrease in endothelial cell migration observed in this 
study contrasts with enhanced migration of retinal endothelial cells due to high glucose 
observed during diabetic retinopathy (Aiello et al. 1994, Huang and Sheibani 2008). This 
illustrates the importance of the source of endothelial cells and also demonstrates a 
rationale for the variety of vascular complications exhibited in the diabetes. In this study, 
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the intracellular processes that are involved in the observed changes in cell migration due 
to hypoxia and/or high glucose demonstrated the following; 
- The role of p27Kip1 in cell migration was inconclusive but the differences in 
expression profile of cells within the wound healing model highlight the need 
for further in-depth investigation. 
- Activation of PKCβII was central to the hyperglycaemia induced decrease in the 
migration of ECs and supports the notion of glucose mediated activation of 
ROS (This was further supported by the work using silymarin). 
- Activation of p42/p44 MAPK was required for high glucose mediated changes 
in cell migration. 
- The PI3K pathway was required for the hypoxia induced increase in EC 
migration. This could be due to the hypoxia induced activation of growth 
factors. 
- HIF-1α appeared to be a common factor between both hypoxia and 
hyperglyaecemia affected cell migration. 
 
Increased concentration of glucose is known to lead to the production of ROS in 
endothelial cells and has been proposed as a unifying mechanism for four different 
metabolic pathways of excessive glucose metabolism which are increased flux of glucose 
through polyol and hexosamine pathway, increased production of AGEs and activation of 
the PKC (Brownlee 2005, Nishikawa et al. 2000). Use of anti-oxidants has successfully 
prevented some of the deleterious effects of high glucose produced by ROS which were 
mediated through the over activation of PKCβII (Gallo et al. 2005, Kunisaki et al. 1994). 
Therefore we also used an anti-oxidant, silymarin which was able to prevent the glucose 
mediated decrease in the cell migration.  To our knowledge, there are no reports of using 
silymarin in preventing the deleterious effects of glucose on the migration although 
another anti-oxidant, thiamine has been successfully used in bovine aortic endothelial 
cells to overcome the glucose induced decrease in cell migration (Ascher et al. 2001).  
 Silymarin was formulated as a freeze dried wafer once it was confirmed to restore 
the reduced migration due to high glucose. This has potential for more direct therapeutic 
use as a topical application to wounds. The ability of freeze dried wafers to retain the 
effectiveness of the drug is an important finding and will be further investigated in future 
projects to realize the larger goal of a development of a suitable formulation for chronic 
wounds of diabetes. The following cartoon summarizes the findings of this thesis; 
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Fig. 8.1 Summary of the findings High glucose concentration attenuates the migration of 
HMVECad by over production of ROS and over activation of PKCβII which could be 
interfering with the stabilisation, translocation and transcriptional activities of HIF-1α. 
Silymarin treatment mimicked the effect of PKCβII inhibitor by restoring the migration of 
cells via its anti-oxidant activities. On the other hand, hypoxia and growth factors such as 
VEGF increase the migration by increasing the stability and transcriptional activity of HIF-
1α, which might be mediated through PI3K-Akt pathway. 
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8.2 Conclusion 
 Hypoxia and hyperglycaemia have an opposing effect of the migration of 
microvascular endothelial cells of dermal origin. Hypoxia increased and hyperglycaemia 
decreased the migration of cells. The change in migration response to varying 
concentration of glucose and oxygen tension appears to be mediated via multiple 
molecular pathways. Hypoxia appears to increase the migration via activating PI3K 
pathway whereas hyperglycaemia appears to decrease the migration due to the 
overproduction of ROS and activation of PKCβII pathway. HIF-1α seems to be a common 
link between the two which is activated in presence of hypoxia and its activity is hindered 
in the presence of high glucose. Anti-oxidant effects of silymarin seem to be successful in 
restoring the high glucose induced reduction in the migration of cells. Silymarin formulated 
as a freeze dried wafer disc retained its effectiveness against the deleterious effects of 
high glucose concentration. 
8.3 Future work 
a) Relationship between the migration and proliferation need further investigation 
as we and others observed that the migration and proliferation although 
interlinked might not be occurring simultaneously in a cell of a monolayer 
(Gerhardt et al. 2003). This could be further ascertained by staining the cells 
for mitosis markers such as phospho-histone or Ki67 which would help to 
understand the proliferation status of stalk and tip cells of a monolayer. 
b) The link between HIF-1α and hypoxia/hyperglycaemia affected migration, 
although established to some extent, would benefit further by the use of other 
molecular biology techniques such as anti-sense technology or use of siRNA to 
establish a direct link between them.  
c) The role of HIF-1α and small GTPases such as RhoA, Rac1 and cdc42 in 
mediating the migration may not be independent of each other. Establishing a 
link between these two would enhance the understanding of the effects of the 
diabetic milieu on the angiogenesis of wound healing. 
d) Mechanistically, on reflection, it would have been beneficial to assess the role 
of both p38 along with p42/p44 MAPK pathways in mediating the 
migration/proliferation during hyperglycaemia. As the role of PI3K-Akt pathway 
produced pro-migratory effects in hypoxia was established, it would be 
interesting to understand the effect that different isoforms of PI3K have in the 
regulation of migration. Further, the role of PI3K-Akt in mediating the high 
glucose induced decrease in cell migration should be further explored. The 
greatest paradox about the effect of hyperglycaemia on the migration and by 
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that extension on angiogenesis is that of the contrast between decrease in 
wound healing process and increase in proliferative diabetic retinopathy. 
Clearly, the environment and cell origin will have some bearing but it may be 
that the relative levels of hypoxia and hyperglycaemia differs between the two 
conditions. It would be of a great interest to study the effect of hyperglycaemia 
on the migration/proliferation of microvascular endothelial cells of dermal and 
simultaneously of retinal origin. In this respect the role of PKCβII would be 
interesting to ascertain as ruboxistaurin (a PKCβ inhibitor – developed by Eli 
Lilly) came up to the stage of approval before it was withdrawn by the company 
for its use in proliferative retinopathy (Anonymous 2007). 
e)  Molecular mechanism/s through which silymarin produces its effect also needs 
investigation. The development of freeze dried wafers as a suitable formulation 
would benefit from future work of testing them on an in vivo model of wound 
healing. 
 
It is a continuous and arduous task to develop a suitable formulation containing a 
therapeutic agent (á la magic pill) for chronic wounds of diabetes, as wound healing itself 
is a complex process and the presence of diabetes further complicates the picture. While 
it is recognised that this complexity exists and has also been demonstrated by this study, 
it also illustrates that the combination of mechanistic and therapeutic study provides some 
hope for resolution in a clinical context. This is a challenge for the combination of multiple 
disciplines of biomedical sciences, but it may also be paraphrased as a ‘juggernaut’ which 
takes a lot of energy to initiate movement, but once moving, the power of its size and 
impact fully evident. 
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